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Nucleotide excision repair (NER) is a dominant pathway in the repair of 
DNA damage, which removes DNA lesions caused by u.v. light and bulky chemical 
adducts. Mutations in NER genes give rise to the human inherited diseases 
xeroderma pigmentosum (XP), Cockayne's syndrome and trichothiodystrophy. In 
NER, ERCC1 acts as structure-specific endonuclease in a complex with XPF. This 
complex is also involved in recombination events. This laboratory has previously 
reported the first NER-deficient mouse model, the ERCC 1-deficient mouse. The 
main aims of this work were to set up two new mouse models, by conventional and 
conditional gene targeting, to investigate the functions of ERCC 1, which has not, 
thus far, been associated with any known human disorders. 
To facilitate gene targeting studies, a series of overlapping ERCC 1 genomic 
clones were retrieved from a bacteriophage library. Analysis of the mouse ERCC 1 
5 '-flanking region revealed a novel transcription initiation site. Furthermore, several 
potential liver- and brain- specific transcription factor binding sites were present. 
A novel ERCC 1-deficient mouse line, designated KT#209, was generated by 
the targeted deletion of the ERCC 1 exon 3-5 region. In addition to the aberrant 
nuclei in the KT#209 ERCC 1-I- livers, as reported in previous ERCC 1 knockouts, 
we also found microvesicular steatosis and mitochondrial abnormalities in livers of 
both our ERCC 1-deficient lines. These findings suggested that oxidative stress may 
damage nuclear and/or mitochondrial DNA, leading to the abnormal lipid deposits. 
We also found that other repair proteins (MSH2, PMS2 and PCNA) and an 
immediate early gene product, c-fos, were elevated in both ERCC 1-deficient liver 
extracts. A delay in cerebellar development was found in both our ERCC 1-deficient 
lines and the possibility of a cerebellar disorder was investigated. Also, we have 
demonstrated that some thymocyte markers were changed in flow cytometnc 
profiles, suggesting a possible role for ERCC 1 in V(D)J recombination. 
To overcome the limitations of premature death in the ERCC 1-deficient mice, 
we used a conditional gene targeting strategy. We reconstructed a functional ERCC 1 
allele with loxP sites flanking exons 3 and 5. In vitro analysis demonstrated that the 
ERCC1 exon 3-5 region between the loxP sites was deleted after transient expression 
of Cre recombinase. We have generated mice with this foxed ERCC 1 allele, which 
xi 
will be used for Cre/loxP-mediated recombination in a tissue- and/or 
developmentally- specific manner. 
Computer analysis suggested that the ERCC1 protein might have roles in 
non-sequence-specific DNA binding and helicase function in DNA repair pathways. 
Finally, a new anti-mouse ERCC 1 antibody was generated in this project and used in 
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DNA damage induced by a broad range of agents threatens cellular integrity. 
Multiple DNA repair pathways have evolved early in evolution to protect the 
genomic stability over time. Because similar repair pathways are found in 
prokaryotic and eukaryotic cells, the extensive knowledge about Escherichia coli (E. 
coli) and Saccharomyces cerevisiae (S. cerevisiae) has facilitated studies of these 
repair mechanisms in mammalian cells. A comprehensive discussion of DNA 
damage and repair is beyond the scope of this thesis; instead, a concise description of 
the major DNA damages and principle repair pathways will be presented in this 
chapter, which will focus on nucleotide excision repair (NER), especially in the 
ER CC] gene. Furthermore, this chapter also discusses genomic instability within the 
mitochondria and repair and apoptosis in this organelle. 
Gene targeting is the most direct and unambiguous way to eliminate gene 
function and is therefore the preferred method for the direct isolation of the mutant 
phenotypes. In 1993, this laboratory reported the first nucleotide excision repair 
mouse model, ERCC]-deficient mice, by using gene targeting (McWhir et al., 1993). 
A novel ERCCJ mutant line is also described in this thesis. The principle and 
advanced usage of gene targeting are discussed in this chapter. Finally, due to the 
aneuploidy and polyploidy in the ER CC] null hepatocytes, we will briefly discuss 
the relationship between polyploidy and cell cycle. 
1.2 DNA damage 
DNA damage can be simply classified into two classes on the basis of origin: 
spontaneous damage arises as a consequence of normal cellular process such as 
replication, and environmental damage refers to lesions induced by exogenous 
factors such as ionising radiation. The variety of spontaneous alterations and 
environmental damaging agents are reviewed in Friedberg et al., 1995; Wiseman and 
Halliwell, 1996. 
Errors in base-pairing, introduced during replication are the major endogenous 
sources of spontaneous damage. Mispaired bases arise mainly by DNA biosynthetic 
errors that escape the polymerase editing functions, but mismatches also populate a 
recombination heteroduplex produced by strand transfer between related sequences 
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that have diverged at the nucleotide level. Inappropriate base pairing can also result 
from spontaneous deamination in pH-dependent reaction, which converts cytosine, 
adenine and guanine to uracil, hypoxanthine and xanthine in the DNA molecule, 
respectively. Misincorporation of uracil during DNA replication also occurs if the 
synthesis of TMP from dUMP is inhibited, which results in an increase in the 
abundance of dUTP relative to TTP and thus promotes the incorporation of uracil 
relative to thymine into DNA. Hydrolysis is responsible for the deamination of DNA 
bases (e.g., cytosine to uracil), and spontaneous hydrolysis of the glycosyl bond 
between the DNA bases and deoxyribose sugars can also result in the loss of bases, 
depurination and depyrimidination. 
Reactive oxygen species (ROS) include oxygen free radicals [superoxide (02), 
hydroxyl (OH), peroxyl (R02) and alkoxyl (RO) ], singlet oxygen (102)1,  and 
strong non-radical oxidants such as hydrogen peroxide (H 202); furthermore, nitric 
oxide (NO) and the derived peroxynitrite (ONOO) can be include in this category. 
Oxidative stress may ensue when excessive ROS are formed in living cells through 
normal metabolism, exogenous sources (from diet, alcohol, smoking, and 
irradiation), leakage from mitochondrial oxidative phosphorylation (OXPHOS), 
hydroxylation reaction by P450 cytochrome monooxygenase, degradation by 
peroxisome and action of phagocytic cells. High levels of oxygen radicals can 
detrimentally alter cellular macromolecules including lipid peroxidation products 
(e.g., n-aldehyde, malondialdehyde), prostaglandin F 2-like compounds (e.g., 8-
isoprotanes), DNA-hydroxlation products [e.g., 8-hydroxy-2 '-deoxyguanosine (8-
OH-dG), thymine glycol (TG)], and protein hydroxylation products, such as oxidised 
amino acids. 
Exogenous DNA-damaging agents can be subdivided into physical agents 
(ionising irradiation and ultraviolet light) and chemical agents. The deposition of 
energy from ionising radiation (such as y rays and X rays) can produce potentially 
lethal double- and single- strand breaks in DNA; it can also lead to production of 
reactive oxygen species. 
''02 is a derivative of molecular oxygen is which all valence electrons are spin paired. It differs from 
ground state (triplet) molecular oxygen in the reversal of the spin direction of one electron in the 
outermost valence shell. 
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Ultraviolet (UV) damage results in several types of DNA photoproducts which 
are responsible for induction of mutations and development of skin cancer. Two 
major types of DNA lesions induced by LTVB (280-320 nm) and UVC (200-280 nm) 
irradiation are cyclobutane pyrimidine dimers (CPD) and pyrimidine (6-4) 
pyrimidine photoproducts [(6-4)photoproducts, (6-4)PPs]. In addition, UV 
irradiation produces, though at much lower frequency, pyrimidine monoadducts, 
purine dimers and a photoproduct between adjacent A and T bases. CPDs are 
formed between the 5,6 bonds of any two adjacent pyrimidines: 5'-TpT, 5'-TpC, 5'-
CpT or 5'-CpC. (6-4)PPs are characterized by a stable bond between positions 6 and 
4 of two adjacent pyrimidines, and are most commonly seen at 5'-TpC, and 5'CpC. 
Alkylating agents are chemical compounds with affinity for nucleophilic 
centres in organic macromolecules such as DNA. The reaction of an alkylating agent 
may lead to depurinationldepyrimidination and the appearance of alkali-labile abasic 
sites. Alkylation at phosphodiester groups of the DNA backbone, 06  or N7 of 
guanine and N3 of adenine, are the most frequently encountered. Some nonpolar 
compounds such as N-2-Acetyl-2-Aminofluorene (AAF), aflatoxin, and 
benzo[a]pyrene undergo metabolic activation by the cytochrome p-450 system to 
more reactive forms, which, like typical alkylating agents, can also produce DNA 
damage. 
Cross-linking agents such as nitrogen mustard, mitomycin and cis-platinum can 
react with two opposite nucleophilic centres in the DNA duplex and result in 
interstrand cross-links. They prevent DNA strand separation and hence can 
constitute complete blocks to DNA replication and transcription. Furocoumarins 
with planar tricyclic configurations (psoralens) can also form cross-links during 
photosensitized reaction. Such changes introduce significant helix distortion, 
kinking, and unwinding of DNA. 
1.3 DNA repair 
1.3.1 Direct reversal of DNA damage 
In this repair only a single gene product and one-step reaction might be 
required for the direct reversal of DNA damage [reviewed in Friedberg et al., 1995; 
Sancar, 1996). A typical example is the monomerisation of cis-syn cyclobutane 
ru 
pyrimidine dimer via photoreactivation, which is a light-dependent process mainly 
through photoreactivating enzyme (DNA photolyase) reaction. The crystal structure 
of this enzyme from E. coli suggests that the catalytic flavin cofactor in the core of 
this protein can flip the pyrimidine dimer out of the DNA duplex. Despite the 
possible existence of DNA photolyase or photolyase-like proteins in mammals, the 
significance of this process remains to be established in higher eukaryotes. 
6 	 6 
0 -methylguanine transferase (0 -MGT) is thought to have the capacity to 
6 
remove the highly mutagenic 0 -methylguanine and other alkyl groups. The methyl 
group is transferred from the DNA to a cysteine residue on this enzyme to form S- 
6 
methyl cysteine and result in permanent inactivation of 0 -MGT. This process plays 
an important role in maintaining genomic integrity against alkylating agent attack. 
1.3.2 Base excision repair (BER) 
BER protects cells from DNA damage induced by hydrolysis, ROS, ionising 
radiation and strong alkylating agents; generally, it removes relatively small lesions 
that do not substantially distort the DNA helix (reviewed in Friedberg et al. 1995; 
Krokan et al., 1997; Lindahi et al., 1997; Wilson, 1998). This repair system includes 
several types of glycosylase that remove the modified bases by cleavage of the base-
sugar glycosidic bond, leaving noncoding apurinic/apyrimidinic (AP) sites in DNA. 
The AP site is further processed by AP endonuclease, which cleaves the DNA 
backbone generating a 3'-hydroxyl group and a deoxyribose-phosphate (dRP) moiety 
at the 5'-terminus. After this incision has been made, a higher eukaryote can repair 
abasic sites using at least two distinct pathways: the short patch (1-nucleotide gap 
filling) and the long patch (2-6 nucleotide resynthesis) BER. In the short patch 
pathway, DNA polymerase 3 (pol3) has an intrinsic AP lyase activity that removes 
5'-dRP by 13-elimination, and then fills the single-nucleotide gap; thereafter the nick 
is sealed by the DNA ligase IIJIXRCC 1 heterodimer or other ligase to complete 
repair. Alternatively, the long patch BER requires PCNA and pol ö or 13 in the 
resynthesis step and DNase IV (FEN-1) to remove a flap DNA substrate. In this 
pathway, the DNA is finally ligated by DNA ligase I (Klungland and Lindahl, 1997) 
Recently, investigators suggest that two human glycosylases, hNTHI (a human 
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homolog of E. coli endonuclease III) and hOGG1 (8-oxoguanine DNA glycosylase), 
also have intrinsic AP lyase activities which introduce a DNA strand break 3' to the 
baseless sugar even in the absence of poi (Aspinwall et al., 1997; Hilbert et al., 
1997; Boiteux and Radicella, 1999). Moreover, a nucleotide excision repair enzyme, 
XPG, may serve as a cofactor to improve the binding activity of hNTH1 with regard 
to repair of oxidative DNA damage (Kiungland et al., 1999). (Figure 1.1). 
1.3.3 Mismatch repair (MMR) 
MMR contributes to genomic stability by correcting single-base mismatches 
and short insertion/deletion mispairs, generated as a consequence of DNA replication 
errors and homologous recombination (reviewed in Modrich, 1997; Fishel, 1998; 
Jiricny, 1998; Kolodner and Marsischky, 1999). In E. coli, the MutS protein 
recognises the DNA lesions and further interacts with MutL to activate a sequence-
specific endonuclease MutH, which nicks the unmethylated daughter strand of DNA 
at hemimethylated GATC sites about 1-2 kb distance away from the mismatch. A 
complex containing the MutS and MutL homodimers and probably also MutH 
molecules threads the DNA through itself in a bi-directional, ATP-dependent manner 
to generate a so-called a loop. A helicase II (UvrD) aids entry of exonuclease to 
degrade DNA in either a 3' to 5' or 5' to 3' direction from the incision, which is then 
re-synthesised by DNA polymerase III holoenzyme complex. The MMR process in 
eukaryotes resembles that of E. coli to a great extent, although it is more complex. 
Six MutS homologs (MSH1-6) and three MutL homologs (MLH1, PMS1, and 
PMS2) have been identified. Recognition of nuclear DNA mismatches is 
accomplished by two distinct heterodimers containing MSH2/MSH6 or 
MSH2/MSH3 polypeptides, whereas MSH4 and MSH5 play some roles in meiotic 
function and MSH1 has a less well characterised role in mitochondria. The 
MSH2/MSH3 complex functions in the preferential repair of 2-4 bp insertions and 
deletions, whereas the MSH2/MSH6 complex has a preference for removing single 
base mismatches. The recognition complex, coupled with an MLH1/PMS2 
heterodimer, again appears to involve ATP-triggered translocation. No MutH 
homologue has been determined and the mechanism of strand discrimination remains 
E. 
Figure lii Schematic representation of base excision repair pathway by human 
enzymes 
A model for the mechanism of BER pathway, adapted from Klungland et al. 
(1999). Left, XPG serves as a cofactor for the efficient function of hNTH1 for repair 
of oxidised DNA lesions such as 5,6-dihydrouracil (DI-HJ). The initial step is carried 
out by bifunctional enzyme, hNTH1, which has both DNA glycosylase and AP lyase 
activity. Right, subpathways involving single nucleotide replacement or long-patch 
replacement for removal of DNA lesions are illustrated. UDG, uracil DNA 
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a mystery in eukaryotic cells; furthermore, many details of the subsequent excision 
repair are yet unknowm. A model for human MMR is presented in Figure 1.2. 
1.3.4 DNA double-strand break (DSB) repair 
DSBs are induced by extrinsic agents such as ionising radiation and also occur 
spontaneously as an outcome of certain recombination reactions. Two main 
pathways are known to be involved in the repair of DSBs in eukaryotics: an error-
free process via homologous recombination repair (HRR) (reviewed in Kanaar et al., 
1998; Thacker, 1999; Thompson and Schild, 1999) and a homology-independent, but 
error-prone, end-to-end rejoining, which is called nonhomologous DNA end joining 
(NHEJ) (reviewed in Jeggo, 1998; Lieber, 1998; Muller et al., 1999; Smith and 
Jackson, 1999) to distinguish it from HRR. Both pathways contribute to DSB in 
yeast and mammals, but lower eukaryotes, such as S. cerevisiae, prefer to use the 
other chromosome or sister chromatid as a substrate for HRR and higher eukaryotes 
predominantly use NHEJ. Recent studies in yeast have suggested that a specific 
single strand annealing (SSA) is also involved in HRR pathway (reviewed in 
Fishman-Lobell and Haber, 1992; Davies et al., 1995). The models for HRR, SSA 
and NHEJ are presented in Figure 1.3. 
1.3.4.1 Homologous recombination repair (HRR) 
In S. cerevisiae, mutants in the RAD52 epistasis group of genes (RAD50, 
RAD51, RAD52, RAD54, RAD55, RAD57, RAD59, MREJ], and XRS2) are 
hypersensitive to ionising radiation and exhibit HRR defects. The high degree of 
conservation of the RAD52 group of genes from yeast to mammals suggests a similar 
role for these proteins. After the DSBs have been produced, a 3'-OH single-stranded 
DNA (ssDNA) overhang is generated at the end of DSBs by a nuclease and a 
helicase. The RAD55-RAD57 heterodimer and RAD52 play a crucial role to 
stimulate RAD5 1 binding to ssDNA complexed with RPA (replication protein A). 
The RAD52 has also been shown to facilitate the annealing of ssDNA during 
recombination. Another key component in this process, RAD54, contains a DNA 
helicase motif and belongs to the SWI2/SNF family. The ssDNA invades an 
unbroken double-stranded homologue to form a heteroduplex (Holliday junction), 
Figure 11.2 Suggested mechanism for mismatch correction in human cells. 
The hMSH2 protein is proposed to form a complex with either the hMSH6 or 
the hMSH3 protein. The recognition of single nucleotide mismatches is 
predominantly effected by the hMSH2-MSH6 complex, whereas the hMSH2-
hMSH3 complex preferentially recognises 2-4 bp insertions and deletions (e.g., CA-
dinucleotide loop). These complexes interact with a heterodimer of MutL 
homologues, hMLH1-hPMS2. The signal directing repair to the newly replicated 
strand is not known for eukaryotes. See text for detail. 
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and synthesis on this template reconstitutes the damaged strand. Although the real 
function of the RAD50/MRE1 l/XRS complex seems ambiguous, some data suggest 
that they are involved in both HRR and NHEJ. 
1.3.4.2 Single strand annealing 
The single strand annealing (SSA) pathway is utilised during recombination 
between repeated sequences. The first step in SSA is the same as the HRR of 
processing of the DNA ends: 5'—+ 3' degradation of DNA strand that yields single 
strand tails. It has been suggested that RAD52 is involved in annealing of the two 
complementary single stranded regions (Van Dyck et al., 1999). The RAD1 and 
RADIO complex has been implicated in the removal of heterologies from the end of 
recombination intermediates (Fishman-Lobell and Haber, 1992; Bardwell et al., 
1994; Davies et al., 1995). Moreover, some studies suggested that MSH2 and MSH3 
are also required in this process (Fishman-Lobell and Haber, 1992; Sugawara et al., 
1997). 
1.3.4.3 Nonhomologous (or illegitimate) DNA end joining (NHIEJ) 
In vertebrate cells, it appear that NHEJ is the dominant pathway during GO, 
Gl,and early S phases of the cell cycle, whereas HRR play a significant role in late S 
and G2 phases (Lieber, 1998; Sonoda et al., 1998). NHEJ is also required for repair 
of site-specific DSBs generated during V(D)J rearrangement in developing B and T 
lymphocytes2 . The DNA-dependent protein kinase (DNA-PK) and XRCC4, which 
specify functions in NHEJ-based DSB repair, have recently been isolated and 
characterised. The Ku protein component of DNA-PK is a heterodimer of 70 and 86 
kDa subunits [referred to as Ku 70 (XRCC6) and Ku 80 (XRCC5) respectively]. The 
large catalytic domain of DNA-PK is a single polypeptide of 470 kDa, termed the 
DNA-PK catalytic subunit (DNA-PKcs). This complex contains one binding site for 
DNA ends and a second binding site for double-stranded DNA internal to the ends, 
thus mediating the synapsis of the opposing DNA ends. Then broken ends in NHEJ 
can be aligned either by base-pairing interactions via microhomologies of one to nine 
2  Diversity in the T-cell receptors and immunoglobulins is achieved by the recombination 
rearrangement of multiple V (variable), D(diversity) and J(junctional) coding gene segments. This 
process is known as V(D)J recombination. 
WE 
Figure 1.3 Schematic representation of double strand break repair pathway 
In homologous recombination, processing of the double strand break is 
effected by 5'-3' exonuclease activity. The exposed 3' tail invades the homologous 
template (sister chromatid) and primes DNA synthesis to fill the gap (adapted from 
Kanaar et al., 1998). 
In single strand annealing, the heavy lines symbolise the homologous repeat 
sequences. After degradation by a single strand exonuclease, single strand tails are 
created. Annealing of the two complementary single stranded regions results in a 
structure leading to the deletion of the intervening sequence after the resolution of 
this structure (adapted from Van Dyck et al., 1999). 
Illegitimate recombination also involves processing on a break-proximal 
sequence, but to a lesser extent than homologous recombination. Small regions of 
homology (1-9 bp) may play a role in stabilising the processed termini prior to 
rejoining and ligation (adapted from Lieber, 1998). 
See text for detail. 
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nucleotides, or through protein factors that serve to bring termini into close 
proximity. Excess DNA beyond the points of microhomology can be removed either 
by an exonuclease or flap endonucleases. A flap endonuclease, FEN-1, has been 
assumed to be an appropriate enzyme (Harrington and Lieber, 1995), although its 
role in DSB repair and V(D)J recombination has not been determined. Gaps are then 
filled by DNA polymerase and the nicks sealed by ligase. Recent studies have 
pointed out that XRCC4 protein is associated with mammalian DNA ligase IV in 
cells, and may enhance DNA ligase IV activity (Critchlow et al., 1997; Grawunder et 
al., 1997). 
1.3.5 Nucleotide excision repair 
1.3.5.1 Mechanism of nucleotide excision repair 
Nucleotide excision repair (NER), which removes a wide range of structurally 
distinct DNA lesions induced by u.v. damage (CPD5 and 6-4 PPs), bulky chemical 
adducts and intrastrand cross-links, is a major repair pathway to maintain genomic 
integrity in both prokaryotes and eukaryotes. The process involves five steps: 
recognition, incision, excision, resynthesis and ligation (reviewed in Friedberg et al. 
1995; de Laat et al., 1999; Sancar, 1996; Wood, 1999). 
In E. co/i, the (UvrA)2(UvrB) protein complex firstly recognises and binds the 
distorting lesions; later it leaves only UvrB hooking onto the damage sites and 
recruits UvrC to initiate the incision on both sides: the 8th phosphodiester bond 5' 
and the 3rd or 5th phosphodiester bond 3' to the lesions. The UvrD and DNA 
polymerase I mediate the excision and synthesis, releasing the 12-13 base 
oligonucleotide with the bound Uvr complex. Finally, the resultant gap is filled by 
DNA ligase. 
In S. cerevisiae, the DNA damage site is recognised by RAD 14 and unwound 
by the helicase activity of RAD3 and RAD 25, which convert the DNA lesion into a 
substrate for S'nuclease RAD1/RAD1O complex and 3' incision by RAD2 nuclease. 
After the damaged site is removed, the repair event is accomplished by single-strand 
binding protein, replication factor C, DNA polymerase and ligase. 
In mammals, there are two strand-specific repair subpathways in NER, one is 
transcription-coupled repair (TCR) which preferentially deals with active genes in 
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the transcribed strand, and the other is global genome repair (GGR) that removes 
DNA damage independent of the transcriptional status in the genome. Defective 
GGR and TCR have been documented in several inherited human diseases. GGR is 
defective in xerodema pigmentosum (XP), and eight different genetic 
complementation groups (XPA to XPG and XPV) have been found on the basis of 
cell fusion studies. However, the XPV protein (DNA polymerase TI) does not play a 
role in NER and may function instead in an error-free replication process. TCR is 
defective in Cockayne's syndrome (CS) and two CS complementation groups (CSA 
and CSB) have been identified. 
Recent studies have shown that XPC-hHR23B, XPA and RPA are involved in 
the recognition step (Evans et al., 1997; Mu and Sancar, 1997; Sugasawa et al., 
1998). XPC-hHR23B complex is the earliest damage detector to initiate GGR prior 
to damage verification by XPA. Alternatively, the TCR lesions are initially detected 
by RNA polymerase II (poll) elongating complex including CSA and CSB (de Laat 
et al., 1999). Indeed, with the exception of XPC and CS proteins, TCR is believed to 
involve the same DNA repair machinery as GGR. The association of XPA with RPA 
leads to the formation of a complex which binds DNA lesions with a greater affinity 
than either protein alone (Ikegami et al., 1998; Stigger et al., 1998). Although the 
precise role of XPE still remains to be elucidated, in vitro studies suggest an XPE 
subunit p48 is involved in GGR recognition step (Hwang et al., 1998; Hwang et al., 
1999). The helicase activity of XPB and XPD with opposite polarity (3'->5' and 
5'-)~ 3' respectively) are required early in NER as they open DNA around the lesion. 
These two DNA helicases are also subunits of the TFIIH, which is comprised of nine 
polypeptides and probably plays an essential role in DNA repair, transcription, cell 
cycle progression and apoptosis. The current notion is when transcription is stalled 
at a site of damage, a transcription-repair coupling factor (TRCF), such as CS 
proteins, with high affinity for the stalled elongation complex recruits the repair 
complex (Coin et al., 1999; Riou et al., 1999; Tirode et al., 1999). 
After opening the double helix, the removal of the DNA lesion requires 
structure specific nucleases, ERCC 1 -XPF complex and XPG. XPG first makes an 
incision on the 6th ± 3 phosphodiester bond 3' from the lesion, and then the 5' 
incision occurs at 20 ± 5th phosphodiester bond from the lesion by the ERCC1-XPF 
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heterodimer. The result is the release of a 26- to 29-nucleotide oligomer (Huang et 
al., 1992; Moggs et al., 1996; Sijbers et al., 1996). From protein-protein interaction 
studies, XPA and RPA proteins can recruit both ERCC1-XPF complex and TFIIH, 
and XPG may interact with several TFIIH subunits (Li et al., 1994; Saijo et al., 1996; 
Nocentini et al., 1997; de Laat et al., 1998). Following the excision events, the 
resynthesis step is accomplished by DNA polymerase 5 and/or c, PCNA and RFC, 
and finally the nick is joined up by DNA ligase I (LIG1) (Figure 1.4). 
1.3.5.2 Mammalian NER genetics 
NER genes have been extensively investigated in two mammalian cell systems: 
one consists of cell lines derived from XP, Cs and TTD patients and the other 
comprises a series of mutant rodent cell lines, the majority originate from Chinese 
hamster ovary (CHO) cells, generated by exposure to mutagenic agents such as 
methyl methanesulfonate or u.v. light. Eleven rodent complementation groups 
(RCG1 to 11) have been isolated and the human genes correcting rodent repair 
defects are called excision repair cross-complementing (ERCC) genes. Among these 
genes, ERCCJ, ERCC2 (XPD), ERCC3 (XPB), ERCC4, ERCC5 (XPG), ERCC6 
(C5B), ERCC8 (CSA) and ERCC]1 (XPF) have been cloned. Recently, XPV has 
been identified as DNA polymerase r (Masutani et al., 1999a, 1999b). A 
comparison of core NER factors in different species is summarised in Table 1.1. 
Table 1.1 Core proteins involved in nucleotide excision repair 
Function F. co/i S. ct'revisiae Human 
Recognition UvrA2B RADI4 XPA, XPC-hHR23B 
Unwinding UvrB TFIIH TFIIH 
3' incision UvrC RAD2 XPG(ERCC5) 
5' incision UvrC RADI/RADIO ERCC1/XPF(ERCC4) 
Synthesis UvrD, DNA poll DNA p01 11/I11 DNA p0! S/c 
Ligation DNA ligase DNA ligase DNA ligase I 
Specific forTCR TRCF RAD26, RAD28 CSA, CSB(ERCC6) 
14 
Figure 11.4 Schematic representation of human nucleotide excision repair 
pathway. 
A model for the mechanism of mammalian nucleotide excision repair (NER), 
adapted from Wood, 1997. NER is a major pathway that removes UV and chemically 
induced damage from DNA. The biochemical steps in the repair of a damaged base 
include damage recognition, formation of incisions of -26-29 nucleotides apart on 
each side of a lesion, removal of the damage as part of an oligonucleotide and filling 
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1.4 Human inherited diseases of nucleotide excision repair (NER) 
Three rare hereditary human diseases have been associated with a defect in 
NER: xeroderma pigmetosum (XP), Cockayne's syndrom (CS) and photosensitive 
trichothiodystrophy (TTD) (reviewed in Friedberg et al., 1995; Cleaver and Kraemer, 
1995). The striking difference between XP and other syndromes is that XP patients 
develop UV-induced skin cancer, whereas CS and TTD patients do not, despite their 
photosensitive skin. However, it was noted that both CS and TTD could be 
associated with XP. The principle clinical features of these disorders are 
summarised in the Table 1.2. 
I anie i.h iviain matures 01 me JNLK syndromes Al', CS, and TTD 
Clinical and Biochemical features XP CS TTD 
Clinical 
Sun sensitivity +/++ + + 
Pigmentation abnormalities + - - 
Skin cancer + - - 
Ichthyosis - - + 
Brittle hairs/nails - - + 
Neurological abnormalities -1+ + + 
Short stature -1+ + + 
Decreased fertility - + + 
Dental caries - + + 
Biochemical 
Overall genome repair 	 + 
Transcription coupled 	 -1+ 
1.4.1 Xeroderma pigmentosum 
XP is an autosomal recessive disease characterised by extreme sensitivity to 
sunlight, pigmentation abnormalities, and cutaneous and ocular deterioration. The 
incidence of this disorder is one in 40,000 in Japan, being higher in those of 
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European origin and Americans. Approximately 80% of XP patients are categorised 
in 'classical' XP, i.e., defect in NER, in contrast to the remaining 20% of patients 
who are designated as XP-variants (XPV), who have a defect in DNA polymerase 1 
and may use DNA polymerase 4 for an error-prone postreplication repair. To date 
there is no cure for XP, so management is limited to avoidance of exposure to 
damaging UV radiation by staying indoors. XP patients develop skin tumours at an 
extremely high frequency (2,000 fold higher than normal individuals) because of 
their inability to repair UV-induced DNA damage. These tumours comprise basal 
cell carcinomas and squamous cell carcinomas on sun-exposed areas of the skin and 
melanomas that are more uniformly distributed. 
In addition to skin, other LTV-exposed sites, such as the anterior of the eye and 
the tip of the tongue, also develop cancers at a very high frequency in XP patients. 
Approximately 20-30% of XP patients, mainly with gene mutations in XPA, XPB, 
XPD or XPG, also have progressive neurological abnormalities. Since the brain is 
inaccessible to UV-radiation, it is likely that oxidative DNA damage (such as 8-
oxoguanine and thymine glycol) may be responsible for these disorders. 
1.4.2 Cockayne's syndrome 
CS patients show growth arrest and neurologic abnormalities, including neuro-
dysmyelination, mental retardation, dwarfism, skeletal and retinal disorders, 
immature sexual development, and microcephaly with a characteristic 'bird-like' 
face. Dental problems and sun-sensitivity are also common clinical features. The 
mean patient age at the time of diagnosis was about 2 years with an ageing 
phenotype, and death in most cases before the age of 20 due to progressive 
neurological degeneration. Although CS patients also have photosensitive skin, CS 
patients do not develop skin cancer at an increased rate. 
Cell fusion experiments have shown that there were two complementation 
groups in the classical form of CS: CSA and CSB. Mutations in the XPB, XPD or 
XPG genes can lead to a combined XP-CS phenotype, albeit very rare. 
1.4.3 Trichothiodystrophy 
17 
Trichothiodystrophy (TTD) is an autosomal recessive disorder in which 
patients present brittle sulphur-deficient hair, fish-like scales on the skin (ichthyosis), 
mental retardation, short stature and distinctive facial features (protruding ears and 
receding chin). Although about half of the reported cases of TTD showed 
photosensitivity, these patients did not manifest a predisposition of skin cancer. In 
addition to the TTDA gene, XPB and XPD mutations have also been identified in 
TTD by cell complementation studies. 
1.5 ERCC1 
As described above, the discovery implicating defects in NER as being 
responsible for the genetic disorders XP, Cs and TTD, provided the impetus for the 
recent cloning of many of human, rodent and yeast genes involved in this process. 
ERCCJ is one of few NER genes for which, so far, no mutations have been found in 
human NER disease complementation groups and any other known human disorders 
(van Duin et al., 1989). However, it remains possible that a human ERCCJ inherited 
disorder is to be identified, or the inactivation of ERCC 1 may not be compatible with 
viability in humans. 
1.5.1 Cloning and gene structure of ERCC1 
The human ERCCJ (hERCCJ) gene was the first mammalian DNA repair gene 
to be cloned by virture of its ability to complement the CHO mutant cell line 43-313, 
which is sensitive to u.v. light and mitomycin C (Westerveld et al., 1984). Recently 
a missense mutation at the 98th residue (Val-*Glu) of ERCC 1 has been characterised 
in this cell line (Hayashi et al., 1998). The hERCCJ gene, comprising ten exons 
spanning -15 kb, is located in chromosome 19q 13.2-13.3 (van Duin et al., 1986), 
where it is closely linked (-250 kb) to ERCC2, along with two other repair genes 
LIGJ and XRCCJ, suggesting a closing linkage in nature of the gene functions to 
repair DNA damage (Rubio et al., 1994; Dabholkar et al., 1995; Lamerdin et al., 
1996). The major hERCC1 mRNA transcript is 1.1 kb; a rare alternatively spliced 
form, which lacks exon 8 encoding 24 amino acids, and two differential 
polyadenylation sites result in additional transcripts of 1 kb, 3.4 kb and 3.8 kb 
respectively (van Duin et al., 1987). The cloned /iERCCJ cDNA probe was used to 
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screen a mouse brain ?gt10 cDNA library and isolate the mouse ERCCJ (mERCCJ) 
homologue, which also contains 10 exons spanning -P16kb in mouse chromosome 7 
(van Duin et al., 1988). 
The ER CC] cDNA of vertebrates is strongly conserved in evolution. The 
sequence similarity between the human and the mouse coding region is 82%, and the 
expression of ER CC] in both cases is driven by a promoter devoid of classical 
promoter elements, such as GC-rich regions, CAAT and TATA boxes. The 
transcripts of mER CC] occur at low levels in all tissues and developmental stages. 
The 3'-flanking region of both hERCCJ and mER CC] genes overlaps with another 
gene ASE] (antisense ER CC]), the relationship of which remains to be elucidated 
(van Duin et al., 1989; Whitehead et al., 1997). 
1.5.2 The ERCC1 protein 
The hERCC1 and mERCC1 proteins comprise 297 and 298 amino acids 
respectively, with an estimated molecular weight of 33 kDa. The overall identity 
between both proteins is 82%, with most of the amino acid variation being at the N-
terminal region of the proteins. The identity in the first 100, second 200 and 200-298 
amino acids are 70%, 97% and 89%, respectively (Friedberg et al., 1995). 
The proteins involved in NER are very similar in all eukaryotes, from yeast to 
mammals (Figure 1.5). It turned out that the amino acid sequences of the hERCC 1 
and mERCCI proteins show significant homology with the Saccharomyces 
cerevisiae RADIO and Schizosaccharomyces pombe SwilO. It was shown that 
ERCC 1 -XPF complex is a structure-specific endonuclease which is necessary for the 
5' incision during NER in mammalian cells. Similar findings were also 
demonstrated in the budding yeast RAD 1 -RAD 10 complex and the fission yeast 
SwiiO-Radl6 complex, where RAD1 and Rad16 share homology with XPF 
(Tomkinson et al., 1993; Bardwell et al., 1994; Can et al., 1994; Friedberg et al., 
1995; Brookman et al., 1996). Indeed, Yagi et al. reported that XPF, a 120 kDa 
protein, can be co-immunoprecipitated with hERCC 1 from normal cell extracts by an 
anti-hERCC1 antibody (Yagi et al., 1997). A recent study has demonstrated that the 
minimal domain in hERCC1 protein for stable XPF binding spans residues 224 to 
297, whereas XPF residues 8 14-905 are deemed sufficient for the stable binding to 
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Figure 11.5 Alignirnent of the amino acid sequence of S. cerevisiae RADIO, S. 
ponbe SWII[11O and human, mouse and lily ERCC1. 
Amino acid positions are shown on the left of sequences. Gaps are represented 
by dots. Identical (dark shadow) and similar (light shadow) amino acids are 
represented by shaded letters. 
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Mouse _ERCC1 	1 MDPOKDEESRPQPSGPPTRRKFVIPLEEKEVPCAOVKPLFRSSRNPTIPATSAHHQ1TAYXTQ PGOAGATVP 	S 
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hERCC1 (de Laat et al., 1998). Furthermore, the ERCC1/XPF complex was isolated 
using an XPA affinity column, suggesting the formation of a ternary complex 
between XPA and the ERCC1/XPF heterodimer (Park and Sancar, 1994). Two 
hybrid analysis and in vitro studies with truncated recombinant proteins have shown 
that there is a direct interaction between residues 92-119 of hERCC1 and residues 
75-1 14 of XPA (Li et al., 1994). RPA was also suggested to interact with ERCC1-
XPF, presumably via XPF, and to stimulate the nuclease activity (de Laat et al., 
1998). 
The N-terminal 91 amino acids of hERCC 1 is poorly conserved in RAD 10 and 
largely absent in Swi 10. A putative nuclear location signal is located at the hERCC 1 
N-terminal region of protein between residues 16-23. The central area of the 
hERCC1 (amino acids 92-210) shares -30 % similarity with RADIO and -50% with 
Swi 10. A putative hERCC 1 DNA binding domain is located at amino acid residues 
134-156. The C-terminal amino acids of hERCC 1 also show homology with the C-
terminal part of the E. coli UvrC (van Duin et al., 1986). A plant ERCC1 from 
Lilium long y'lorum shows a higher similarity (71%) to hERCC 1 in 221 overlapping 
amino acids , albeit it lacks the first 68 amino acid residues and has 49 additional 
amino acid residues at the C-terminal (Xu et al., 1998). 
In addition to a role in NER, the RAD 1 -RAD 10 complex is also involved in 
mitotic recombination mediated by single-strand annealing. A reduced frequency of 
mating type switching in SwilO mutants may correlate with defective 
recombinational events (Schmidt et al., 1989; Fishman-Lobell and Haber, 1992; 
Davies et al., 1995; Paques and Haber, 1997). 
1.6 Mitochondrial genetics and disorders 
Mitochondria are maternally inherited and provide the main source of energy 
in the cell. They contain their own DNA (mtDNA), which encodes 13 components 
of the respiratory chain (Anderson et al., 1981). It has been estimated that 90% of 
cellular oxygen is consumed in mitochondria and 2% of the oxygen is converted to 
superoxide free radicals by complexes of the electron transport system (ETS) 
(Chance et al., 1979; Harman, 1994). Because mtDNA lacks protective histones and 
lies in close proximity to the ETS, the mitochondrial genome is 10-20 times more 
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prone to oxidative damage and has a higher somatic mutation rate than nuclear DNA 
(nDNA) (Clayton, 1991; Yakes and Van Houten, 1997). If damage accumulates, the 
function of ETS will diminish with a concomitant fall in cell bioenergetics and 
subsequent cellular dysfunction. This section addresses the oxidative DNA damage 
processing in these organelles. 
1.6.1 The mitochondrial genome 
This is reviewed in Larsson and Clayton, 1995; Grossman and Shoubridge, 
1996; Shadel and Clayton, 1997; Boore, 1999; Taanman, 1999; Wallace, 1999. 
Mitochondria are the sites of cellular oxidative respiration and responsible for 
the production of energy (ATP, adenosine triphosphate) in eukaryotic cells. When 
energy is released from ATP, a molecule of ADP (adenosine biphosphate) and 
phosphate are formed. The ADP can be thought of as a discharged battery. ADP is 
'charged' into ATP by the mitochondria in a process called oxidative 
phosphorylation (OXPHOS). In every mammalian somatic cell, there are several 
identical copies (2-10) of mtDNA per mitochondrion and hundreds or thousands of 
mitochondria per cell, depending on the cell's energy requirements. The small, 
extrachromosoml mtDNA (-46.6 kb) is a maternally inherited circular molecule. 
The two strands [Heavy (H) strand and Light (L) strand] can be separated on 
denaturing caesium chloride gradients due to a strand bias in G+ T base composition. 
The DNA contains 37 genes encoding 13 protein subunits of complex I, III and IV of 
the electron transport system, two rRNAs of the mitochondrial ribosome, and 22 
tRNAs necessary for the translation of these proteins. The remaining ETS proteins 
are encoded by nDNA and transported into the mitochondria after assembly 
elsewhere in the cell. Complex I (NADH dehydrogenase) contains the largest 
number of mitochondrial subunits, with mtDNA encoding seven of 43 subunits of 
complex I. Complex II (succinate dehydrogenase) is entirely nuclear encoded while 
complex III (ubiquinol cytochrome c reductase) has only one subunit encoded by 
mtDNA among its 10 proteins. Three of the 13 subunits of complex IV (cytochrome 
c oxidase) and two of 16 subunits of complex V (H -translocating ATPase) are from 
mtDNA (Figure 1.6). 
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Figure 1.6 Schematic diagram of (A) map of the mitochondrial genome and the 
most common mutations associated with selected mitochondrial disorders, and 
(1) OXPIHIOS 
The human mtDNA map, showing the location of selected pathogenic mutations 
within the 16,569-base pair genome. The different shaded areas represent the 
structural genes for the seven subunits of complex I (NADH-CoQ 
oxidoreductase, ND), the three subunits of cytochrome oxidase (COX), 
cytochrome b (Cyt b), the two subunits of ATP synthetase (ATPase 6 and 8), the 
12S and 16S ribosomal RNAs (rRNA) and the 22 transfer RNAs (tRNA), 
identified by one-letter codes for the corresponding amino acids. Point 
mutations in structural and protein-coding genes are shown inside the circle, 
with the clinical phenotype indicated. The position of the most common single 
deletion, which is 5 kb long, and the multiple deletions are indicated by the arcs 
outside of the circle.(adapted from Johns, 1995). 
Abbreviations: LHON, Leber's hereditary optic neuropathy; MELAS, the syndrome of 
mitochondrial encephalopathy, lactic-acidosis, and stroke-like episodes; MERRF, 
myoclonic epilepsy with ragged-red fibres; NARP, neuropathy, ataxia, and retinitis 
pigmentosa; OH,  the origin of heavy-stranded DNA replication; °L,  the origin of light-
stranded DNA replication; Cyt-b, apocytochrome-b subunit; ND-I, ND-2, ND-3, ND-
4L, ND-5 and ND-6, NADH dehydrogenase subunits; CO I, CO II and CO III, 
cytochrome-c oxidase subunits; 12S and 16S, ribosome RNA subunits; A6 and A8, 
ATPase subunits. The large open space at the top (which includes OH)  is the noncoding 
D (displacement) loop. 
The five respiratory complexes are shown within the mitochondrial inner 
membrane. Above is the cytosol and below is the mitochondrial matrix. The 
subunit composition of each complex is presented in the table below (adapted 
from Wallace, 1992; Wallace, 1999). 
Abbreviations: NADH, nicotinamide adenine dinucleotide-reduced; FMN, flavin 
mononucleotide; FAD, flavin adenine dinucleotide; Fe-S, iron-sulfur centre; Q, C0Q; b, 
cytochrome b; c, the mobile electron carrier; c 1 , cytochrome c 1 ; a and a3 , cytochrome a 
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1.6.2 Mitochondria disorders 
This is reviewed in Wallace, 1994; Larsson and Clayton, 1995; Wallace et al., 
1995; DiMauro et al., 1998; Morgan-Hughes and Hanna, 1999; Schapira, 1999; 
Simon and Johns, 1999. 
The mitochondrial dysfunction is increasingly recognised, both in "classic" 
mitochondrial disorders, such as maternally inherited Leigh disease (MILS), and, 
more recently, in more common late-onset neurodegenerative disorders such as 
Parkinson's disease, Alzheimer's disease, Huntington's disease, amyotrophic lateral 
sclerosis. The pathogenesis of, or predisposition to ageing and cancer may also be 
related to changes in mitochondria. Since mitochondria are under the control of two 
genomes, mutations in both nDNA and mtDNA can result in abnormalities in 
OXPHOS genes, respiratory complex assembly genes, mitochondnal protein 
turnover genes and mitochondrial import apparatus genes. Thus, the genetic 
classification of mitochondrial disease is rather complex. Table 1.3 summarises the 
most important disorders in mitochondria arising from both genomes. Figure 1.6 (A) 
also indicates the map position of some diseases due to defects of mtDNA. It is 
worth noting that some mouse models of mitochondrial disorders have been 
established. For instance, mice lacking the Anti (adenine nucleotide translocator) 
gene are viable, but they develop mitochondrial myopathy and hypertrophic 
cardiomyopathy (Graham et al., 1997). The MnSOD2 (mitochondrial form of 
superoxide dismutase)-deficient mice died from cardiomyopathy at about postnatal 
day 8 and exhibit striking lipid deposits in the liver (Li et al., 1995; Melov et al., 
1998). Inactivation of the nuclear gene encoding mitochondrial transcription factor 
Tfam may provide a model for the mtDNA deletion syndrome (Larsson et al., 1998; 
Wang et al., 1999). 
1.6.3 Mitochondria and cell death 
This is reviewed in Cai et al., 1998; Green, 1998; Green and Reed, 1998; 
Kroemer et al., 1998; Bossy-Wetzel and Green, 1999; Blackstone and Green, 1999; 
Deveraux and Reed, 1999; Gross et al., 1999. 
Mitochondria may play a decisive role in both apopotosis and necrosis. 




Mitochondrial Disorders 	mtDNA 	 ,zDNA 	 Clinical Features 
Leber's hereditary optic neuropathy MTNDI 	3460, MTND4 	11778, 	 painless, subacute, bilateral visual loss, with central scotomas and abnormal colour vision; onset 
(LHON) 	 MTND6 14484 	 midlife (30 years, range= 1-70) 
Nit encephalopathy, lactic-acidosis, 	MTTLI 3243 tRNA LCU 	 stroke-like attacks, loss of consciousness, seisures. lactic acidosis 
and stroke-like episodes (MELAS) 
Chronic 	progressive 	external MTTLI 3243 tRNALCU 
ophthalmoplegia (CPEO) MTND5-MTATP8 (4977 bp deletion) 
Pearson's 	marrow 	- 	 pancreas single large deletion (2 to 8 kb) 
syndrome 
Kearns-Sayre syndrome single large deletion (2 to 8 kb) 
Myoclonic epilepsy with ragged-red MTTK 8344 tRNAL 
fibers (MERRF) 	 MTTK 8356 tRNA 
Neuropathy, ataxia, and retinitis MTATP6 8993 
pigmentosa (NARP) 
Leigh's syndrome (MILS) 	 MTATP6 8993 (>90% all mtDNA) 




DEAF 	 MTRNRI 1555 (12S RNA) 
I Friedreich's ataxia 
mitochondrial depletion syndrome 	copy number mutation 
I Hereditary spastic paraplegia 
Mohr-Tranebjaerg syndrome 




homocitrullinuria (HHH) syndrome  
ptosis, ophthalmoplegia, limb myopathy, psychiatric disorder; Pathology: ragged red fibers 
sideroblastic anaemia, thrombocytopenia, neutropenia, pancreatic insufficiency, and hepatic 
dysfunction 
retinitis pigmentoa, lactic acidosis, neurosensory hearing loss, ataxia, heart conduction defects, elevated 
CSF (cerebral-spinal fluid) protein 
Myoclonus, epilepsy, cerebellar dysfunction, hearing loss, polyneuropathy, dementia; Pathology: 
ragged red fibers 
seizures, dementia, ataxia, retinal pigmentary changes, sensory neuropathy, neurogenic proximal 
muscle weakness 
Xp22.1-p22.2 (Ela subunit of pyruvate 	early onset and frequently lethal, ataxia, hypotonia, spasticity, deveolomental delay, optic atrophy, 
dehydrogenase); 	5p15 	(flavoprotein ophthalmoplegia, degeneration of the basal ganglia accompanied by vascular proliferation 
subunit of complex II); 9p34(SURFI, 
complex IV) 
symmetric foci of necrosis in the basal ganglia, thalamus and brainstem 
22q1332-qter.(thymidine phosphorylase, 	leukoencephalopathy, external ophthalmoplegia, peripheral neuropathy, intestinal dysmotility, limb 
TP) 	 weakness, hearing loss, diverticulosis; missense mutation (GI4I9A, G1443A, A3371C in TP) 
aminoglycosi de- induced deafness 
9ql3 (frataxin, regulating iron transport) 	cerebellar ataxia, lack of tendon reflex in the legs, peripheral neuropathy, hypertrophic cardiopathy 
GAA repeat within the first intron of the frataxin gene 
in vitro nuclear complementation can 	lethal infantile respiratory failure, lactic acidosis, and muscle , liver or kidney failure; random loss of 
restore normal mtDNA levels) 	 the mtDNA from disrupting the regulation of mtDNA copy numbers during development 
I 6q24.3 (paraplegin, Alp- ase protease) 	progressive weakness and spasticity, mental retardation, peripheral neuropathy, ataxia, retinitis 
pigmentosa, optic atrophy, deafness, ichthyosis; 9.5 kb deletion of Paraplegin 
Xq21.3-22 (DDP1, import of the 	progressive sensorineural deafness, cortical blindness, dystonia, dysphagia, paranoia; truncation/or 
mitochondrial protein) 	 deletion of II kDa DDPI protein 
13ql4 (ORNTI, omithine transporter of growth retardation, seizures, spasticity associated with persistent hyperornithinemia and episodic 
urea cycle) 	 hyperammonaemia, homocitrulline; 3 bp deletion (Fl 88i\), missense mutation (EI80K) 
caspase, Bax protein, and perhaps ceramide, has long been known to lead to 
mitochondrial dysfunction and cell death. These cellular stresses can disrupt the 
mitochondrial respiratory chain, probably at the cytochrome b-c 1 /cytochrome c step 
and release caspase-activating proteins such as cytochrome c (cyto c), apoptosis-
inducing factor (AIF) and intramitochondrial caspases. Release of these proteins 
activate Apaf-1, which in turn self-associates and binds procaspase-9, thereby 
resulting in a downstream caspase programme that culminates in apoptosis. 
Alternatively, in some cells, where osmotic disequilibrium leads to an 
expansion of the matrix space, organelle swelling and rupture of mitochondria can 
induce a slower non-apoptotic mechanism resembling a necrotic demise through 
production of ROS, loss of the mitochondrial membrane potential (iPm) and 
declining ATP production. 
At least two protein families, the BCL-2 and the lAP (inhibitor of apoptosis) 
family, have been proposed to be involved in apoptosis regulation. The BCL-2 
family members, which possess up to four conserved BCL-2 homology (BH) motifs, 
designated BH 1 to 4, include both inhibitors and promoters of apoptosis. Inhibitors 
of apoptosis include BCL-2 itself, BCL-X (BCL-X L, BCL-Xa, BCL-Xf3), MCL-.1 
and Al, whilst BAX, BCL-X, BAD, BAK and BIK promote apoptosis. Some 
members of the BCL-2 family can interact with each other by forming homo- or 
hetero- dimers. The members of lAPs, characterised by a putative zinc-binding 
domain of -70 amino acids, termed the baculoviral TAP repeat (BIR), were also 
shown to be involved in suppressing apoptosis. Several of the human TAPs (XJAP, 
c-lAP-i and c-TAP2) have been reported to block caspases 3, 7 and 9 directly. 
1.6.4 Repair in mitochondrial DNA 
For a long time very little was known concerning DNA repair mechanisms 
and responsible enzymes in mitochondria, although it seemed that mitochondria 
would need efficient DNA repair activity to remove DNA damage. The original 
observation that mitochondria do not excise UV-induced DNA pyrimidine dimers led 
to the unsupported but generally circulated idea that mitochondria lacked the 
capacity to repair damaged DNA. It is likely that the redundancy of mtDNA in cells 
precludes a requirement for repair (Clayton et al., 1974). However, it is now clear 
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that this organelle is not entirely deficient in DNA repair activity. It was 
demonstrated that many types of DNA damage, including abasic sites, thymine and 
cytosine lesions, formamidopyrimidine, 8-oxo-dG and alkylated purine, could be 
efficiently removed from mtDNA in vivo (Myers et al., 1988; Driggers et al., 1993; 
Pinz and Bogenhagen, 1998). Many of these lesions in mtDNA may be processed 
via a BER pathway which should be maintained to permit repair of the frequent 
spontaneous base loss that occurs in any DNA. The uracil-DNA glycosylase (IJDG) 
and several endonucleases that nick 5' of 8-oxo-dG, AP sites and thymine glycol, 
have been identified in mitochondria of yeast, rodents and humans (reviewed in 
Croteau and Bohr, 1997; Bogenhagen, 1999; Bohr and Dianov, 1999; Croteau et al., 
1999; LeDoux et al., 1999; Marcelino and Thilly, 1999; Sawyer and Van Houten, 
1999). 
The gene coding human UDG has two alternative splicing products in the N-
terminal region: one containing a nuclear localisation signal and the other a 
mitochondrial targeting signal (Haug et al., 1998). In the mitochondria, the filling of 
a gap created by the action of an AP endonuclease is thought to occur by a specific 
DNA polymerase y  (Shadel and Clayton, 1997). Moreover, a lyase activity was 
identified in human DNA polymerase y  since this enzyme was able to catalyse in 
vitro the release of the 5' terminal deoxyribose phosphate (dRP) flap followed by a 
subsequent ligation step (Longley et at., 1998). A mitochondrial DNA ligase III has 
also been identified in X laevis and vertebrates (Pinz and Bogenhagen, 1998). 
There is little evidence that NER functions in mitochondria to remove bulky 
DNA adducts. However, the removal of DNA lesions by 4-nitroquinoline-1 oxide 
(4NQO), generally thought to be removed via the NER pathway, has been detected in 
an in vitro assay using mitochondrial protein extracts (Snyderwine and Bohr, 1992). 
Considering that many chemical carcinogens form adducts with mtDNA, the lack of 
NER in this organelle is striking. More research is required to ascertain the possible 
role of NER in repairing some lesions in mtDNA. 
No enzymes involved in postreplication MMR of mtDNA have yet been 
identified in mammalian cells. It has been reported that mutations in the S. cerivisiae 
27 
Figure 1.7 Mitochondria and cell death 
The model of apoptosis and apoptosis suppression is adapted from (Green, 
1998; Green and Reed, 1998; Deveraux and Reed, 1999; Gross et al., 1999). 
Cellular stress can trigger mitochondria to release cyto c (closed circle) and 
possibly AIF and intramitochondrial caspases (open circle). Two mechanisms of 
mitochondrial fate have been proposed: (1) osmotic disequilibrium leading to an 
expansion of the matrix space, organelle swelling and subsequent rupture of the outer 
membrane; (2) channels in the outer membrane are opening, thus releasing cyto c 
into the cytosol. Cyto c binds to Apaf-1, inducing it to associate with procaspase-9 
and initiating the proteolytic cascade. The BCL-2 and lAP family are involved in 
apoptosis suppression. See text for detail. 
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MSHJ gene induce a high rate of mtDNA mutations (Reenan and Kolodner, 1992), 
but a complete MMR pathway in yeast mitochondria has not yet been described. 
Recent studies showed that extracts of mitochondria from human, mouse and 
rat cells were able to catalyse homologous recombination of plasmid DNA substrates 
(Thyagarajan et al., 1996). It has also been suggested that mammalian mitochondria 
possesses a DNA double strand break repair activity similar to that seen in the 
nucleus, which catalyse DNA end-joining of linearised plasmid DNA in vitro 
(Coffey et al., 1999; Lakshmipathy and Campbell, 1999). 
1.7 Gene Targeting 
Gene targeting can be defined as "homologous recombination between 
chromosomal DNA sequences and newly introduced exogenous sequences, enabling 
the transfer of any desired alteration of the cloned sequences into the genome of a 
living cell" (Capecchi, 1989). Embryonic stem (ES) cells are derived from the inner 
cell mass of 3.5 day blastocyst and remain pluripotent even after gene targeting 
(Balinski, 1975). ES cells can proliferate in vitro in an undifferentiated state under 
the appropriate culture conditions (Evans and Kaufman, 1981). Precise alteration of 
endogenous genes through homologous recombination in ES cells has been used 
extensively to generate null or knockout mutations. Gene targeting has proven to be 
a powerful method to study the function of proteins and human diseases. Recently, 
advanced technology to investigate more sophisticated perturbations such as subtle 
gene mutation and conditional gene targeting are also available (reviewed by Melton, 
1994; Moore and Melton, 1995). Numbers of targeted mutant mice are growing 
rapidly (more than 800 reported in T-Base http://www.jax.org/cbase)  and it has been 
estimated that 3,000 strains will be available by the year 2,001 (Simpson et al., 
1997). 
1.7.1 Gene targeting strategies 
When DNA is transferred into ES cells, it has a number of possible fates 
including nucleolytic degradation, random integration and homologous 
recombination with chromosomal DNA (Bollag et al., 1989). It is probable that gene 
targeting occurs through a RAD52-like recombination pathway, which plays a minor 
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role in higher eukaryotes compared to non-homologous end joining event (Bollag et 
al., 1989). The ratio of random integration to homologous recombination events in 
mouse cells has been estimated at 1000:1 (Thomas and Capecchi, 1987). To 
maximise the chances of identification and retrieval of targeted clones, gene 
targeting is performed with large numbers of cells and selection strategies to enrich 
for rare homologous recombination events. 
The most widely employed strategy for gene targeting in ES cells is the 
positive-negative selection (PNS) procedure (Mansour et al., 1988). The most 
common positive selectable marker in use is based on the bacterial neomycin 
phosphotransferase gene (neo) disrupting the coding sequence of the mouse gene. 
The antibiotic G418 is used to select for cells in which the DNA construct containing 
the neor  gene has been integrated, either randomly or by homologous recombination. 
An HPRT (hypoxanthine-guanine phosphoribosyltransferase) minigene in 
combination with HAT (hypoxanthine, aminopterin and thymidine) and HPRT-
deficient ES cells has also been used successfully (Reid et al., 1990; Selfridge et al., 
1992). 
Positive selection schemes select both cells which have undergone the desired 
gene targeting events and those which have undergone random integration events. It 
is therefore necessary to use a negative selectable marker, at the termini of regions of 
homology, to enrich for homologous recombinants. A common negative selectable 
mark is the Herpes simplex virus thymidine kinase gene (HSV-tk). To select against 
HSV-tk activity, the nucleotide analogue gancyclovir (Mansour et al., 1988) or FIAU 
(1 -[2' -deoxy-2 '-fluoro-3-D-arabinofiiranosyl] -5-iodouracil) (McMahon and Bradley, 
1990) can be used. These drugs do not interfere with the potential of ES cells to 
contribute the germ line of chimeras. Using the PNS procedure, enrichment factors 
between 15 and 1,000-fold have been described (Mansour et al., 1988; McMahon 
and Bradley, 1990; Mansour et al., 1990). After selective enrichment, surviving 
clones can be screened by polymerase chain reaction (PCR) to identify targeted 
clones and further confirmed by Southern blot. A major advantage of the PCR 
technique is its sensitivity, allowing the detection of homologous recombination 
events from less than 100 cells (McMahon and Bradley, 1990). 
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1.7.2 Gene targeting in the HM-1 ES cell line and production of knockout mice 
The male HPRT-deflcient ES cell line, HM- 1, was derived from blastocysts of 
an HPRT-deficient 129/01a mouse line, which lacks the promoter and first two exons 
(-40kb) of the X-linked HPRT allele (Thompson et al., 1989; Magin et al., 1992a, 
1992b). Since HPRT is X-linked, and male ES cells are hemizygous for this gene, 
loss of function of one HPRT allele gives rise to HPRT-deficient cells. X-linked 
HPRT (EC.2.4.2.8) catalyses an early step of the purine salvage pathway in 
mammals. It is possible to select for HPRT activity in vitro with medium 
supplemented with hypoxanthine, aminopterin and thymidine (HAT). Aminoptenn 
is an inhibitor of de novo synthesis of purines and pyrimidines. The HPRT activity 
enables cells to bypass the aminoptenn induced metabolic block by utilising 
hypoxanthine and thymidine via the purine and pyrimidine salvage pathways. Hence 
by incorporating an HPRT minigene into gene targeting vectors as a selectable 
marker, HPRT-deficient cells can be used to produce knockout mice (Selfridge et al., 
1992). Figure 1.8 outlines a typical gene targeting strategy employed in HM-1 ES 
cells. 
1.7.3 Double replacement gene targeting 
A lot of human diseases result from point mutations and do not disrupt gene 
expression completely. Furthermore, in many cases, subtle alterations are required 
such as changing promoter/enhancer specificity, altering the pattern of RNA splicing, 
introducing single codon changes, or exchanging protein domains . It is therefore 
more desirable to be able to make subtle alterations of the genome. To this end, a 
method of "double replacement" gene targeting has been developed. This targeting 
strategy requires the use of an HPR T-deficient cell line such as HM-1 in order to 
exploit the ability to select for and against HPRT activity (Stacey et al., 1994; Moore 
et al., 1995) (see Figure 1.9). The first step results in the targeted introduction of an 
HPRT selectable marker into the desired locus, enabling a null allele to be generated 
if required. The second round is designed to replace the HPRT minigene with intact 
homologous sequences bearing the desired mutation. Selection against HPRT 
activity is achieved by culturing cells in the toxic punne analogue 6-thioguanine. 
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Figure 11.8 A gene targeting strategy employed in THITM-1 ES cells 
Schematic representation of the procedure involved in generating mice 
heterozygous for a targeted gene alteration (adapted from Melton, 1994). 
ES cells are isolated from the inner cell mass of blastocysts from strain 
129/01a mice. Gene targeting is performed whilst in culture and targeted ES cells are 
injected into the blastocyst cavity of a host embryo from a different strain (e.g. 
Balb/C). Injected embryos are implanted into pseudopregnant foster mothers for 
development to term. Chimaeric offspring are identified by means of altered coat 
colour. 
To assess whether the ES cells have contributed to the germline of these 
animals, the chimaeras are test mated (e.g. with Balb/C). Germline transmission of 
the 129/01a derived gametes is determined by transmission of the 129/01a markers 
for coat and eye colour. The 129 derived HM-1 cells are homozygous for the white 
bellied agouti (Aw)  allele, and homozygous for the chinchilla (cdi)  allele at the albino 
locus, which confers a tan (chinchilla) coat colour. The HM-1 cells also carry a 
homozygous recessive allele (p) at a third locus (P) which confers pink eyes. The 
Balb/C recipient embryos and studs are homozygous for the wild type alleles at the 
agouti (A) and pink eyed (F) loci as well as being albino (c/c). The albino locus is 
epistatic to the pink eyed locus so Balb/C have white coats and pink eyes. Following 
test matings between HM- 1 chimaeras and Balb/C studs germline transmission of the 
ES cell markers is recognisable at birth; germline pups are grey with black eyes and 
will have the genetic make-up c/c, p/F, AW/A.  The combination of a single 
chinchilla allele with the alleles of the agouti locus results in a grey coat colour, and 
eye pigmentation is also restored. 50% of the germline offspring will carry the 
targeted allele. Non germline pups have the genetic make-up of the Balb/C strain and 
are thus white with pink eyes. 
32 
4-. 4-- 
4-- 4- .4-. 4. .4- 	4- 
4-. .4-. 4.. 4.. 4.. 
M* C~ , 0 




HM-1 ES cell line 
ERCCJ gene 
L 
I 	Targeting Vector 
4I44IfH.II1Th011fl Targeted gene 
1 
Targeting specific PCR 
C h 
Z 
Germline pup 	 Non-germline pup 
Targeted ES cell-derived progeny 	 Host embryo-derived progeny 
(129 Ola x Balb/C) 	 (BalbIC x BaIb/C) 
Figure 1.9 Double replacement gene targeting 
A hypothetical two step 'double replacement' strategy for the introduction of a 
point mutation in exon five of the mouse ERCCJ gene is shown schematically. The 
endogenous gene is represented by vertical open boxes for exons and horizontal 
boxes for introns. The homologous sequences of the first round 'knockout' vector are 
shown in black, the HPRT minigene is shown as a striped box and the TK gene is 
shown as a stippled box. Homologous sequences of the second round targeting vector 
are shown in grey and the subtle alteration is indicated by an asterisk. 
The first targeting step is designed to knockout the gene by replacing one of 
the exons and its flanking sequence with an HPRT minigene. The knockout vector 
also contains a TK gene to enable positive-negative selection. Selection at this stage 
is for HPRT (HAT) and against TK (gancyclovir). Homologous recombination 
events are confirmed by PCRs specific for the targeted allele. 
In the second targeting step the HPRT marker itself is replaced by the gene 
segment carrying the subtle alteration. Selection at this stage is for the loss of HPRT 
activity using 6TG. Random integration of the vector will not result in loss of the 
minigene. The presence of the subtle alteration can be confirmed using PCR analysis, 













The homologous recombination events at both targeting steps are identified using 
PCR. 
1.7.4 Conditional gene targeting 
In the experiments described above, gene targeting is mediated by the 
endogenous recombination machinery of ES cells. Recently, several well-
characterised enzymatic systems such as Cre/loxP and F1pIFRT discovered in other 
organisms and active in the site-specific recombination process have been shown to 
work efficiently in transfected mammalian cells. By combining these systems with 
transgenic technologies, it has become possible to introduce conditional genome 
alterations that are spatially and temporally restricted. This section briefly describes 
the Cre/loxP system which has been used extensively (reviewed in Kilby et al., 1993; 
Rajewsky et al., 1996; Cohen-Tannoudji and Babinet, 1998; Lobe and Nagy, 1998). 
Cre is a bacteriophage P1-encoded 38 kDa recombinase that catalyses 
sequence-specific DNA recombination between two 34-base-pair consensus 
sequences, termed loxP sites. The loxP sites are palindromic except for an 8-bp 
asymmetric core sequence that provides each loxP site with an orientation. When 
two loxP sites lie in the same orientation in the same DNA strand, recombination will 
excise the intervening DNA segment as a circular molecule, leaving a single loxP 
site on each reaction product. Conversely, if the recognition sites are in the opposite 
orientation, inversion of the intervening region will occur. Furthermore, 
intermolecular recombination between loxP sites on different chromosomes can also 
take place. 
By flanking a gene of interest with two loxP sites (termed 'floxing') in ES 
cells, it is thus possible to excise the genomic locus, and hence delete the gene by 
Cre-mediated recombination. The key to the success of this recombination system 
relies on the chosen method of Cre expression. In the targeted ES cells, the transient 
expression of Cre recombinase can successfully induce Cre-mediated recombination 
in vitro (Xiao and Weaver, 1997). In order to study conditional or stage specific 
gene changes, it is first necessary to produce gennline mice with the foxed allele. 
The recombinase is then introduced by mating the foxed mice with mice bearing a 
Cre transgene under the control of an appropriate lineage-specific and/or temporal- 
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specific promoter (Schwenk et al., 1998). The catalysis of a deletion between two 
loxP sites will only occur in those cells where or when Crc is expressed. Thus 
conditional gene targeting can be used to monitor the consequences of a gene 
inactivation that might result in early embryonic lethality using simple gene 
knockout. 
1.7.5 Mouse models to study nucleotide excision repair 
The recent development of inactivating specific genes in mice has 
significantly accelerated our understanding of molecular, cellular, and even 
behavioural aspects of human disease processes. However, it is often the case that 
the phenotypic consequences of gene inactivation in the mouse do not accurately 
model the consequences in humans. For instance, HPRT deficiency in man results in 
the severe neurological disorder Lesch-Nyhan syndrome, whilst HPRT-deficient 
mice are phenotypically normal, reflecting species differences in the affected purine 
metabolism pathway (Hooper et al., 1987). With this in mind, the mouse models of 
defective NER and corresponding human syndrome are summarised in Table 1.4 
(Harada et al., 1999 and reviewed in de Boer and Hoeijmakers, 1999; Friedberg and 
Meira, 1999). 
1.8 Polyploidy and cell cycle 
Although cells are mostly diploid, a common developmental strategy that 
accompanies differentiation is to change the DNA content of the cells. In plants, 
more than half of natural species of flowering plants are polyploid; the bananas we 
eat are triploid (3n) 3 and the wheat is hexaploid (6n) (Hieter and Griffiths, 1999). It 
is also well known that polyploidy is a major force in plant evolution (Soltis and 
Soltis, 1995). Animal species are less commonly polyploid, however, amphibians 
and salmonid fish have clearly evolved by tetraploidy, which could give animals lots 
of genes to adapt to new environments (Brodsky and Uryvaeva, 1985). A rat species 
In this thesis the haploid chromosome set in polyploidisation is designated as "n " and the quantity of 
DNA in the unreplicated haploid set is "C". 
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Table 1.4 Properties of NER mouse models and corresponding human syndrome 
Gene Mouse mutation -- 	UV-sensitivity' Skin cancer Relevant or different phenotypes 
Human Mouse Human Mouse 
ERCC 1 KO n.a. +++ n.a. n.d runted growth, early death with aberrant nuclei in liver cells 
truncation 
XPA KO +++ +++ ++ ++ skin cancer predisposition after exposure to u.v. light 
XPB KO n.a. n.a. n.a. n.a. lethal mutation 
XPC KO + + ++ ++ skin cancer predisposition after exposure to u.v. light 
XPD KO n.a. n.a. n.a. n.a. lethal mutation 
point mutation +1- +1- - + Like human TTD, except neurodysmyelination 
XPG KO +++ +++ ++ n.a. mice are viable but have retarded growth and die before 
weaning 
CSA KO ++ ++ - n.d. mild growth retardation, CS symptoms mildly present, retinal 
degeneration 
CSB KO ++ ++ - + As CSA, skin cancer predisposition after UV exposure 
mHR23b KO n.a. - n.a. n.d. mice die in utero or premature 
n.a., not applicable; n.d., not determined; KO, knockout; UV sensitivity' of human skin and cultured mouse embryo fibroblasts. 
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in Argentina, Octodontoidea, seems to thrive in spite of carrying an extra set of 
chromosomes, upsetting a common impression that a double complete chromosome 
set spells death or a reproductive dead end (Lessa and Cook, 1998; Holden, 1999). 
Although most researchers focus on polyploidy in neoplastic mammalian tissues 
(Lengauer et al., 1998), it is also quite common in non-neoplastic tissues. Various 
amounts of polyploidy have been discovered in cerebellum, neuronal tissue, uterus, 
thyroid gland, epidermis, pancreas, ovary, placenta, urinary bladder, liver, trachea, 
bone marrow and myocardium (Wagner et al., 1968; Stangel et al., 1970; Yates and 
Mann, 1973; Ehrie and Swartz, 1974; Gilbert and Pfitzer, 1977; Mann et al., 1978; 
Barrett et al., 1983; Biesterfeld et al., 1994; Madoiwa et al., 1999). Hepatocytes can 
reach the highest level of polyploidy at 64C and megakaryocytes may attain 128C 
(Biesterfeld et al., 1994). The occurrence of polyploidy results from the irreversible 
transformation of an individual cell from a diploid to a polyploid state and may arise 
in different cell cycle phases (Biesterfeld et al., 1994). Since the mitotic cycle is a 
complex integrated process which ensures cellular growth, reproduction of the 
genetic material and cell division, it is important to learn the genetic regulation of the 
mitotic cycle. This section also briefly discusses genetic control of the cell cycle. 
1.8.1 Mechanism of polyploidisation 
Polyploidisation may be an important way to fulfil the specific functions in 
tissues and organs. In eukaryotes, the mitotic cycle is the only mechanism for cell 
reproduction. Mitosis ensures that the segregation of each double chromosome 
(chromatids) is equally distributed between the daughter cells. However, in some 
developmental situations, chromosome replication and segregation can be uncoupled 
resulting in polyploidy. There appear to be four major mechanisms for 
polyploidisation including polyteny and endocycle (or endoreduplication), 
endomitosis, polyploidising mitosis and cell fusion. Figure 1.10 outlines the model 
for cell cycle and polyp loidisation (reviewed by Brodsky and Uryvaeva, 1985). 
(A) Polyteny and endocycle (or endoreduplication) 
Polyteny is the repeated doubling of the number of chromatids in the diploid, 
or conjugated diploid, set of chromosomes without subsequent mitosis. In polytene 
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Figure 1.10 The model for polyploidisation and cell cycle 
(A). Forms of the cell cycle and mechanisms of genome multiplication. C, haploid 
level of DNA; n, haploid chromosome set 
The mitotic cycle does not always conclude with cell division. Two main forms 
of incomplete cycle and two corresponding modes of genome multiplication are 
displayed in this diagram. 
The mitotic process is interrupted at some stage and subsequent phases are 
omitted. The cell does not divide and a polyploid mononucleated or a bi- or 
multinucleated cell results. 
The entire process of mitosis is omitted, and the cell is blocked in the G2 
phase. As a result, the cell nucleus contains doubled chromatids which, after 
several endocycles, give rise to polytene chromosomes. 
(B). Rearrangement of nuclear material and the formation of polyploid nuclei by 
bimitosis (adapted from Brodsky and Uryvaeva, 1985). 
See text for detail. 
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cells, mitotic functions are permanently repressed, and the resulting endocycle, also 
designated endoreduplication or endoreproduction, consists of only S phase and a 
gap phase (Brodsky and Uryvaeva, 1985). The most well known polytene cells are 
the giant salivary gland chromosomes of insects. In the adult Drosophila, low level 
polyploidy (8C -64C) is found in many tissues and high level polyploidy (>500C) is 
found in the nurse cells of the adult ovary (King, 1970; Endow and Gall, 1975; Dej 
and Spradling, 1999). In vertebrates, one example of polytenization is the giant cells 
of the mammalian trophoblast. In these cells of the rodent placenta repeated 
endocycfes may result in cells with up to 1000C in which the DNA exists in a 
polytene arrangement (Pearson, 1974; Brodsky and Uryvaeva, 1985; Zybina and 
Zybina, 1996). 
Endomitosis 
Endomitosis was originally defined as the division of chromosomes within the 
nucleus in the absence of the disruption of the nuclear membrane and spindle 
formation. This data was shown by autoradiographic studies in septal cells of the 
testicular follicles of the grasshopper Melanoplus (Brodsky and Uryvaeva, 1985). 
This process is also described in the platelet precusors, the megakaryocytes, which 
undergo an endomitotic cell cycle and lead to the formation of a single polylobulated 
nucleus with an increased cytoplasmic volume, and subsequently gives rise to 
platelets (Mazur, 1987). However, a recent study has demonstrated a breakdown of 
the nuclear membrane and formation of unusual multipolar spherical spindle in 
megakaryocytes that limits chromatid segregation (Vitrat et al., 1998). 
Polyploidising mitosis 
Polyploidising mitosis corresponds to variants of incomplete mitosis including 
acytokinetic mitosis and mitosis of binucleated cells (bimitosis), and non-separation 
of the daughter nuclei. Acytokinetic mitosis in diploid cells results in binucleated 
cells with two diploid nuclei (2nx2). These cells are very common among 
hepatocytes, myocardium, pigment epithelium of the retina, sympathetic ganglia, 
fibroblasts of loose connective tissue and mesothelium. Furthermore, the adjacent 
chromosomes of binucleated cells may fuse through bimitosis and form a tetraploid 
nucleus after the anaphase separation. The tetraploid cells were also acquired in a 
culture of animal cells by means of coichicine mitosis (c-mitosis) to block the mitosis 
in metaphase. Mononucleate polyploid cells may also be induced by the fusion of 
the daughter chromosomal complexes during telophase (Brodsky and Uryvaeva, 
1985). 
(D) Cell fusion 
Fusion of cells is an important biological process to form polyploidisation in 
fertilisation of the ovum and formation of skeletal muscles. During chronic 
granulomatous inflammation, the Langhan's or foreign body-type giant cells are 
formed by the coalescence and fusion of epithelioid cells, with only rare internal 
nuclear division. They may achieve diameters of 40-50 pm and may contain as 
many as 50 nuclei. A variety of in vitro studies could also introduce new genetic 
material in the cell fusion process and consequently result in genotypyic changes 
(Brodsky and Uryvaeva, 1985). 
1.8.2 Genetic control of the cell cycle 
During the normal cell cycle, duplication of genomic DNA is systematically 
followed by mitosis resulting in two daughter cells with diploid DNA content, 
equivalent to the parent cells. To maintain euploid gene balance, DNA sequences 
must be replicated every cell cycle but not more than once (Diffley, 1996). The 
normal cell division cycle consists of S (synthesis) and M (mitosis) phases, preceded 
by the gaps GI and G2, respectively. Progression through the cell cycle is regulated 
by the sequential activation and inactivation of cyclin-dependent kinases (Cdks). 
Cdk activities are controlled by several different mechanisms, including binding of 
positively acting regulatory cyclin subunits, inhibition by Cdk inhibitors (CKTs), 
phosphorylation of Cdks by Cdk-activating kinase and dephosphorylation by cell-
cycle-regulated phosphoiylases. If the DNA damage checkpoint fails, DNA repair 
will be compromised and cells will undergo consequences of replicating the damaged 
template (Reviewed in Hartwell and Kastan, 1994; Nasmyth, 1996; Roberts, 1999; 
Sherr and Roberts, 1999; Yang and Kornbluth, 1999). However, in some instances 
the replication machinery is able to replicate across lesions in the template DNA, so- 
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called tranlesion synthesis (Friedberg et al., 1995). A recently discovered DNA 
polymerase E appears to be involved in the bypass of damage so avoiding this 
consequences of replicating the damaged template (Wood and Shivji, 1997; Gibbs et 
al., 1998; Bridges, 1999). 
(A) Gi phase for controlling the approach to S phase 
A number of GI regulatory mechanisms are now well established. The most 
important 'regulators' of these include CKI, retinoblastoma (Rb) family and p53. 
Two families of mammalian CKI have been described, based on protein sequence 
[NK4b 	[NK4a 	ENK4c 	 ENK4d 
similarity. Members of the [NK4 family (p15 	, p16 	, p18 	and p19 	) 
contain an ankyrin repeat motif and are specific for Cdk4 and Cdk6, acting as 
inhibitors of cyclin Ds (Dl, D2 and D3). The KIP/CIP family including 
Wafl/Cipl/Sdil 	 Kipi 	 Kip2 
p21 	(P21), P27 (p27), p57 	(P57) share an N-terminal domain of 
approximately 80 amino acids that is necessary and sufficient to bind to and inhibit 
Cdk2/cyclinA, Cdk2/cyclinE and Cdk4/6-cyclinDs (Sherr and Roberts, 1995; 
Nakayama and Nakayama, 1998; Johnson and Walker, 1999; Pavletich, 1999). 
The Rb family, including pRb (p105), p107 and p130, plays an integral role in 
negatively regulating E2F-dependent transcription (Weinberg, 1995; Mulligan and 
Jacks, 1998). E2F comprise a group of at least six related proteins that regulate the 
expression and timing of various genes important for cell-cycle progression, such as 
thymidine synthase, nbonucleotide reductase and B-myb (Johnson and Schneider-
Broussard, 1998). Rb-family members, in their hypophosphorylated active state, 
retain cells in GO or GI phases by repressing the transcription of the E2F family of 
transcription factors that are required for progression of quiescent cells toward S 
phase (Weinberg, 1996). Furthermore, pRb (p105) can also repress transcription of 
endogenous cell cycle genes containing E2F sites through recruitment of histone 
deacetylase (HDAC), a modulator of core-histone-DNA interactions that is linked to 
repression of gene expression (Brehm et al., 1998; DePinho, 1998; Robin X et al 
1998). 
Functioning as a transcription factor, p53 up-regulates expression of genes that 
contain p53-binding elements, mainly by transactivating p21, which mediates the 
arrest of cells at the GUS boundary (el-Deiry, 1998; Gartel and Tyner, 1999). 
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Moreover, p53 protein affects global genomic DNA repair and binds proteins 
involved in DNA repair, such as XPB, RPA and RAD51(Dutta et al., 1993; Lim and 
Hasty, 1996; Wang et al., 1996). In many cellular system, p53 promotes apoptosis of 
cell harboring 'irreparable' or high DNA damage (Bates and Vousden, 1996). 
(B) The S phase control 
In eukaryotic cells, DNA replication is initiated at specialised sequences 
termed replication origins. The initiation events must be restricted to once per cell 
cycle, to avoid over-replication of parts of the genome. It has become clear that in S. 
cerevisiae the origin recognition complex (ORC), mini-chromosome maintenance 
(MCM) proteins and, possibly, Cdc6 (and its fission yeast homologue Cdcl8) are 
required for the initiation of DNA replication (Dutta and Bell, 1997; Kearsey and 
Labib, 1998). Biochemical analysis of the ORC, which contains six polypeptides 
ranging from 50 to 104 Mi., has shown that it contains ATPase activity that is 
modulated by origin of DNA binding (Klemm et al., 1997). The MCM family 
(MCM2-MCM7) contain a DNA-dependent ATPase motif, which could suggest that 
the MCMs serve as a DNA helicase (Rowles and Blow, 1997). The overall 
regulation of origin-firing appears to be orchestrated by the protein kinase 
Cdk2/cyclin A or E. Recently, the human homologue of Cdc6 and Cdc 18 have also 
been isolated (Williams et al., 1997; Hateboer et al., 1998). 
The proteins necessary for chromosomal replication interact to form large 
multiprotein complexes termed replisomes, containing DNA polymerase aTh, PCNA, 
RF-C, a DNA helicase which opens the DNA helix, the single-strand DNA binding 
protein RP-A, and DNA ligase I which synthesises a phosphodiester bond to join 
Okazaki fragments or repair single strand nicks (Baker and Bell, 1998; Gordon and 
Wright, 1998). 
The controls determining the order of S phase and nuclear division can be 
disrupted in some cells such as Drosophila nurse cells and mammalian trophoblast 
giant cells, where multiple S phases occur in the absence of mitosis (MacAuley et al., 
1998; Royzman and On-Weaver, 1998). 
(C) After replication—G2 and M phase control 
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The Cdc2/cyclinBl complex, termed Mitosis Promoting Factor (MPF), is the 
major mitotic kinase, which is responsible for the phosphorylation of the major 
components of chromatin structure such as histone Hi and HMG (high-mobility-
group) proteins, and of other components of the G2/M transition machinery (King et 
al., 1994; Morgan, 1996, 1997). Cdc2 should thus be an important target of 
checkpoint signalling pathways. Fission yeast Cdc2 is inhibited by phosphorylation 
on Tyr 15. This phosphorylation is catalysed by the kinase Weel, and 
dephosphorylation is catalysed by the phosphatase Cdc25 (Rhind and Russell, 1998). 
The DNA damage and replication checkpoints block entry into mitosis by 
inactivating Cdc2. This is accomplished in part by maintaining the Cdc25 
phosphatase in a phosphorylated form that binds 14-3-3 proteins. The 14-3-3-bound 
form of Cdc25 is prevented from activating Cdc2, and leading to arrest in the G2 
phase of the cell cycle. Checkpoint kinases that regulate the interactions between 
Cdc25 and 14-3-3 proteins include S. pombe Cdsl (fission yeast) and Chkl 
(mammalian) (Connell et al., 1997; Chen et al., 1999). 
In M phase, the spindle checkpoint is thought to monitor the attachment of the 
kinetochores of all chromosomes to the mitotic spindle and the tension extended on 
the kinetochores by microtubules (Nicklas, 1997). Genetic studies have shown that 
sister chromatid segregation depends on the machinery for degrading mitotic cyclins, 
a ubiquitin-protein ligase called anaphase-promoting complex or cyclosome(APC/C) 
(reviewed in Zachariae and Nasmyth, 1999). In S. cerevisiae chromatid disjunction 
involves the APC/C-mediated degradation of the Pds 1 protein, which exists in a 
complex with the Espl protein (related to the fission yeast CutiP). When Espi is 
liberated, it promotes the cleavage of the cohesin Scc 1 and Smc 1 subunits from the 
cohesin multiprotein complex, which holds the sister chromatids together. Cleavage 
of Sccl and Smcl results in release of cohesion between the sister chromatids, and 
their separation to opposite spindle poles (Uhlmann et al., 1999; Zou et al., 1999). In 
this pathway, Cdc20 has been shown to be a substrate-specific activator of the 
APC/C and the MAD and BUB proteins prevent activation of the APC/C (Kallio et 
al., 1998; Wassmann and Benezra, 1998). Figure 1.11 outlines the molecular 
pathways regulating the cell cycle. 
43 
Figure 1.11 A simplified representation of the molecular pathway regulating the 
cell cycle. 
Schematic representation of the cell cycle and some reported regulators (adapted 
from Coffman and Studzinski, 1999). 
Gil events: Induction of p21 (also known as WAF1 or CIP1) appears to be at 
least partially dependent on p53 and occurs when cells are exposed to DNA-
damaging agents. p21 appears to inhibit all of the cyclin-CDK complexes. Rb 
is bound to the transcription factor E2F during G1, but under phosphorylation, 
E2F is released and activates the transcription of genes required for transition 
into S phase. A family of Rb-like molecules (Rb, p107, p130) may function 
similarly or in combination. 
S phase: The proteins which are involved in replication origin licensing are the 
origin recognition complex (ORC) and mini-chromosome maintenance (MCM) 
proteins. 
G2 and M phase: One principal G2 regulating activity is MPF (Cdc2/cyclin Bi) 
kinase activity, which can be inhibited by p21. MPF activity can also be 
inhibited by removal of either Cdc2 or cyclin B 1 subumits. 
Model for proteolytic cleavage of one of cohesin's subunits in the spindle-
assembly checkpoint (adapted from Uhlmann et al., 1999). 
The spindle assembly checkpoint mechanism is thought to monitor the 
attachment of kinetochores of all chromosomes to the mitotic spindle and the 
tension exerted on the kinetochores by microtubules. Proteolytic cleavage of 
one of cohesin's subunits is necessary for sister separation, suggesting that 
cohesion complexes link sister chromatids. Mad2 is included in the scheme as a 
known inhibitor of APCCdC20 . 
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1.9 Project Aim 
The ERCC1 gene was the first human NER gene to be isolated using human 
genome DNA to transfect an NER-deficient Chinese hamster ovary cell mutant. The 
first mouse model for defective NER was also developed for this gene by this 
laboratory. Two other ERCCJ-deficient mutant lines have also been reported by 
Hoeijmakers' group. All these mice showed characteristic aberrant nuclei in the 
liver. Because these mice were generated by insertional mutagenesis in the central or 
C-terminal region of ER CC] gene, we suspected that these animals might still 
possess a residual ERCC 1 activity. The first aim of this project was to produce a 
fully inactivated ERCC1 knockout mouse to compare the phenotype with our 
existing knockout. Furthermore, our original ERCCJ knockout mice died before 
weaning at the age of three weeks precluding further observations on changes in 
adult organs. The second aim was to employ the Cre/loxP recombination system in 
gene targeting to overcome this obstacle. 
The ERCC1 protein and the XPF (ERCC4) product form a heterodimer, which 
makes the 5' incision of the damaged strand in NER and also has a function in a 
mitotic recombination process. Chinese hamster ERCC 1 and ERCC4 mutants and 
mouse embryo fibroblasts from ERCCJ-deficient mice are also sensitive to cross-
linking agents in addition to their NER defects. I also report here an investigation of 
the possible role of ERCC 1 in recombination repair. In addition, the characterisation 
of a novel anti mouse-ERCC 1 antibody is also described. 
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Chapter 2 
Materials and Methods 
Ergi 
2.1 Materials 
2.1.1 Laboratory reagents and suppliers: 
Amersham Life Science UK Ltd.: Hybond-C extra supported nitrocellulose 
membrane, Hybond-N nylon membrane, ECL detection reagents. 
BDH Ltd.: dimethyldichiorosilane, hydrochloric acid, Sarkosyl NL30, xylene, xylene 
cyanol. 
Boehringer Mannheim UK Ltd.: deoxyribonucleotides, proteinase K. 
Difco Laboratories: agar, bacto-tryptone, bacto-yeast extract. 
Fisher Scientific UK Ltd.: 3M blotting paper, boric acid, butanol, calcium chloride, 
citric acid, disodium hydrogen orthophosphate, disodium hydrogen orthophosphate, 
EDTA, filter paper, glacial acetic acid, hydroxyquinolin, isoamyl alcohol, 
isopropanol, sodium acetate, sodium chloride, sodium citrate, sodium hydroxide, 
sodium dihydrogen orthophosphate, potassium acetate, trichioroacetic acid. 
Gibco BRL Life Technologies Ltd.: 1 OObp DNA marker ladder, agarose, formamide, 
guanidine hydrochloride, Hind III digested X DNA marker ladder, phenol, Tris, low 
melting point agarose, NACS columns, hybridisation bags, urea. 
ICN Biomedicals Ltd.: Dulbecco's PBS tablets. 
Millipore (UK) Ltd.: disposable sterile filters, Immobilon P. 
National Diagnostics: ecoscint A. 
New England Biolabs (UK) Ltd.: prestained broad range molecular weight marker 
proteins, 3X reducing SDS sample buffer. 
New England Nuclear Life Science Products: Genescreen Plus. 
Perkin-Elmer Corporation: ABI PRISM dye terminator cycle sequencing reaction 
ready kit. 
Promega (UK) Ltd.: oligo dT, random hexamers, RNasin. 
Qiagen Ltd.: tip 500 columns. 
Scotlab Ltd.: acrylamide/bis-acrylamide solutions. 
Sigma-Aldrich Company Ltd.: bovine serum albumin, bromophenol blue, dextran 
sulphate, DTT, ethidium bromide, ficoll, formaldehyde, glycerol, herring sperm 
DNA, IPTG, mineral oil, MOPS, new methylene blue, NP-40, parafilm M, PMSF, 
sodium bicarbonate, thymidine, Triton X-100, Tween 20, X-Gal. 
Vector Laboratories, thc. : VECTASTAIN® ABC kits 
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2.1.2 Oligonucleotides 
All oligonucleotides were synthesised by the Oswel DNA service. The 
sequences of all primers used are given in Table 2.1. 
Table 2.1 Oligonucleotides 
CODE SEQUENCE (5'—*3') DESCRIPTION 
033M CCAGTGTTGAAGTTTGTGCG ERCCJ exon 4 (429-448) 
035M CGAAGGGCGAAGTTCTTCCC ERCC1 exon 5 (598-579) 
432E GGAAGAACTTCGCCCTTTCG ERCCJ exon 5 (580-598) 
529N GGTGCAGTCAGCCAAGATGC ERCCJ exon 6 (683-664) 
262W AGCCTACCCTCTGGTAGATT HPRTexon 9(960-984) 
GTCG  
A09 GGACCACCCACCAGGAGGA ERCC1 exon 2(141-161) 
AG 
ERCC1-Nco 'ccattagccATGGACCCTGGGAA ERCCJ exon 1 (99-119); 
GGACGAG (ccATGG: NcoI) for recombinant protein 
G7853 ATTAACCCTCACTAAAGGGA T3 promoter in pBluescript 
II SK (+) (795-775) 
G7854 AATACGACTCACTATAGGGC T7 promoter in pBluescnpt 
II SK (+) (622-642) 
T7471 CAACTACTTGAAGTCAAAGT ERCC1 5'-flanking region 
CTCCC 
Z8303 ccattagccatgGTCAAGCCCTTAT ERCC1 exon 3 (204-224); 
TCAGATCG (ccatgG: NcoI) for recombinant protein 
Z8304 cgcggatcCACATCCACTTGAAC ERCC] exon 5 (623-603); 
CAGCAG (ggatcC: BamHI) for recombinant protein 
Z8305 cgcggatccgCGAGGCACTTTGA ERCCJ 	exon 	10 	(992- 
GGAAGGG (ggatcc: BamHI) 972); 	for 	recombinant 
protein 
'lowercase letters: non ERCC 1 coding sequences 
EM 
2.1.3 Bacterial strains 
Bacterial strains used in this study are given in Table 2.2. 
Table 2.2 Bacterial strains used in this course of studies 
Strain Genotype Comments 
for high-level 
expression of gene 
BL21(DE3) K ompThsdsB(rB-mB-) gal dcm (DE3) cloned into expression 
(Novagen) vectors containing 
bacteriophage T7 
promoter. 
supE44 	LlacU169 	(180 	1acZAM15) for recombinant DNA 
DH5a hsdRl 7 recAl 	endAl 	gyrA96 	thi-1 manipulation with 
relA 1 blue/white screening 
K802 e14(mcrA), mcrBl, hsdR2, galK2, for phage infection 
galT22, supE44, metBi 
ii(mcrA)183 zl(mcrCB-hsdSMR- for recombinant DNA 
XL1-Blue mrr)1 73 endAl supE44 thi-1 recAl manipulation with 
(Stratagene) gyrA96 relAl Lac [F'proAB blue/white screening, 
lacIqlacZAM15Tnl 0(tet1)] Tet-resistant 
2.1.4 DNA /RNA modifying enzymes 
Boehringer Mannheim UK Ltd.: Kienow polymerase, restriction endonucleases. 
Gibco BRL Life Technologies Ltd.: bacterial alkaline phosphatase, restriction 
endonucleases, T4 DNA kinase, Taq DNA polymerase. 
New England Biolabs (UK) Ltd.: restriction endonucleases, T4 DNA ligase. 
2.1.5 Radioactive reagents 
Amersham International plc.: Redivue [a- 32P]-dCTP (--'3000 Ci/mmole, lOmCi/ml). 
2.1.6 Plasmids 
The plasmids used are presented in Table 2.3. 
Table 2.3 Plasmids 
PLASMID DESCRIPTION REFERENCE 
pBluescript II SK(+) Cloning vector (Thummel et al., 
1988) 
for high-level expression of target gene; (Studier, 1991) 
pET-29c(+) fusion protein could contain C-terminal 6 
a.a. His.Tag; Kan-resistance 
pGAPDH Mouse GAPDH cDNA (Fort et al., 1985) 
pMC/CreN Cre recombinase expression vector 
pTZME Mouse ERCC1 cDNA (van Duin et al., 
1988) 
2.1.7 Mammalian cell culture lines 
The cell lines used are presented in Table 2.4. 
Table 2.4 Mammalian cell lines 
CELL LINE DESCRIPTION REFERENCE 
CH09 Wild-type Chinese hamster (Wood 	and 	Burki, 
ovary cell line. 1982) 
CH043-313 ERCCJ-deficient Chinese (Wood 	and 	Burki, 
hamster ovary cell line. 1982) 
HM-1 HPRT-deficient embryonic (Selfridge et al., 1992) 
stem cell line (Magin et al., 1992) 
MRC5V1 SV40 transformed wild-type (Huschtscha and 
human fibroblast cell line Holliday, 1983) 
PF 20 Immortalised wild type Melton et al., 1998 
mouse embryonic fibroblast 
cell line.  
PF24 Immortalised ERCCJ- Melton et al, 1998 
deficient mouse embryonic 
fibroblast cell line.  
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2.1.8 Antibiotics 
Sigma-Aldrich Company Ltd.: ampicillin, penicillin G, streptomycin, kanamycin. 
2.1.9 Mammalian cell culture reagents 
Becton Dickinson Labware: plasticware. 
Difco Laboratories: trypsin. 
Gibco BRL Life Technologies Ltd.: foetal calf serum, Glasgow's Modified Eagle 
Medium (BHK2 1), horse serum, L-glutamine, new-born calf serum, non-essential 
amino acids, sodium bicarbonate, sodium pyruvate. 
Sigma-Aldrich Company Ltd.: b-mercaptoethanol. 
2.1.10 Bacterial culture reagents 
Difco Laboratories: agar, bacto-tryptone, bacto-yeast extract 
2.1.11 Media 
2.1.11.1 Bacterial culture media 
BBL top agar: 1% (w/v) trypticase, 0.65% (wlv) bacto-agar, 10mM MgSO 4 and 
0.5% (wlv) NaCl, adjusted to pH 7.0 with NaOH. 
Luria Broth (LB): 1% (w/v) bacto-tryptone, 0.5% (w/v) bacto-yeast extract, and 
0.5% (wlv) NaCl, adjusted to pH 7.2 with NaOH. 
Luria Agar: 1.5% agar, 1% (w/v) bacto-tryptone, 0.5% (wlv) bacto-yeast extract, and 
0.5% (w/v) NaCl, adjusted to pH 7.2 with NaOH. 
Terrific Broth (TB): 1.2% (w/v) bacto-tryptone, 2.4% (w/v) bacto-yeast extract, 0.4% 
(vlv) glycerol, 170mM potassium dihydrogen orthophosphate, and 72mM 
dipotassium hydrogen orthophosphate. 
When required, ampicillin or kanamycin were added immediately prior to use, to a 
final concentration of 100tgIm1. 
2.1.11.2 Mammalian tissue culture media 
Glasgow's Modified Eagle's Medium (GMEM) (McPherson, 1962, with 
modifications by W. House, Medical Research Council Institute of Virology, 
University of Glasgow, 1964) was used as the base culture medium for mouse and 
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human fibroblast cell lines. Freezing medium for long term storage of cells consisted 
of the appropriate supplemented culture medium with additional DMSO and FCS to 
final concentrations of 10% (v/v) and 20% (vlv) respectively. 
Fibroblast and cerebellar cell culture medium: 10% (vlv) FCS, 1X non-
essential amino acids, 1mM sodium pyruvate, 25U/ml penicillin, 25g/ml 
streptomycin, in GMEM. 
2.1.12 Solutions and buffers 
Bacterial alkaline phosphatase buffer: 530mM Tris-HC1 pH 7.5, 95mM MgCl2, 
50mM DTT. 
Carnoy fixative: 3 parts methanol, 1 part glacial acetic acid. 
CA: 24 parts chloroform, 1 part isoamyl alcohol. 
Citrate buffer: 8.55% sucrose, 5% DMSO, 40mM tn-sodium citrate, pH 7.6. 
Denaturation buffer: 0.5M NaOH, 1.5M NaCl. 
Coomassie stain: 0.025% (w/v) Coomassie blue R-250, 40% (v/v) methanol, 7% 
(v/v) glacial acetic acid. 
Coomassie destain: 40% (v/v) methanol, 7% (vlv) glacial acetic acid. 
Dialysis buffer: 10mM Tris-HC1 (p1-17.5) 0.1mM EDTA (p117.5). 
Electroblotting buffer: 48mM Tris-HC1, 39mM glycine, 20% (v/v) methanol, pH 9.2. 
Electroporation buffer: 21mM HEPES, 5mM D-glucose, 8mM Na 2HPO4, 5mM KC1, 
140mM NaCl. 
FACS stock solution: 3.4M tn-sodium citrate, 0.5M Tris —HCl, 1% NP40, 
0.52mg/ml spermine tetrahydrochlonde, pH 7.6. 
FACS Solution A: 30jigIml trypsin in stock solution. 
FACS Solution B: 0.5mg/mI trypsin inhibitor, 0.1mg/ml ribonuclease inhibitor in 
stock solution. 
FACS Solution C: 0.42mg/mi propidium iodide, lmg/ml spermine 
tetrahydrochlonde in stock solution. 
Formalin: 4% (v/v) formaldehyde in phosphate buffered saline. 
Formamide sample buffer: 2.3X MOPS, 50% de-ionised formamide, 11% 
formaldehyde. 
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Haematoxylin: 4.6% (v/v) glacial acetic acid in Harris hematoxylin solution. 
lox kinase buffer: 50mM Tris-HCI pH 7.5, 100mM MgC12, 100mM DTT, 10mM 
ATP, 0.5j.tglml BSA. 
lox T4 DNA ligase buffer: 200mM Tris-HCL pH 7.6, 75mM MgCl2 50mM DTT, 
250 j.tg/ml BSA, 5mM ATP. 
2X lysis buffer: 100mM Tris-HC1 pH 8.3, 250mM NaCl, 2% NP-40, 4mM EDTA, 
200mM Na2HPO4, 2mM PMSF. 
iox MOPS: 200mM 3-(N-morpholino) propane-suiphonic acid (MOPS), 50mM 
Sodium acetate, 10mM EDTA, pH 7.0. 
Neutralising buffer: 3M NaCl, 0.5M Tns-HC1, pH 7.0. 
Northern blot stripping solution: 0.01% (w/v) SDS, 0.01X SSC. 
Oligo labelling buffer: 50i.tl solution A, 125tl solution B, 75p1 solution C. 
Solution A: 1.25M Tris-HC1 pH 8.0, 0.125M MgC1 2, 25mM 13-mercaptoethanol, 
0.5mM each of dGTP, dATP and dTTP. 
Solution B: 2M HEPES buffer adjusted to pH 6.6 with NaOH. 
Solution C: Random hexadeoxyribonucleotides OD260 nm=90 units/ml in TE. 
P1: 50mM Tris-HCI pH 8.0, 10mM EDTA, 100igIml RNase A. 
P11: 20mM NaOH, 1% (w/v) SDS. 
Pill: 2.55M potassium acetate pH 4.8. 
PCA: 25 parts redistilled phenol, 24 parts chloroform, 1 part isoamyl alcohol. 
iox PCR: 50mM KC1, 1.5mM M902,  10mM Tris-HCL pH 8.3, 0.01% (w/v) gelatin, 
0.45% (v/v) Triton X-100, 0.45% (v/v) Tween 20. 
QBT: 750mM NaCl pH 7.0, 50mM MOPS, 15% (v/v) ethanol, 0.15% (vlv) Triton X-
100. 
QC: 1M NaCl pH 7.0, 50mM MOPS, 15% (v/v) ethanol. 
QF: 1.25M NaCl pH 8.2, 50mM MOPS, 15% (v/v) ethanol. 
lox RT buffer: 500mM Tris-HC1 pH 8.3, 60mM MgC12, 400mM KCI, 10mM DTT. 
5X sample buffer: 20% (v/v) glycerol, 100mM EDTA, 0.1% (w/v) bromophenol 
blue. 
SDS-PAGE running buffer: 250mM Tris-HC1, 1.92M glycine, 2% (w/v) SDS. 
20X SSC: 3M NaCl, 0.3M tn-sodium citrate, pH 7.0. 
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Southern blot stripping solution: 1% (wlv) SDS, 0. 1X SSC. 
5X T4 DNA Ligase: 250mM Tris-HC1 pH7.6, 50mM MgCl2,  5mM ATP, 5mM DTT, 
25% (w/v) polyethylene glycol-8000. 
lOX TBE: 0.9M Tris-HC1, 0.9M boric acid, 20mM EDTA. 
Tail buffer: 400mM NaCl, 10mM Tris-ETC1, 3mM EDTA, 1% (wlv) SDS. 
TBST: 50mM Tris-HCI pH 7.5, 150mM NaCl, 0.05% (v/v) Tween 20. 
TE buffer: 10mM Tris-HC1, 1mM EDTA, pH 8.0. 
Transformation buffer: 50mM CaCl 2 , 10mM Tris-HC1. 
2.1.13 Antisera 
Amersham Life Science UK Ltd.: Anti-rabbit IgG, peroxidase-linked specific whole 
antibody (from donkey) (NA934). 
Calbiochem-Novabiochem UL Ltd.: anti-p53 mouse monoclonal IgG2a (Clone Pab 
421). 
Caltag Ltd: anti-mouse CD4 PE-conjugated rat monoclonal IgG2a (clone CT-CD4), 
anti-mouse CD8a FITC-conjugated rat monoclonal IgG2a (clone CT-CD8a). 
Pharmingen: anti-mouse CD3 FITC-conjugated monoclonal IgG2a (clone HIT3a). 
Santa Cruz Biotechnology, Inc.: anti-hMSH2 rabbit polyclonal IgG (N-20), anti-
hPMS2 rabbit polyclonal IgG (C-20), anti-p21 mouse monoclonal IgG2a (F-5), anti-
PCNA mouse monoclonal IgG2a (PC-10). 
Sigma-Aldrich Company Ltd.: anti-mouse IgG peroxidase-conjugated goat 
polyclonal IgG, anti-calbindin-D-28K mouse monoclonal IgGi (clone CL-300). 
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2.2 Methods 
2.2.1 Bacterial culture 
2.2.1.1 Growth of E. Coli 
Cells were grown at 37 0C, either in suspension in LB or TB with shaking, or 
on the surface of Luria agar plates. Cells grown on Luria agar plates supplemented 
with ampicillin were incubated at 30 °C to prevent growth of satellite colonies. 
2.2.1.2 Storage of E. Coli 
For long term storage, 900j.il of a fresh culture, grown overnight in LB 
supplemented with antibiotic where necessary, was mixed with 100j.tl DMSO, and 
frozen at -70 °C. Cells were recovered by scraping the surface of the frozen culture 
with a sterile inoculating loop and streaking onto a Luria agar plate. For short term 
storage (4-6 weeks), bacteria were streaked onto Luria agar plates, and stored at 4 °C. 
2.2.1.3 Transformation of E. coli 
Bacteria were transformed with plasmid DNA by the method of Mandel and 
Higa (1970) with the modifications by Dagert and Ehrlich (1974) (Dagert and 
Ehrlich, 1979; Mandel and Higa, 1970). An inoculating loop was used to scrape 
bacterial growth from a fresh Luria agar plate of E. coli and was added to 50m1 of 
LB supplemented with MgCl 2 to a final concentration of 20mM. Cells were grown 
with vigorous shaking at 37 °C until the OD600nm of the suspension equalled 0.2, and 
the cells were in log phase growth. The cells were chilled on ice for 5 minutes, and 
then spun down at 1,500rpm for 15 minutes at 4 °C. The pellet was gently 
resuspended in 20m1 ice-cold transformation buffer, incubated for 30 minutes on ice, 
subsequently re-pelleted at 1,500rpm for 15 minutes at 4 °C, and finally resuspended 
in 2m1 ice-cold transformation buffer. The suspension of competent cells was then 
incubated on ice for a minimum of 2 hours prior to use. 
Approximately lOng of plasmid DNA in a volume of 5-10j.tl was added to 
lOOjil of competent cells, which were then incubated on ice for 30 minutes. 
Following heat shock at 37 °C for 5 minutes, 400p1 of warm LB was added, and the 
mixture incubated at 37 °C for 1 hour to allow expression of antibiotic resistance. 
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Thereafter, the cells were spread onto Luria agar plates with ampicillin selection, and 
incubated overnight at 30'C. 
Where appropriate, 30jil of 2% (w/v in dimethylformamide) X-Gal and 20.tI 
of 100mM IPTG were also spread over the surface of the plate to enable blue-white 
colour selection of colonies containing recombinant plasmids. 
2.2.2 A. DASH II mouse genomic library screening 
2.2.2.1 Growth of E. coli K802 plating cells and titration of phage 
A single colony of E. co/i K802 from an LB plate was picked and placed in a 
sterile 250m1 conical flask containing 20mls of terrific broth supplemented with 
0.2% (v/v) maltose. The culture was incubated overnight at 37 °C with vigorous 
aeration. The following day the culture was decanted into a 50m1 Falcon tube and 
the cells pelleted and resuspended in 20m1 10mM CaCl 2, 10 MM  MgSO4. Plating 
cells were stored at 4 °C for a maximum of three weeks. To titrate phage, 1 Opi of an 
appropriate dilution of phage in LB medium or SM solution (50mM Tris.HC1, 
100mM NaCl, 8mM MgSO4 , pH 7.5) was added to 100tl of K802 plating cells in a 
plastic tube, mixed then incubated for 20 minutes at room temperature to allow 
adsorption of phage by bacteria. Following this, 3mls of molten BBL top agar (50°C 
) was mixed with the phage/cells and poured evenly onto an L-agar plate. The plates 
were left for 10 minutes for the agar to set and plates were incubated overnight at 
37°C. Plate lysate stocks were prepared as above but with phage/bacteria MOl 
adjusted to achieve confluent lysis. To lift phage from the L-agar plate, 5mls of SM 
solution was added to each plate and placed on a gently shaking table for 30 minutes. 
The supernatant was poured into a fresh tube, a few drops of chloroform were added 
to the stock which was then titred. 
2.2.2.2 Preparing filter replicas of library plates 
Nylon membrane (Hybond N, Amersham) were placed on the surface of 
library plates (precooled to 4 °C) for 5 minutes and asymmetrical marks made in the 
membrane made with an ink soaked needle to facilitate the localisation of positive 
plaques. Membranes were carefully removed and placed (DNA side up) on 
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Whatman 3M paper pre-soaked with denaturing solution (0.5M NaOH, 1 .5M NaCl) 
for 5 minutes then transferred onto filter paper pre-soaked with neutralising buffer 
(0.5M Tns.HCI, 1.5M NaCl, pH 8.0) for 5 minutes then transferred onto filter paper 
pre-soaked with 2xSSC. Filters were air dried for 30 minutes then baked at 80 °C for 
1 hour. 
2.2.2.3 Pre/hybridisation of filter replicas 
Baked filter replicas were rinsed briefly with distilled H20 and 6xSSC then 
placed into a sealed plastic hybridisation container and incubated with lOOmI 
prehybridisation buffer (50% formamide, 5xSSC, 50mM NaPO4 , pH7.2, 1% (w/v) 
SDS, 350.il lOmg/ml sonicated herring sperm DNA) for a minimum of 1 hour at 
37°C. Following prehybridisation the cDNA probe was added and hybridisation 
carried out for 18 hours at 37'C. Hybridised filters were washed three times for 30 
minutes at 55 ° C in prewarmed 0.1xSSC, 0.1% (v/v) SDS then exposed overnight at - 
70°C. 
2.2.2.4 Picking X bacteriophage plaques 
Well separated plaques, corresponding to putative positive hybridisation 
signals, were plugged from L plates with an inverted sterile pipette tip and placed in 
1 ml of SM into which 1 drop of chloroform was added to inhibit bacterial growth 
during storage. To ensure the phage had diffused out of the agar the plaque 
suspensions were left for at least 1 hour before further use. 
2.2.2.5 Lysis of ?, bacteriophage liquid culture 
Prewarmed LB medium (250m1) was supplemented with 0.2% maltose (w/v), 
10 MM  MgCl2 and 10 mM CaC1 2 and inoculated with 500p.l of a fresh overnight 
K802 culture. Several cultures were set up in parallel and inoculated with different 
amounts of recombinant bacteriophage clones, typically 1x109 pfu of plate lysate 
stock completed lysed a 250ml culture in 6 hours. X DNA was isolated as described 
in Section 2.2.3.3. 
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2.2.3 Nucleic acid isolation 
2.2.3.1 Small-scale preparation of plasmid DNA 
A modification of the method described by (Ish-Horowicz and Burke, 1981) 
was used to prepare amounts of plasmid DNA up to 10g. Bacteria were grown 
overnight at 37 °C in Sm! LB or TB supplemented with ampicillin to a final 
concentration of 50g/ml. 1 .5m1 of the culture was transferred to a microffige tube, 
and the cells pelleted by centrifugation for 5 minutes. The pellet was resuspended in 
100tl of solution P1, and the cells lysed by addition of 200tl of solution P2 with 5 
minutes incubation on ice. 1 50j.il of cold solution P3 was added, with gentle mixing, 
and the tube incubated on ice for a further 15 minutes. Precipitated chromosomal 
DNA, SDS and protein were sedimented by centrifugation for 10 minutes in a 
microcentrifuge, and the supernatant, containing the plasmid DNA, removed to a 
fresh tube. The supernatant was centrifuged again for a further 10 minutes to remove 
residual debris, and then plasmid DNA was precipitated by addition of lml cold 
ethanol. Following 10 minutes centrifugation, the nucleic acid pellet was washed 
twice with 70% (v/v) ethanol, vacuum dried, resuspended in 50p1 sterile distilled 
water and stored at -20 °C. 
2.2.3.2 Large scale preparation of plasmid DNA (Qiagen prep.) 
For preparation of larger amounts of plasmid DNA, up to 500pg, a column 
purification method was employed. Bacteria were grown for 24 hours at 37 °C in 
50m1 of TB supplemented with ampicillin to a final concentration of 1 00tgIml. Cells 
were pelleted by spinning at 4,000rpm for 20 minutes at 4 °C. The pellet was 
resuspended in lOml of solution P1 supplemented with RNase to a final 
concentration of 0.5tgIml, and the cells lysed by addition of lOml of solution P2 
with 5 minutes incubation at room temperature. lOml of cold solution P3 was added, 
with gentle mixing, and the tube incubated on ice for a further 20 minutes. 
Precipitated chromosomal DNA, SDS and protein were sedimented by centrifugation 
at 16,000rpm for 10 minutes at 4 °C. The supernatant was removed promptly, filtered 
and applied to a Qiagen-tip 500 column, previously equilibrated with lOm! of QBT 
buffer. After washing twice with 30ml QC buffer, the plasmid DNA was eluted from 
the column with 15m! QF buffer. 1 2m1 of isopropanol was added to precipitate the 
DNA, which was then spun down at 10,000rpm for 10 minutes at 4 °C. The DNA 
pellet was resuspended in 400tl of sterile distilled water, prior to transfer into an 
microfuge tube, whereupon the DNA was reprecipitated with 40i.il of P3 and imi of 
cold absolute ethanol. Following 10 minutes centrifugation, the nucleic acid pellet 
was washed twice with 70% (v/v) ethanol, vacuum dried, resuspended in 200.il 
sterile distilled water and stored at -20 °C. 
2.2.3.3 Preparation of bactriophage ?. DNA 
Chloroform was added to the lysed 250m1 culture to a final concentration of 
1% (v/v). The culture was transferred to a 250m1 centrifuge tube and incubated at 
room temperature for 30 minutes. Cell debris was pelleted by centrifugation for 10 
minutes at 5,000 rpm in a Sorvall GSA rotor. The supernatant (200m1) was 
transferred to a fresh tube and equilibrated to 37 °C and 400d buffer 1 (20mg/mI 
RNase A, 6mg/mI DNAse I, 0.2mg/rn!, BSA, 10 mM EDTA, 100mM Tris.HCL, 
pH7.5) added and the sample incubated for 30 minutes to degrade bacterial DNA and 
RNA. The centrifuge tube was transferred to an ice bucket and 50m1 of ice cold 
buffer 2 (3M NaCl and 30% (w/v) PEG6000 was added and the sample stored for 1 
hour on ice (or overnight). Phage were pelleted by a 10 minute spin at 10,000 rpm in 
a Sorvall HB4 rotor. All of the supernatant was removed and the phage pellet 
resuspended with 9 ml of buffer 3 (100mM Tris.HC1, 100mM NaCl, 25 mM EDTA, 
4% (w/v) SDS, pH 7.5) and transferred to a 50m1 Falcon tube. The tube was mixed 
gently and incubated at 70 °C for 20 minutes then placed on ice. When cool, 1 
volume phenol/chloroform was added and mixed by inverting the tube many times 
until a complete emulsion had formed. The phases were separated by centrifugation 
at 5,000 rpm for 5 minutes at room temperature. Then a wide-bore pipette was use to 
transfer the aqueous phase to a clean tube. If interphase was thick, 
phenollcholoroform extraction was repeated once . Then an equal volume of 
chloroform was added to aqueous phase and extracted once. The aqueous phase was 
removed into a 2ml eppendorf tube and buffer 4 (1/10 volume 3M sodium acetate 
and 0.8 volume isopropanol) was added and mixed. DNA was precipitated by a 10 
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minute centrifugation at 10,000 rpm at room temperature. Pellets were washed 
twice with 70% ethanol, air dried then dissolved in 100-200 tl dH 20. 
2.2.3.4 Preparation of mammalian genomic DNA 
DNA was prepared from mouse tail samples, tissue samples and fibroblasts by 
the same method. Cultured cells were harvested by scraping in ice cold PBS, and 
pelleted by centrifugation at 1,300rpm for 5 minutes. Cell pellets and tissue samples 
were digested overnight at 37 °C in 750il tail buffer supplemented with proteinase K 
to a final concentration of 280 j.tg/ml. The supernatant was extracted twice with 750p.l 
PCA and vigorous shaking, and subsequently once with 750p.l CA to remove traces 
of phenol. The DNA was precipitated for 10 minutes at room temperature by 
addition of 750 jil of isopropanol. Following 10 minutes centrifugation, the nucleic 
acid pellet was washed twice with 70% (v/v) ethanol, vacuum dried, resuspended in 
200p1 sterile distilled water and stored ,either at 4 °C in the short term, or at -20 °C for 
longer periods. 
2.2.3.5 Preparation of mammalian RNA (RNAzO1 TM B method) 
A modification of the method described by (Chomczynski and Sacchi, 1987) 
was used for the isolation of total RNA from all cultured cells and tissues. The 
method used the commercially available reagent RNAz01TM  B (Biogenesis Ltd.) and 
followed the protocol supplied by the manufacturers. Briefly, approximately 3 00mg 
of tissue was homogenised with 6ml RNAz01TM  B using an Ultra-Turrax T25 
homogeniser (IKA-Laboratechnik). Cultured cells were lysed directly in the culture 
dish by the addition of RNAz0ITM  B (lml per 35mm petri dish) and the RNA was 
solubilised by pipetting the lysate a few times. The RNA was extracted by the 
addition of 0. 1 m chloroform per lml of homogenate, followed by vigorous shaking 
of the mixture for 15 seconds prior to placing on ice for 5 minutes. The suspension 
was then centrifuged at 12000g for 15 minutes at 4 °C. The aqueous phase was 
transferred to a fresh tube and the RNA precipitated by the addition of an equal 
volume of isopropanol. The RNA was left to precipitate at 4 °C for at least 15 minutes 
and then pelleted by centrifugation at 12,000g. The RNA pellet was then washed in 
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8mls 70% ethanol by vortexing followed by centrifugation at 7500g for 8 minutes at 
4°C. The pellet was allowed to air dry before being resuspended in 200tl of sterile 
distilled water for storage at -70 °C. 
2.2.3.6 Estimation of DNA concentrations 
DNA samples were diluted in imI of distilled water and the absorbency at 260 
and 280nm measured in a spectrophotometer (Perkin-Elmer, Lambda 15, UV/\TIS 
Spectrophotometer). Double stranded DNA of concentration 50gIm1 has an OD260 flm 
= 1.0. The ratio OD260nm/OD280nm gives an estimate of nucleic acid purity. A value of 
around 1.8 indicates that the preparation is not significantly contaminated with 
protein or phenol. 
2.2.3.7 Estimation of RNA concentrations 
RNA samples were diluted in imI of distilled water and the absorbency at 260 
and 280nm was measured in a spectrophotometer (Perkin-Elmer, Lambda 15, 
UV/VIS spectrophotometer). An OD260flm = 1.0 represents an RNA concentration of 
40 igIml. The ratio OD260nmIOD280nm  gives an indication of nucleic acid purity. A 
value of OD260nmIOD280nm= 2.0 indicates a pure preparation of RNA. 
2.2.4 Nucleic acid manipulation 
2.2.4.1 Restriction of DNA with endonucleases 
DNA was digested with 10 units of the desired endonuclease per tg of DNA 
using buffer and temperature conditions recommended by the manufacturer. For 
double digests involving enzymes with different recommended buffers, reactions 
were either carried out using an intermediate buffer, or DNA was digested in two 
sequential digests separated by a DNA purification procedure. Digestion reactions 
were terminated by heating at 65 °C for 10 minutes, phenol extraction, or by the 
addition of 5X sample buffer for agarose gel electrophoresis. 
2.2.4.2 Dephosphorylation 
61 
Bacterial alkaline phosphatase (BAP) is a phosphomonoesterase that 
hydrolyses 3' and 5' phosphates from DNA and RNA. It is suitable for removing 5' 
phosphates prior to end labelling and for dephosphorylating linearised plasmid 
vectors prior to insert ligation. Approximately 1 ng of DNA, in 90j.tl of sterile 
distilled water, was mixed with 10tl of lox BAP buffer and 66 units of BAP. The 
reaction mix was incubated for one hour at 65 °C, following which the DNA was 
purified by phenol extraction to remove all traces of the enzyme. 
2.2.4.2 Phosphorylation and ligation of PCR products 
In the process of cloning PCR products it was necessary to phosphorylate their 
5' termini by means of a kinase reaction. Reactions were performed on gel purified 
PCR products in 1 Oil volumes containing 1 tl i ox kinase buffer, and 1 tl of T4 
DNA kinase. Following incubation at 37 °C for 1 1 /2 hours, a further ljfl of iox kinase 
buffer was added, along with linearised plasmid vector DNA and 2 units of T4 DNA 
ligase. The total volume was made up to 201.il with sterile distilled water, and the 
ligation reaction incubated overnight at 15 °C, after which it was used to transform 
competent E. coil. 
2.2.4.3 Blunt-ending of DNA fragments 
Overhanging ends, generated by restriction endonucleases were converted to 
blunt ends by 'filling-in' using the Kienow fragment of E. coil DNA polymerase I. 
Approximately 1 p.g of DNA, in 39tl sterile distilled water, was mixed with 5p.1 iox 
nick translation buffer, 5p1 of 5mM dNTP's and 6 units of Klenow. The reaction mix 
was incubated at room temperature for 1 hour and the reaction stopped by phenol 
extraction. 
2.2.4.4 Ligation 
Linearised vector and insert DNA fragments were gel purified (described in 
section 2.2.4.6) prior to ligation. Approximately 200ng of insert DNA was ligated in 
a reaction with vector to insert DNA concentrations at a 3:1 molar ratio. Ligations 
were carried out in a 20tl reaction volume containing 4j.il of 5)( T4 ligase buffer and 
2 units of T4 DNA ligase and incubated overnight at 15 °C. Products of the ligation 
reaction were then used to transform E. coli. 
2.2.4.5 Electrophoresis of DNA in agarose gels 
DNA fragments were separated on 0.8-2% (w/v) electrophoresis grade agarose 
gels containing 0.5p.g/ml ethidium bromide and 1X TBE. DNA samples were mixed 
with 115  volume of 5X sample buffer prior to loading. Electrophoresis was carried out 
horizontally at 30-100V in a 1X TBE buffer system. Hind III digested bacteriophage 
X DNA marker ladder and a lOObp DNA ladder were used as size markers. After 
electrophoresis, DNA was visualised by UV illumination. 
2.2.4.6 Recovery of DNA from agarose gels 
If DNA was to be recovered from agarose gels, low melting point agarose was 
used, and the desired section of gel excised following electrophoresis. An equal 
volume of LX TBE, 0.2M NaCl was added, and the gel melted at 65 °C. ipi of 
glycogen was added to act as a carrier, and increase the proportion of DNA 
ultimately recovered. Next, an equal volume of redistilled phenol saturated with lx 
TBE, 0.1M NaCl was added, the mixture vortexed until an emulsion was formed, 
then spun down in a microfuge for 5 minutes. The aqueous phase was removed into a 
fresh tube, and 1 OOpi of butanol added to remove traces of phenol. The mixture was 
vortexed, then spun down for 1 minute and subsequently the butanol layer discarded. 
1/10th volume 3M sodium acetate pH 5.0 and 2 1 /2 volumes of cold absolute ethanol 
were added, and the DNA precipitated at -70 °C for 20 minutes. Following 10 minutes 
centrifugation, the nucleic acid pellet was washed twice with 70% (v/v) ethanol, 
vacuum dried, and resuspended in 10111 sterile distilled water. 
2.2.4.7 Electrophoresis of RNA in agarose gels 
RNA samples were electrophoresed on denaturing 1% (w/v) agarose gels 
containing 0.5tg/m1 ethidium bromide, IX MOPS and 0.66M formaldehyde. 20 jig of 
total RNA in 20g1 of sterile distilled water was added to an equal volume of 
formamide sample buffer and 1/4  volume of 5X sample buffer. Samples were heated 
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for 5 minutes at 65°C and snap chilled on ice immediately prior to loading. 
Electrophoresis was carried out in a 1X MOPS buffer system at 100V for 3-4 hours. 
2.2.4.8 Transfer of DNA from agarose gels to membranes (Southern blot) 
This procedure was originally developed by (Southern, 1975) and modified by 
(Smith and Summers, 1980). For Southern analysis of genomic DNA, lOp.g of DNA 
was cut with an appropriate restriction enzyme, and the resulting fragments were 
separated by agarose gel electrophoresis. The gel was soaked in denaturation buffer 
for 30 minutes preceding DNA transfer onto Genescreen Plus nylon membrane (New 
England Nuclear) by capillary action using denaturation buffer as the transfer 
medium (Reed and Mann, 1985). A wick made of wet blotting paper was placed on a 
platform, with both ends of the blotting paper immersed in denaturing buffer in a 
reservoir underneath the platform. The gel was laid on top of the wick, bordered with 
cling film. A sheet of nylon membrane, previously equilibrated in denaturing buffer) 
was placed on top, overlaid by three sheets of moistened blotting paper and a stack of 
dry paper towels. A weighted glass plate was put on top of the paper towels. Transfer 
was allowed to proceed for 12-24 hours, after which time the membrane was 
neutralised for 30 minutes in neutralising buffer, and air-dried. 
2.2.4.9 Transfer of RNA from agarose gels to membranes (northern blot) 
Following electrophoresis the gel was soaked for two 20 minute periods in 
lox SSC, with gentle agitation. Transfer was as described for DNA, except that i ox 
SSC was used as the transfer medium. When transfer was complete, the membrane 
was rinsed in 2X SSC and baked for 2 hours at 80 °C under a vacuum. 
2.2.4.10 Nucleic acid hybridisation 
2.2.4.10.1 Labelling DNA by random priming with hexadeoxyribonucleotide 
primers 
Radioactively labelled DNA was obtained using the randomly primed DNA 
labelling method (Feinberg and Vogelstein, 1983). This method is based on the 
hybridisation of a mixture of hexanucleotides to the DNA, and allows small amounts 
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of DNA to be labelled to high specific activities. Many sequence combinations are 
represented in the hexanucleotide primer mixture, which leads to binding of primer 
to template in a statistical manner. The complementary strand is synthesised from the 
3'OH termini of the hexanucleotide primers using Kienow polymerase, 
simultaneously incorporating radiolabelled dCTP into the newly synthesised DNA 
strand. DNA fragments to be labelled were purified from agarose gels. 
Approximately lOng of DNA dissolved in 32p1 of sterile distilled water was 
denatured by boiling for 5 minutes, followed by incubation at 37 °C for 10 minutes. 
lOiil of oligo labelling buffer, 20.tg of BSA, 50pCi of a-32P-dCTP and 2 units of 
Kienow polymerase were added, and the mixture incubated overnight at room 
temperature. 4.5mg of sonicated herring sperm DNA was added to the probe, which 
was then denatured prior to hybridisation by boiling for 5mm. 
2.2.4.10.2 Separation of unincorporated radionucleotides 
Unincorporated nucleotides were separated from the labelled DNA by 
chromatography on a NICK  Column (Pharmacia). The column was equilibrated 
with 400p.l TE before the labelling reaction was added to the column. The labelling 
reaction was run into the column by the addition of 400pJ  TE. The labelled DNA was 
then eluted into a fresh Eppendorf tube by the addition of a further 400.jl TE. 
2.2.4.10.3 Hybridisation 
Membranes onto which DNA had been transferred were blocked by 
prehybridising in 30m1 of 6X SSC, 1% (w/v) SDS, and 10% (wlv) dextran sulphate 
with 3.5tg of denatured sonicated herring sperm DNA for two hours placed in an 
oven at 65 °C in a hybridisation bag (Gibco BRL). Hybridisation was performed by 
addition of denatured radiolabelled probe to the prehybridisation mixture, and 
incubation for a further 12-24 hours at 65 °C. Membranes to which RNA was bound 
were treated identically, except that incubations were performed at 60 °C. Following 
hybridisation, non-specifically bound DNA molecules were removed by washing. 
The membrane was first immersed in 2X SSC at room temperature for 5 minutes 
with agitation, and then twice in 2X SSC, 1% (w/v) SDS for 30 minutes at either 
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65°C or 60°C. Finally the membrane was rinsed in 0.1X SSC for 10 minutes at room 
temperature, and sealed in a plastic bag to prevent drying out. Radioactive DNA 
molecules bound to the membrane were then visualised by autoradiography or 
phosphonmagery. 
2.2.4.10.4 Removal of probes and re-use of blots 
Radiolabelled DNA probes hybridised to nucleic acids immobilised on nylon 
were removed by the method described in the manual supplied with Genescreen Plus 
membranes. Southern filters were boiled three times for 10 minutes, with gentle 
shaking, in 0.1X SSC, 1% (w/v) SDS. Northern filters were washed five times for 3 
minutes in hot 0.1X SSC, 0.0 1% (wlv) SDS. The blots were then autoradiographed to 
confirm that dehybridisation was complete. Filters could then be dried and 
hybridisation repeated as above. 
2.2.4.10.5 Autoradiography 
Autoradiography was used to visualise, on film, radioactive molecules 
hybridised to the membrane. Autoradiography was performed using Cronex (Du 
Pont) X-ray film in a cassette with intensifying screens (Cronex Lightning Plus, Du 
Pont). Cassettes were stored at -70 °C during exposure to slow the reversal of 
activated bromide crystals to their stable form and give an enhanced signal. 
2.2.4.10.6 Phosphorimagery 
Phosphorimagery was performed using a storage phosphor screen (Molecular 
Dynamics). After exposure of the screen, signals were visualised using a Molecular 
Dynamics phosphorimager, and analysed with ImageQuant software (Version 3.3). 
2.2.4.11 DNA sequencing 
DNA sequencing was performed using an ABI PRISM dye terminator cycle 
sequencing reaction ready kit (Perkin-Elmer Corporation), on an Omnigene thermal 
cycler (Hybaid Ltd.). Extension products were then separated on an ABI PRISM 377 
DNA sequencer (Perkin-Elmer). Approximately 0.4.tg of double stranded template 
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DNA was mixed with 3.2pmoles of the required oligonucleotide primer and 8.il of 
terminator ready reaction mix in a final volume of 20tl. The reaction mixture was 
overlaid with a drop of mineral oil before thermal cycling. Extension products were 
purified by the addition of 2.0.tl 3M sodium acetate pH 5.0, 50p.l absolute ethanol, 
and incubation on ice for 10 minutes followed by 15 minutes centrifugation. The 
pellet was washed with 70% (v/v) ethanol, vacuum dried and stored dry at 4 °C before 
electrophoresis. Electrophoresis was performed by the DNA sequencing facility 
within the Institute of Cell and Molecular Biology. 
2.2.4.12 Polymerase chain reaction (PCR) 
2.2.4.12.1 Amplification of DNA by the polymerase chain reaction 
All PCRs were carried out in 50.tl volumes in lx PCR buffer supplemented 
with EDTA, to a final concentration of 0.4mM, and dNTPs, to a final concentration 
of 0.1mM, and 2.5 units of Taq DNA polymerase. Approximately lOOng of DNA 
was used per reaction, along with 300ng of each primer. Cycle conditions varied for 
different primers pairs, generally, denaturation was carried out at 94 °C for 1 minute, 
followed by 1 minute at an appropriate annealing temperature, and synthesis at 72 °C 
for 30 seconds to 2 minutes. 35-40 cycles were carried out for all genotyping PCRs. 
All experiments were carried out using a Techne PHC-2 thermal cycler. 
2.2.4.12.2 Rapid screening using PCR 
To facilitate the rapid screening of colonies of cultured mammalian cells, a PCR-
based strategy that bypassed the need for DNA purification was employed 
(McMahon and Bradley, 1990). When colonies were picked from dishes to be 
transferred into multiwell plates, half of each colony (circa 1,000 cells) was 
transferred into a 1.5m1 microfuge tube. The cells were pelleted by centrifugation for 
30s, and the medium removed using a pipette. The pellet was resuspended in 40jil 
IX PCR buffer to which proteinase K had been added to a final concentration of 
0.1mg/mi, and incubated at 65 °C for two hours. The proteinase K was inactivated by 
heating at 90°C for 15 minutes, and 1 0tl of sample used as a template for PCR. 
67 
2.2.5 Mammalian cell culture 
2.2.5.1 Growth of embryonic stem cells 
HM-1, a feeder independent line of murine ES cells (Magin et al., 1992) were 
maintained in Glasgow-modified Eagle's medium (GMEM), supplemented with lx 
leukemia inhibition factor, 5% fetal calf serum, 5% new born calf serum, 1mM 
sodium pyruvate, 2mM glutamine, 0.1mM non-essential amino acids and 0.1 mM 13 -
mecaptoethanol. Cells were prompted to adhere to flasks and dishes by coating the 
plastic surfaces with 0.1% (w/v) gelatin. 
To passage cells, the medium was aspirated, the bottom of the flask or dish 
rinsed with 1 -2mls of trypsin, then a further 1 -2mls of trypsin added and incubated at 
37°C until the cells had become detached. Thereupon 5 volumes of medium were 
added, the cell suspension transferred to a sterile 50m1 tube, and cells pelleted by 5 
minutes centrifugation at 1,300rpm. The supernatant was discarded, and the cells 
resuspended in an appropriate volume of medium, and an aliquot transferred into a 
tissue culture flask. 
For long term storage, cells were kept in liquid nitrogen. Cultures to be frozen 
were trypsinised, spun down, the supernatant removed, and cells resuspended in ice 
cold freezing medium. lml aliquots were placed at -20 °C for 2 hours, then transferred 
to -70°C overnight, before removal into liquid nitrogen. Frozen aliquots were thawed 
rapidly at 37 °C and diluted in 9mls of medium, before being pelleted by 
centrifugation at 1,300rpm for 5 minutes. The supernatant was discarded, the cells 
resuspended in an appropriate volume of medium, and transferred into a flask. 
2.2.5.2 Electroporation 
In order to achieve expression of cloned DNA sequences in ES cells, a 
linearised /or circular expression vector was introduced by electroporation. Cells to 
be electroporated were trypsinized, pelleted by centrifugation, and resuspended in 
0.8ml of electroporation buffer (21 mM HEPES, 5mM D-glucose, 8mM Na 2HPO4 , 
5mM KC1, 140mM NaCl). The suspension was mixed with 200ig of plasmid DNA 
in 100 jfl sterile distilled water, and transferred into an electroporation cuvette (0.4cm 
electrode, Bio-Rad). The cuvette was slotted into a Gene Pulser (Bio-Rad), and the 
cells were pulsed. Then cells were incubated at room temperature for 10 minutes 
before plating. 
2.2.5.3 Isolation of mouse embryonic fibroblast strains 
Primary fibroblasts were isolated from E12.5 embryos. Following dissection, 
embryos were incubated in 0.5m1 trypsin for 30 minutes at 37 °C. 1 5mls of medium 
were added, the embryo mechanically disaggregated with a pipette, and cells plated 
out into 90mm dishes. In order to derive established fibroblast cell lines, primary 
fibroblast cultures were passaged until cells lost growth potential and underwent 
"crisis"'. Thereupon the medium was changed periodically until an immortalised cell 
line emerged. 
2.2.5.4 Cerebellar cell cultures 
The cerebella were removed from P8 or P12 mice. They were cut into 
fragments and dissociated with trypsin (0.3 mg/ml) for 10 minutes. Cells were 
dissociated by passing through a 21 gauge needle, and the resulting suspension was 
then washed in culture medium (GMEM with 10% FCS, 1mM sodium pyruvate, 
25U/ml penicillin, 25 jig/mi streptomycin and 1 x non-essential amino acids). Cells 
were plated at a density of 7-8 x 1 0 5/cm2 onto plastic petri dished and maintained in a 
37°C incubator and medium was changed every 2 days. 
2.2.5.5 Growth of mammalian fibroblasts 
Human and mouse fibroblasts were maintained, passaged and stored in the 
manner outlined in section 2.2.5.1, except that plasticware was not gelatinised prior 
to use. 
2.2.5.6 UV survival assays 
Normal cells proliferate a finite number of times before entering senescence, a viable state of 
permanent growth arrest. Various oncogenes or other unknown reasons permit a temporary escape 
from senescence that ends in crisis. Rare cells may activate a telomere maintenance mechanism, 
escape from crisis, and become immortalised (Reddel; 2000). 
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To measure UV survival of cultured cells, 1O 5 cells were plated per 30mm 
dish. The following day the medium was aspirated from the dishes and replaced with 
0.2 ml of sterile PBS and the dishes were UV irradiated (254nm) at a fluence of 
0.1 5J m-2 S-1 . The medium was then replaced and the dishes were incubated for a 
further five days when the cells were fixed in Camoy fixative and stained with 
Crystal Violet. The degree of cell growth was then determined by extracting the dye 
from the stained cells using 70% ethanol and measuring the optical density at 575nm. 
Each UV dosage was done in duplicate and survival was determined relative to 
unirradiated control dishes as the ratio of the mean OD / mean OD of cells in 
unirradiated dishes. 
2.2.5.7 Mitomycin c survival assay 
To determine mitomycin c (MMC) cytotoxicity, 4x10 4 cells were plated per 
well of 24 mutltiwell tissue culture plate (Becton Dickinson). The following day the 
medium was removed and wells were rinsed twice with 0.2 ml of sterile PBS 
immediately prior to treatment with either lml of medium or lml of medium 
containing MMC at various concentrations. Following treatment for 24 hours at 
37°C in the incubator, the solution was aspirated and wells were rinsed twice with 
medium to remove and dilute residual MMC. The medium was then replaced and 
the dishes were incubated for a further five days. The cells were stained with Crystal 
Violet and processed as described for the UV survival assay. 
2.2.6. Animal procedures 
2.2.6.1 Animal husbandry 
Mice were maintained in accordance with established animal care guidelines 
(Poole 1989), and all procedures were licensed by the Home Office under the 
animals (Scientific Procedures) Act 1986. The mice were kept under a 12 hour light 
and 12 hour dark cycle, with standard mouse diet and tap water. Genotyping was by 
PCR analysis carried out on the biopsied distal 1cm of tail, removed after the pups 
were weaned into single sex cages at 21 days. Individual cage members were 
identified by means of coded ear marking. 
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2.2.6.2 Histological examination and immunohistochemistry 
Tissue samples for haematoxylin and eosin staining were fixed in 4% formalin 
and embedded in paraffin wax. The tissues were sectioned at 5p.m onto microscope 
slides. Cryosections of liver were stained for lipid by oil red 0 and the sections were 
counterstained with haematoxylin. 
Paraffin sections of the tissues described above were deparaffinised and 
rehydrated through xylol and graded alcohols. Sections were processed in citrate 
buffer (pH 6.0) using a microwave oven seven times for 3 minutes. Endogenous 
peroxidase was quenched by treatment with 6% hydrogen peroxide in methanol for 
10 minutes. Sections were washed three times in 0.1 M PBS (pH 7.5). 
Immunohistochemical detection of calbindin was performed using a mouse 
monoclonal antibody to calbindin (Sigma). Detection of primary antibodies was 
performed using routine avidin-biotin-peroxidase techniques (Vector Labs). After the 
reaction, the slides were washed in distilled water, counterstained with haematoxylin, 
and mounted. 
2.2.6.3 Electron microscopy 
Samples of liver were fixed with 2% paraformaldehyde and 2.5% 
glutaraldehyde in PBS buffer (pH 7.4) for 1 hour at 4 °C, rinsed three times in the 
same buffer, and then postfixed with 1% osmium tetroxide in PBS buffer for 1 hour. 
The samples were dehydrated in ethanol and transferred through a propylene oxide 
series to Spun's resin. Semithin sections, with toluidine blue counter stain, were 
examined by light microscopy. Ultrathin sections for electron microscopy were 
contrasted with uranyl acetate and lead citrate and examined with a Philips CM 120 
Biotwin electron microscope. All sectioning and staining for ultrastructural studies 
were performed by Biological Sciences Electron Microscope Facility, University of 
Edinburgh. 
2.2.6.4 Fluorescence activated cell scanning 
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Fluorescence activated cell scanning (FACScan) was used to identify 
individual cells by detection of expressed cell surface markers or DNA content. Cell 
suspensions pass into the FACScanner under pressure, such that a stream of single 
cells pass through a beam of laser light. Cells to which fluorochrome-conjugated dye 
or antibody is bound will fluoresce strongly, and the emitted light is detected by the 
FACScan. Using a combination of different fluorochrome-conjugated antibodies, 
specific for different cell surface marker molecules, it was possible to identify which 
markers were expressed on the surface of an individual cell, and hence to determine 
the phenotypic identity of that cell. 
DNA content. Propidium iodide is a commonly used DNA dye. The 
propidium iodide intercalates in the DNA double helix and fluoresces strongly red 
following exposure to laser light. The extent of the fluorescence varies according to 
the DNA content and is measured by the FACScan. In all cases the analysis was 
carried out on fresh tissue samples. A 0.5cm 3 tissue biopsy was homogenised using a 
sterile scalpel and suspended in 100 j.il of citrate buffer. After adding 450.tl of FACS 
Solution A, the suspension was incubated at room temperature for 10 minutes with 
gentle mixing. The action of the trypsin was stopped and cellular RNA degraded by 
the addition of 325 p1 of FACS Solution B and incubation at room temperature for 10 
minutes. The nuclear DNA was then dyed with the fluorescent stain propidium 
iodide, by the addition of 250.il of FACS Solution C and incubation on ice for 10 
minutes. The suspension was filtered through sterile gauze before analysis on a flow 
cytometer. The analysis was carried out using a Becton Dickson FACScan, and the 
resultant data analysed using Lysis II software. 
T lymphocytes. Cells were washed and adjusted to a concentration of 
1x107/ml in FACS PBS (PBS containing 1% BSA and 0.1% sodium azide). 2 p.1 of 
antibody was then added to 100 p.1 of cell sample (lxi 06  cells) to be stained, either in 
a 15 ml centrifuge tube or in a round bottomed microtitre plate. Samples were 
incubated at 4 °C for 30 minutes, washed three times with FACS PBS, then 
transferred to FACS tubes (Becton Dickinson) and either analysed directly, or fixed 
with a few drops of 10% formalin and stored in the dark prior to analysis, using a 
FACScan with CELLQuest software (Becton Dickinson). Antibodies used for flow 
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cytometry were: R-phycoerythrin-conjugated anti-CD4 (Caltag), FITC-conjugated 
anti-CD8 (Caltag), FITC-conjugated anti-CD3 (Pharmingen). 
2.2.7 Protein procedures 
2.2.7.1 Construction and expression of the recombinant histidine tagged (His-
tag) fusion protein 
pET29-c(+) vectors were used to express polypeptides fused with a His6-tag 
in an E. coli BL2 1 (DE3) host. 2 tl of a ligation reaction containing recombinant 
plasmids were transformed into XL-1 blue cells and then grown on LB-kanamycin 
agar plates overnight at 37 C.  Plasmid DNA from positive clones was prepared with 
the QlAprep Spin Miniprep Kit (QIAGEN Inc.) and sequenced to provide 
confirmation of identify. Plasmid DNA with correct sequence was transformed into 
BL21 (DE3) cells, and grown on LB-kanamycin agar plates overnight at 37 °C. 
Single colonies were picked and put into 10 ml of LB-kanlamp and grown at 
37°C with shaking to an OD600nm  of 0.6-0.8 (about 3-6 h). 5 ml of culture was 
removed as a control before induction, and to the remaining culture 1 M IPTG was 
added to a final concentration of 1mM in order to induce fusion protein expression. 
Cells were then grown for a further 3-6 h. Cells were collected by centrifugation at 
5,500 rpm (Sorvall) for 10 minutes at 4 °C. They were then resuspended in 1 ml of 
ice-cold lx PBS. The cells were lysed by sonication on ice and the lysates were 
microcentrifuged. A sample of both the supernatant and pellet was analysed by SDS-
PAGE and Coomassie staining to indicate the expression and solubility of the His-
tag fusion protein. 
2.2.7.2 Purification of His tagged fusion proteins 
Preparing the cell extract. 1 litre of bacteria expression culture was harvested 
by centrifugation at 10,000-20,000 x g for 20 mm. The cell pellet was then 
resuspended in 20 ml ice-cold lXBinding buffer (8X Binding buffer: 40 mM 
imidazole, 4 M NaCl, 160 mM Tris-HC1, pH 7.9), sonicated and centrifuged as 
described above. The pellet was washed with 20 ml of lx Binding Buffer (without 
denaturant) three times to release trapped proteins. Finally, the pellet was 
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resuspended in 5m1 1X Binding Buffer containing 8M urea and incubated on ice for 
1 hr to completely dissolve the protein. Any remaining insoluble material was 
removed by centrifugation at 39,000 x g for 30mm. The post-centrifugation 
supernatant was filtered by passing through a 0.45 .im filter to prevent clogging of 
the resin. 
Preparing the resin. A few ml of deionized water was added to the dry column 
(PIERCE) and the column flowing was started. The bottle containing His-Bind resin 
(Novagen) was gently mixed by inversion and 5 ml of resin, which can be used to 
purify up to 20 mg of target protein, was then added to the column. When the level of 
storage buffer (20% ethanol) dropped to the top of the column bed, the column was 
washed with the following sequence: 7.5 ml of deionized water, 12.5 ml of 1X 
Charge buffer (8x Charge buffer: 400 mM NiSO4), 7.5 ml of 1X Binding buffer. 
Performing column chromatography. When the Binding buffer drains to the 
top of the column bed, the column was loaded with the prepared cell extract, washed 
with the following sequence (all buffers containing 8M urea): 25 ml of 1X Binding 
buffer, 15 ml of 20 mM imidazole buffer (combine 11 ml of 1X Binding buffer with 
4.1 ml of 1X Wash buffer; 8X Wash buffer: 480 mM imidazole, 4 M NaCl, 160 
mM Tris-HCI, adjust final pH to 7.9). Recombinant proteins were eluted with lx 
Elute buffer containing 8 M urea (4X Elute buffer: 4 M imidazole, 2M NaCl, 80 MM 
Tris-HC1 pH7.9). Eluted proteins were dialysed in the 1X PBS. A gradual removal of 
8M Urea is recommended for refolding the desired protein. After dialysis, the sample 
may be concentrated by sprinkling solid PEG 15,000-20,000 or Sephadex G50 on the 
dialysis tubing (Using dialysis tubing < 6,000 MW) or in a sample concentrator. 
2.2.7.3 Protein isolation 
Whole cell protein extracts were prepared by a method adapted from (Prigent 
et al., 1994), and protein extraction from tissues was adapted from (Symonds et al., 
1993). Cell pellets from cultured cell lines or embryonic fibroblasts were incubated 
for 30 minutes on ice in an equal volume of 2X lysis buffer with protease inhibitor 
(1mM phenylmethylsulfonyl fluoride). Tissue lysates were prepared by 
homogenisation of tissues (fresh or frozen at -80 °C) in lysis buffer with protease 
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inhibitors at 4 °C, followed by sonication. The lysate was centrifuged at 8,000rpm at 
4°C for 15 minutes, and the supernatant removed into a fresh microfuge tube 
Glycerol was added to a final concentration of 30%, and the extract stored at -20 °C. 
2.2.7.4 Protein determination 
10 p.1 of sample buffer or protein standard was mixed with 200 p.1 of 
Coomassie Plus Protein Assay Reagent (PIERCE) in ELISA plates, incubated at 
room temperature for 5 mm, and then read at 570 or 620 nm by ELISA Reader. 
Bovine serum albumin (5 0-2000 p.g/mI) was used as protein standard. 
2.2.7.5 Electrophoresis of proteins 
Proteins were separated by electrophoresis through 12.5% SDS-
polyacrylamide gels (Laemmli, 1970) using an SE250 Mighty Small II slab gel 
electrophoresis unit (Hoefer). Gels consisted of a 5% stacking gel upon a 12.5% 
separating gel. The separating gel was poured first and was composed of 375mM 
Tris-HCI pH 8.8, 0.1% (w/v) SDS, 11.9% (w/v) acrylamide/0.3% (w/v) bis-
acrylamide polymerised by addition of ammonium persulphate and TEMED to final 
concentrations of 0.1% (w/v) and 0.06% (v/v) respectively. The stacking gel was 
composed of 125mM Tris-HC1 pH 6.8, 0.1% (w/v) SDS, 4.9% (w/v) 
acrylamide/0.2% (w/v) bis-acrylamide polymerised by addition of ammonium 
persulphate and TEMED to final concentrations of 0.1% (w/v) and 0.1% (v/v) 
respectively. 
Protein samples were mixed with 1/2  volume of 3X reducing SDS sample 
buffer and heated to 90 °C for 5 minutes prior to loading. Prestained broad range 
protein markers were used as molecular weight markers, and were prepared 
analogously. Electrophoresis was carried out vertically at lOmA in a SDS-PAGE 
running buffer system for 2 hours or until the dye front reached the end of the gel. 
Gels were either blotted onto nitrocellulose membranes or stained. Staining 
was achieved by immersing the gel in a large volume of Coomassie stain for 1 hour, 
and then in Coomassie destain overnight. Gels were subsequently laid on filter paper, 
covered with cling film and dried for two hours at 80 °C under vacuum. 
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2.2.7.6 Transfer of proteins from polyacrylamide gels to membranes (western 
blotting) 
Proteins were transferred from gels onto Hybond-C extra-supported 
nitrocellulose membrane by electroblotting using a Trans-Blot SD semi-dry transfer 
cell (Bio-Rad). The gel and membrane were equilibrated in electroblotting buffer for 
15 minutes. A piece of blotting paper, soaked in transfer buffer, was placed on the 
bottom electrode plate of the unit. On top of this was laid the nylon membrane sheet, 
the gel, and a second piece of blotting paper soaked in transfer buffer. The other 
electrode plate was positioned on top to complete the circuit, and proteins were 
transferred at iSV for 1 hour. In order to confirm that complete transferhad occurred, 
the membrane was immersed in Ponceau S solution for 1 minute, after which the 
colouration was washed off by rinsing in TBST. 
2.2.7.7 Affinity purification of antibodies 
Antibodies were purified from crude serum using antigen immobilised on 
nitrocellulose membrane (Robinson et al., 1988). Preparative SDS-PAGE for fusion 
protein was performed and protein western blotted onto nitrocellulose membrane. 
The membrane was Ponceau S stained to visualise the protein pattern and the 
horizontal strip containing the fusion protein was excised and blocked in 5% (w/v) 
skimmed milk powder in 1xPBS, with shaking for 1 hour. The membrane strip was 
then incubated with 1 OmI of blocking solution containing a 1:100 dilution of 
polyclonal serum for 2-3 hours at room temperature with agitation. The membrane 
was washed four times for 15 minutes each in lx TBST. Bound antibodies were 
eluted by incubation in 2m1 of 0. 1M glycine-HCI pH2.5, 0.1% BSA(w/v) for 5 
minutes followed by a second 2 ml of the same buffer for 10 minutes, both at room 
temperature. Each batch of eluant was immediately neutralised by the addition of 0.5 
ml 1 M Tris pH7.5, the two batches were then pooled and dialysed against three 
changes of 11 each of 1xTBST at 4 °C over 16-20 hours. The affinity purified 
antibody was stored at 4 °C in the presence of 0.1% (w/v) NaN 3 . 
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2.2.7.8 Detection of blotted proteins with antibodies 
Membranes carrying transferred proteins were blocked overnight in 5% (w/v) 
skimmed milk powder in TBST at 4°C with shaking. After briefly rinsing in TBST, 
the membrane was incubated with primary antibody diluted in TBST for 1 hour at 
room temperature with shaking. The membrane was then washed three times for 5 
minutes in TBST, following which it was incubated with a peroxidase-conjugated 
secondary antibody. The membrane was again washed three times for 5 minutes in 
TBST and developed with enhanced chemiluminescence (ECL, Amersham). 
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Chapter 3 
Mapping the 129/01a ERCC1 locus and analysis of the 5'-flanking 
region 
The generation of mice with gene targeted ER CC] alterations required an 
elaborate restriction map of the ERCC] locus and suitable cloned ER CC] DNA 
isogenic with HM-1, the ES cells used for gene targeting. One topic of this chapter 
describes the retrieval of a set of overlapping ER CC] genomic clones from an HM- 1 
genomic X bacteriophage library and the subcloning of homologous DNA for 
targeting vectors. Owing to the construction of an ERCC] transgene and further 
investigation of ERCC] promoter, the other topic involves the analysis of the 5'-
flanking region. 
3.1 Retrieval and mapping ERCC1 clones from the IIM-1 ?. DASH II genomic 
library 
Restriction mapping of ER CC] genes in human and mouse has been published 
(van Duin et al., 1986, 1987, 1988). At the start of this project, nevertheless, limited 
restriction mapping data was available for the ERCC] locus in 129/01a, the mouse 
strain from which HM-1 ES cells are derived. A X DASH II bacteriophage HM-1 
genomic library [a gift from Dr. Thomas Magin, (Porter et al., 1996)] was screened 
for sequences corresponding to the ERCC] locus. The library was constructed from 
a size selected (10-30 kb) Sau3A partial digest of HM-1 genomic DNA and ligated to 
BamHI digested X DASH II arms (Stratagene). The library was screened using a 
870 bp BamHI mouse ERCCJ cDNA probe from pTZME, which includes ERCC] 
exons 1 to 8 and most of experiments in this thesis utilised this eDNA probe. 
The primary screening of the library yielded 20 putative positive signals, 17 of 
which remained positive to tertiary screening (Figure 3.1). Following the 
amplification of well-isolated plaques, recombinant ? DNA was prepared and 
digested by EcoRI (data not shown). Five clones (X3.1, ?.8.1, X14.2, X15.3 and 
?19.2) showed resistance to cutting, but the other clones which cut satisfactorily 
could be categorised into 8 groups. All 8 groups were further characterised by 
restriction endonuclease mapping and Southern analysis with a mouse ER CC] cDNA 
probe containing exons 1 to 8. Considering the group 1 analysis, BamHI digestion of 
the group 1 clones generated the following fragments: 22.5, 9.2, 7.3 and 4.2 kb 
fragments. The -P22.5, 7.3 and 4.2 kb fragments hybridised with the cDNA probe, 
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Figure 3.11 An autoradiograph showing the results of primary, secondary and 
tertiary screening of a positive ERCC1 phage clone 
Twenty 150 mm plates were prepared as the first screening with a 
phage/bacteria MOI adjusted to achieve confluent lysis (The titer of X DASH II 
bacteriophage HM-1 genomic library = 6x10 7 pfulml). Each positive clone from the 
primary screening was screened twice more in 90 mm plates. No positive signal in 
the plate is marked x. 
Pke NoJScrekgNo. -. Secrthziry; Ty 
1 1.1 x x 
2 x x x 
3 3.1 3.1 3.1 
4 4.1 4.1 4.1 
5 x x x 
6 6.1 x x 
7 7.1 7.1 7.1 
8 8.1 8.1 8.1 
9 9.1 9.1 9.1 
10 x x x 
11 x x x 
12 x x x 
13 13.1 13.1 13.1 
14 14.1, 14.2, 14.3 14.1, 14.2, 14.3 14.1, 14.2, 14.3 
15 15.1, 15.2, 15.3 15.1, 15.2, 15.3 15.1, 15.2, 15.3 
16 16.1 16.1 16.1 
17 17.1 17.1 17.1 
18 18.1, 18.2 18.1, 18.2 x, 18.2 
19 19.1, 19.2 19.1, 19.2 19.1, 19.2 
20 x x x 
Phage clones 	4.1 	7.1 	9.1 	14.1 	15.1 	15.2 	16.1 	17.1 
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suggesting that the - 22.5 kb fragment contained the ?. DASH II vector long arm and 
the non-hybridising 9.1 kb fragment included the short arm. For the EcoRl digests, 
there were -j 21, 9.1, 6.0, 5.45, 2.55, 1.7 and 0.95 kb fragments, and 6.0, 5.45, 2.55 
and 0.95 kb fragments hybridised to the cDNA probe. In the BamHJJEcoRJ double 
digests, except for the fragments relating to the long and short arm (- 21, - 9.1 and 
1.7 kb), all other fragemtns (5.6, 3.15, 2.3, 1.65, 1.0 and 0.95 kb) could hybridise to 
the cDNA probe and two close fragments (1.0 and 0.95 kb) seemed to merge as one 
band. The other groups were analysed in the same way. Except for group 5, which 
did not fit the predicted genomic mapping, all clones were consistent with the 
structures observed in the HM-1 genomic ERCC1 locus itself, which indicated that 
they had not undergone any detectable deletions or rearrangement during cloning. 
Mapping data were used to construct a contiguous map of the X clones which is 
shown in Figure 3.2. 
3.2 Subcloning and mapping of BamHI and KpnI fragments of ERCC1 genomic 
DNA 
Based on the genomic map, Group 1 phages (X4) consisted of the whole 
ERCCJ genomic DNA, group 2 (77) contained the 5'-flanking region and group 4 
(X14.1) included the 3'-flanking region. BamHI and KpnI fragments from these 
groups were subcloned into pBluescript II SK (+) and mapped by single and double 
digestion. Restriction mapping of these clones identified four BamHl subclones 
(pBamHI 5.35, pBamHJ_4.2, pBamHl_7.25, pBamHl_2.1) ( Figure 3.3) and two 
KpnI subclones (pKpnl_9.3, pKpnl_4.5) (Figure 3.4). All targeting vector DNA 
homologous to the 129/01a ERCCJ described in this thesis was derived from the 
longest subclone pKpnl_9.3. pBamHI_5.35 included the ERCC1 promoter region 
and pBamHI_2. 1 contained parts of the adjacent gene ASE] (Anti-Sense to ERCCJ) 
(Figure 3.6) (Whitehead et al., 1997). 
3.3 Analysing the ERCC1 5'-flanking region 
3.3.1 Introduction 
The partial sequence of the mouse ERCCJ promoter region has been reported 
(van Duin et al., 1988); however, for the purpose of constructing an ERCCJ 
Figure 3.2 Restriction analysis of ERCC1 ?. DASH 1111 groups retrieved from a 
THIIM-ll ES cell geiniomiic library. 
Single and double digests of genomic DNA from different ER CC] ? DASH 
II groups were separated on 0.8%(w/v) agarose gels stained with ethidium bromide 
(left panels) and blotted and hybridised to the 870 bp BamHI cDNA probe pTZME 
containing ERCCJ exons 1 to 8 (right panels). 
Restriction map: (A) shows the extent of overlap between ERCCJ ? DASH II 
groups. Open and closed circles represent short and long arms of 7 DASH II 
bacteriophage, respectively. The stippled circle (group 6) indicates that the arm is 
not determined. Group 1 phages contain the whole ER CC] genomic DNA. Group 2 
and group 6 phages contain the 5'-flanking region, and group 4 and 7 include the 3'-
flanking region. (B) shows the contiguous map of these clones and their restriction 
fragment size. All sizes in kb. 
Enzyme abbreviations: B, BamHJ; E, EcoRI 
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I 	 I 	 ; 	 I 
	
I 	 I 	I 	II 	I 
20 	 I 	I 	II 	I 
3 	 0 	I 	I 	II 	I 
4 	 I 	I I 	 II 	I 
60 	 I 	 I 	II I 
7 	 0 1 	I 	II 	I 	 II 
8 	 4 	 I I 	II 	I 
(B) 
BwnHI 	I 	5.35 	 1 	4.2 	 I 	 73 	 I 	2.1 
EcoRI 	 I 	
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Figure 3.3 Restriction analysis of BamHI fragments of ERCCJ genomic DNA 
Plasmids (A) pBarnHI_5.35, (B) pBamHI_4.2, (C) pBamHI_7.25, and (D) 
pBamHI_2. 1 consist of 129/01a mouse ERCCJ BamHI fragments, derived from X 
clones 4.1, 7.1 and 16. 1, cloned into the BamHI site of pBluescript II SK (+) 
(Stratagene). Single and double digests of these plasmids were separated on 0.8% 
(w/v) agarose gel stained with ethidium bromide. A contiguous restriction map 
shows these clones. All sizes in kb. Arrow points to adjacent EcoRl site in vector. 
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Figure 3.4 Restriction analysis of KpnI fragments of ERCC1 genomic DNA 
Plasmids (A) pKpnl_9.3 and (B) pKpnl_4.5 consist of 129/01a mouse 
ERCCI KpnI fragments, derived from X clone 4.1, cloned into the KpnI site of 
pBluescript II SK (+) (Stratagene). Single and double digests of these plasmids were 
separated on 0.8% (w/v) agarose gel stained with ethidium bromide. A contiguous 
restriction map shows these clones. All sizes in kb. Arrow points to adjacent EcoRI 
site in vector. 
Enzyme abbreviations: B, BamHI; Bg, BglII; E, EcoRI; K, KpnI. 
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transgene and further studying the regulation of ERCC1, it was necessary to 
sequence a more extensive promoter region. The efficiency and specificity in 
regulation of transcription involves a set of transcription factors which recognise 
short DNA sequences. Usually these sequences are 100 bp upstream of the 
transcription initiation site, but sometimes they are more distant. Most promoters 
contain different combinations of the basic promoter elements, including TATA, 
CAAT and GC boxes, which are typically centred at base -30, -75, and -90 
respectively from the transcription startpoint. All promoters probably require one or 
more of these elements in order to function efficiently. The GC box, which is 
recognised by the factor SP 1, contains the consensus sequence GGGCGG, but the 
context of the GC boxes is different in every promoter (Johnson and McKnight, 
1989; Mitchell and Tjian, 1989). 
A particular set of liver-specific transcription factors, which are present and 
active at a given period of development have been identified. Four distinct 
transcription factors including hepatocyte nuclear factor (HNF)-1, HNF-3, HNF-4 
and CCAAT/enhancer binding protein (CIEBP) that are abundant in liver have been 
identified (Zaret, 1996). The HNF- 1 family, characterised by the presence of a POU 
(Pitl, Octl/Oct2, unc-86) domain and a homeodomain, are present at increased 
levels in the liver and have binding sites in the regulatory regions of many liver-
specific genes (Frain et al., 1989; Baumhueter et al., 1990). The HNF-3 winged-
helix family of regulatory proteins binds DNA and activates the transcription of 
liver-specific genes of diverse metabolic function (Costa et al., 1989; DiPersio et al., 
1991). The HNF-4 family, a member of the steroid/thyroid hormone receptor 
superfamily, contains a characteristic large carboxy-terminal domain potentially 
involved in dimerisation of proteins and ligand binding, as well as two zinc-finger 
motifs involved in DNA binding (Zhong et al., 1994). The members of C/EBP 
family, which share considerable sequence similarity particularly in the carboxy -
terminal portion and the leucine zipper domain, are expressed in a variety of tissues, 
but all are found in the liver (Lekstrom-Himes and Xanthopoulos, 1998). 
Furthermore, many liver-specific genes have binding sites for some widely 
distributed proteins such as AP-1 (Jun/Fos) and NF-1 (Rosenfeld and Kelly, 1986; 
Bohmann et al., 1987). 
Ap-2 is a retinoic acid (RA)-responsive gene. AP-2 mRNA and protein are 
first detected at the initial stages of neural crest cell formation, and the expression of 
AP-2 continues when these cells enter their migratory phase (Mitchell et al., 1991; 
Shen et al., 1997). The cellular stress response relies on at least two ubiquitous 
transcription factors, AP-land NF-KB, which are induced by a number of common 
stimuli, notably stress signals, and are involved in antioxidant redox regulation (Sen 
and Packer, 1996; Karin et al., 1997). 
Simple repetitive DNA stretches or microsatellites manifest themselves as 
conspicuously regular and monotonous paragons throughout the seemingly orderless 
genome. Simple repeats are defined as basic motifs < 6 bases in length which are 
tandemly reiterated 5-100 times (Kashi et al., 1997). Ignoring the coding/non-coding 
potential of sequences, poly (AlT) repeats are the most common mononucleotide 
repeats and poly (CA/GT) the most common dinucleotides. Whilst poly (AAT) is the 
most common trinucleotide, G/A rich repeats are the most common amongst 
tetranucleotides (Hancock and Santibanez-Koref, 1998). Longer stretches of simple 
mono-, di, tetra, and pentanucleotide repeats have not been found to be represented 
in translated region of mature mRNAs; however, certain trinucleotide motifs are 
situated in untranslated portions of mRNA and they code for monomorphic amino 
acid blocks (Ashley and Warren, 1995). Tracts of polyglutamine (20 or more 
residues), or polyproline (more than ten residues), have been found in at least 67 
transcription factors, including human TATA-binding protein and the androgen 
receptor from several species. Expansion of polyglutamine tracts has achieved 
notoriety as a source of human genetic neurodegenerative disease, muscular atrophy 
and Fragile X syndrome (Djian, 1998; Perutz, 1999). Instability of the highly 
polymorphic CA repeats has been reported in hereditary nonpolyposis colorectal 
cancer (HNPCC) (Aaltonen et al., 1993; Fishel et al., 1993). 
3.3.2 Sequence analysis of the 5' regulatory region 
The 1.05 kb EcoRI-KpnI fragment of the ERCCJ 5'-flanking region in 
pBamHI_5.35 was eluted from 0.8% low-melting agarose gel and subcloned into 
pBluescript II SK (+). This fragment was sequenced by the dideoxynucleotide 
termination method initially, but only about 100 bp from both T3 and T7 primers 
could be read before it became illegible sequence repeats (data not shown). We 
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presumed that there may be a secondary structure in this promoter region making 
conventional manual sequencing difficult and later used an ABI PRISM 377 DNA 
sequencer (Perkin-Elmer) to obtain the sequence. Primers with opposite orientation 
were designed and the amplification profile consisted of 15 cycles of 95C (30s), 
66C (30s) and 70C (1mm) and 15 cycles of 95C (30s) and 70°C (1mm). Compiling 
from the published mouse ER CC] cDNA, the partial promoter sequence (GenBank 
accession number X07414 and X07413), the sequence of the mouse skin 5' rapid 
amplification of cDNA ends (5'RACE) #17 insert (Jim Selfridge , unpublished data) 
and the 1.05 kb EcoRI-KpnI fragment in this experiment, we summarise the results 
for the ERCC] 5'-flanking region in Figure 3.5. The putative regulatory consensus 
sequences were identified using on-line programs (TRANSFAC v3.3 
http://www.cbil.upenn.edulcgi-binitess  and BLAST2 from the National Center 
Biotechnology Information (NCBI), http://www.ncbi.nlm.nih.gov/gorf/wblast2.cgi  ) 
(Heinemeyer et at., 1998, 1999). The transcriptional initiation site was defined as 
nucleotide position +1 according to the published promoter sequence. The 1053 
nucleotides sequenced from the EcoRI-KpnI genomic fragment correspond to 
position -1,186 to -134. Following this fragment, 9 bp (at base -133 to -125) was 
derived from the skin 5' RACE clone and consecutive sequences were from the 
published database. The alignments of-1.2 kb 5'-flanking sequences from the mouse 
and human (Martin-Gallardo et al., 1992)(GenBank accession number M63796) have 
57% homology (data not shown). Intron 1 of the human ER CC] gene contains 398 
bp; however, as far as we know, the size of the mouse intron has not yet been 
determined. The genomic fragment contained two stretches of dinucleotide repeats: 
a (CA)25 beginning at base -1,158 and the other (CT) 34 GT(CT)4 starting at base - 
330. 
The previously reported partial mouse ERCCJ promoter sequence, which ended 
170 bp upstream of the transcription start site; however, detailed information about 
this promoter region was lacking. Sequence analyses of -'1.2 kb upstream promoter 
region from this experiment revealed many putative binding sites for transcriptional 
regulatory factors. Strikingly, far upstream of the reported initiation site, a set of 
putative basic promoter elements was found, including a clearly identifiable TATA 
box at base -731, a CAAT box at base -781 and the consensus sequence for a GC 
box, which binds the transcription factor SP1, at base -882. The potential liver-
specific transcription factor binding sites include HNF1IHNF-3 (at base -744 to - 
735), F{NF-4 (at base -387 to -375) and C/EBP family (at base -1,162 to -1,153, - 
1,090 to -1,082, -810 to -803, -688 to -678, -335 to -326, -195 to -190, -107 to -101 
and +48 to 56). Eleven putative SP1 transcription binding sites (at base -1,053 to - 
1,043, -909 to -904, -882 to -877, -630 to -625, -509 to -504, -422 to -413, -388 to - 
380, -338 to -328, -240 to -231, -116 to -106 and -99 to -90 ) were present in this 5' 
regulatory region. Furthermore, five hypothetical NF- 1 sites (at base -791 to -779, - 
472 to -456, -251 to -246, -243 to -236 and +81 to 86), four AP-1 (c-fos/c-jun) 
binding sites (at base -923 to -916, -652 to -646, -568 to --621 and -402 to -396), 
three NF-K binding sites (at base -498 to -489, -261 to -249 and 58 to 68), a 
peroxisome proliferator-activated receptor (PPAR, at base -1,059 to -1,054) and an 
AP-2 (at base -423 to -418) binding sites have also been found in this 5'-flanking 
region. 
Although the TRANSFAC database provides information about genomic 
binding sites of eukaryotic transcription factors and the binding proteins, it has 
limitations and only provides putative transcription binding sites. To further 
investigate the validity of individual protein binding sites, DNase I footprinting and 
DNA band shift assay will be performed in the near future to reveal protein-DNA 
interactions and confirm the binding specificity within the ERCC1 5'-flanking 
region. 
3.4 Discussion 
A genomic map of the 129/01a mouse ER CC] locus was generated. This map 
arose from studies in which a complete set of A phage clones spanning the 129/01a 
ER CC] allele were isolated. The similarity of the HM- 1 ER CC] gene structure with 
that of the published ERCC] allele (from Balb/C) (van Duin et al., 1988) confirmed 
that the 129/01a clones indeed encode the ERCCJ allele. Studies presented here 
indicate that this allele spans approximately 15 kb (Figure 3.3), although the 5' and 
3' flanking regions have not been studied in detail. Due to polymorphic differences, 
the size showed variation with published results (estimated 16-17 kb) and this 
Figure 3.5 Nucleotide sequence of the mouse ERCCJ 5'-flanking region 
The sequence of the mouse ERCCJ 5 '-flanking region was compiled from the 
published mouse ERCC1 cDNA and partial promoter sequence (GenBank accession 
number X07414 and X07413) which begins at -124 in this figure, the 9 bp (at base - 
133 to -125, shown in italics and green) from the mouse skin 5'RACE #17 insert 
(Jim Selfridge , unpublished data) and 1,053 bp (at base -1,186 to -134) from the 
EcoRI-KpnI fragment in this experiment. The tentative transcriptional initiation site 
(0+1) was determined from the published data (van Duin et al., 1988). The exon 1 
and 2 are boxed and the translational iniation site is labelled with *. The poly (CA) 
and (CT) repeats are shown in red. 
BRI 
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GAATTCACAG CGTAGGCATG TGCTTTA 	 -1127 
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CC TCACAACTAG GAAAACAA_AAAAAGATAT AGAGGGATI'A -1067 
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CATA3ATGA CCTGGGCG TGCCCTCTCT C?ATACACGA AGACCA'AAG_AAAATGGAGA -1007 
ATACGTTGGT AACATGC AAAATrTTAA AGAGAATT TTrAAAAGTA TCAACTCGAA -947 
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GGAAAGATTT GCAGCCTAAT GAAGTGACTA_ACAGCATCAG_CCCTTAAGCA TCACTCCAAC -887 
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AAATGGGCGG TAATCAAAAG ATGCTCATCT CCTTCCTC CCCCTI'TTTA ATTAAAAAA -827 
C-EBPa 	 NF-1 CCAAT 
ACCGGAAT TGCTCATTTC_GAAAAAATGG GCAAAGGATA TGAGCCAATC TI'GTTAAAA -767 
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GGATAGGCA AAGGAAATGA GCAAGAACAA AAAAATATAT AAGACCATTA AACTATI'TCC -707 
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TTAGCAATCA CAGAACTACA AG7'I'GGAACG GGGAAACT GTCCTCCAG GAAAIGAI 	-647 
Spi 
ATACTAAGTC ATCATGGGG_CCCAGGTCTC GGAACACAGG TGTCCCTI'CC TTCAGGAAGC -587 
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TCGTCCTCAC ACCCCAGCTG_GGTCAGGTGC TCCCCCTAAC ACGGGCTCAA TQTCCTCG -527 
SP1 	 NF-143 
GCTCTCCCP CCCGACCCTGCCCGCTCTGG GGTCCCTG TCIYACTGTC CCACTGGACT -467 
AP-2 SP1 
TTAAGCCACA GCTGTCGGTA TCAGTCCCTG CTGGGA3C AAGTCGCGAA_TGGCTTAGAA -407 
c-faa/c-Jun 	 SP1 HNF-4 
TTAGACTCAATGTCTGTC GGCTGAGTCC ACCCACGCTT ACAGGGAAGG CCGTCCTCTG -347 
SPI. C-EBPU 
AAATCTCACC TCCCTC 	 -287 
NF-Kf3 NF-1 	NP-i 	SP1 
GT 	 CCT9TC CTCCI1TCCC TCCCCCACCT -227 
C-EBP3 
CCT3ATCA TCACTGAGCC GGATCTGGAG TCTCGGAAGC GCTCAAGAGG GCCI1GGAAC -167 
sPi 
ACAACTACTT GAAGTCAAAG TCTCCCAGGT ACCTrCTACG TGAAGCTTCC ATCCGCCCCA -107 
C-ZBPa SP1 	 - 
AACCACAGCG_GTCCTCCAGG ACCATAGAGA GCAGCGCGAA TACAGTTCCC CCCTCTAACT -47 
CCTCCGGGGA GCAGCGAGAC GAGCGAAGGG CCAGAGGGCC GGAAG4GAGT CTAGCAGGAGJ +14 
TTGTGCTGGC TGTGCGCG TTGTGTCGCC TCTGTTTCCC CCCGIGTAT TTCCTTCTAGI +74 
NF-1 
GCATCGGGAA AGACCAcI 
------ (intron 1) ---------- ---------- IGCCCCAGatg gac...... .  
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difference also appeared in Southern analysis of tail DNA from different mouse 
strains (see Chapter 4, Figure 4.7). Restriction mapping of these clones confirmed 
that a set of overlapping clones has been retrieved and enabled the construction of a 
contiguous map of the whole gene. Comparison of the genomic restriction map with 
that of the contiguous map of the ER CC] X DASH H clones indicated that, with the 
exception of Group 5, the ?. phage clones contained no cloning artefacts. The longest 
plasmid subclone obtained, pKpnl_9.3, was mapped and contained all the sequence 
homology necessary for the construction of an isogenic targeting vector. 
In a series of studies we have found that the level of ERCC 1 expression could 
be detected at high levels in some tissues (see Chapter 8 and Jim Selfridge, 
unpublished data). Our original ERCC] knockout mice and similar findings from the 
Dutch knockout mice have revealed that liver, brain, skin and kidney were affected 
significantly. Nevertheless, ER CC] failed to complement any of the known human 
NER disease complementation groups. Several studies have shown that 
overexpression of ERCCJ and ERCC2 mRNA may be characteristic of epithelial 
ovarian carcinoma and brain tumours (Dabholkar et al., 1992, 1994, 1995; Liang et 
al., 1995). Combined with experimental and clinical findings, it would not be 
unreasonable to imagine that some potential tissue-specific transcription factors or 
other elements could be involved in spatial and temporal regulation of ERCCJ. We 
have shown that the 5' -flanking region of the mouse ER CC] gene contained several 
putative transcription factor binding sites. Further experiments are required, 
including RACE, primer extension, ribonuclease protection, DNA band shift assa, 
Dnase I footprinting and luciferase reporter gene assay to support these predictions. 
Eight potential liver-specific transcription factor binding sites are present in the 
mouse ER CCI promoter, which may be relevant when considering that ER CC] 
knockout mice died before weaning with hepatic failure. Owing to the fatty change 
in the new strain of ER CC] knockout mice (Chapter 6), we also draw attention to 
binding sites for C/EBP families as well as PPAR families, which have been 
implicated in the induction of adipocyte differentiation and fatty acid synthesis (Yeh 
and McKnight, 1995; Brun et al., 1996; Mandrup and Lane, 1997; Darlington et al., 
1998). The HNF-3/3 knockout mice died by E1O-1 1 and failed to form a gut tube 
with severe alterations in foregut morphogenesis, confirming an essential role for 
HNF-33 in early foregut formation (Ang and Rossant, 1994). HNF-4 homozygous 
knockout mice died before E1O.5, lacking normal embryonic structures and having 
only extra-embryonic components (Chen et al., 1994). Mice lacking C/EBPa 
expression have disturbed hepatic architecture with acinar formation, resembling 
proliferative or pseudoglandular hepatocellular carcinoma. In these mice induced 
RNA levels of c-Myc and c-Jun were consistent with a proliferative liver. The 
majority of C/EBPa -I- mice died soon after birth because of an impairment of 
hepatic glycogen storage (Wang et al., 1995; Flodby et al., 1996). Low level 
expression of phosphoenolpyruvate carboxykinase and perinatal lethality was also 
seen in C/EBP/3 knockout mice, suggesting involvement in gluconeogenic pathways 
(Croniger et al., 1997). We are highly interested to study whether ERCC1 alone or in 
combination with other liver-specific transcription factors can confer regulation of 
hepatocyte differentiation and participate in the maintenance of hepatic structure. 
The promoter of the mouse ER CC] gene contained four potential AP-1 binding 
sites and three NF-KB binding sites. We noted that mice lacking c-Jun died at mid-
to late-gestation and exhibit impaired hepatogenesis (Johnson et al., 1993). The 
protein expression of c-Fos in ER CC] knockout mice liver showed a higher level 
than wild-type (Chapter 6). Moreover, null mutants of the p65/RelA, a member of 
NF-KB family of transcription factors, exhibited a similar failure in foetal liver 
development but at a slightly later stage and concomitant with a strong increase of 
apoptosis (Beg et al., 1995). A novel gene encoding the ReIA-associated inhibitor 
(RAT) protein, that binds to the p65/ReIA and inhibits its transcriptional activity, has 
also been identified in the 19q13.2-q13.3 region which contains the three DNA repair 
genes XRCCJ, ERCC2 and ERCCJ (Figure 3.6) (Lamerdin et al., 1996; Yang et al., 
1999). 
Two stretches of CA and CT repeats, identified in the mouse ERCCJ 5'-
flanking region, are similar to the patterns in the published human promoter region, 
whilst other repeats are also present in the human 3'-flanking regions (Si, S2 and S3 
in Figure 3.6)(Smeets et al., 1991; Martin-Gallardo et al., 1992). Interestingly, the 
sequence analysis of the skin/5' RACE #17 insert revealed larger CT repeats, albeit 
the tracts were disrupted with a number of short GT sequences (1 to 4) to produce 
(CT)5, (CT) 6, (CT)7, (CT)8 and (CT)30 repeats. Although the heterogeneity may 
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have arisen as an artefact of RT-PCR, or as a result of the different genetic 
backgrounds from which the cloned sequences were derived, 1 29/01a and Balb/C 
respectively, we cannot overlook the possibility of microsatellite instability in tissue-
specific expression. Similar pyrimidine-rich stretches of DNA (34 nt, 88% C+T in 
human, 82% in hamster, 79.4% in mice and 30 nt, 76.6% C+T in fish) have been 
identified in the 5'-flanking regions of the first exon in another NER gene ERCC2 
(Lamerdin et al., 1996). Sequencing of human DNA ligase I clones derived from 
Hela cells and thymus revealed a 48-50 nt polypurine tract followed by a variable 
number of (GT/CA) residues in intron 6. This entire unit of polypurine tract plus 
(GT/CA)s is repeated three times (Livak et al., 1998). 
If CT repeats are perfect and long enough, they can form intramolecular triple 
helices (H-DNA) (Espinas et al., 1996). Regions of DNA containing CT repeats are 
postulated to have roles in DNA replication, recombination and nucleosomal 
organisation. The Drosophila GAGA factor stimulates the transcription activity, and 
binds specific (CT/GA) rich sequences, identified in the promoters of many 
Drosophila genes, including engrailed (en), Ultrabithorax (Ubx), fushi tarazu (flz), 
the hsp26 and hsp70 heat shock genes and the histone 1-13-1-14 (Biggin and Tjian, 
1988; Soeller et al., 1988; Gilmour et al., 1989; Topol et al., 1991; Lee et al., 1992; 
Lu et al., 1993). Moreover, the GAGA protein of the early Drosophila embryo is 
likely to be involved in the association with heterochromatic satellite sequences in 
the mitotic process. Short CT repeats may also be involved in the function of the 
initiator elements that direct gene expression in a TATA-less promoter. (CA) 
elements are the most abundant and polymorphic repeats in humans as well as other 
species. There are estimated to be 100,000 CA microsatellites scattered throughout 
the human genome ( Weber and May, 1989; Beckman and Weber, 1992). The 
expansion of CA repeats occurring in 5'- and 3'- flanking regions and introns of 
genes have been reported in several tumours. CA repeats are known to convert into 
Z-DNA structure, the name for which is taken from the zigzag path that the sugar-
phosphate backbone follows along the DNA helix (Drew et al., 1988). Altered 
secondary structure in the (CA/GT) rich sequences 5' to the insulin gene has been 
implicated in the regulation of gene expression (Bennett et al., 1995). 
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(CA)m(CT/GA)n have also been found in the promoter region of PAX3 and 
PAX6 gene (Okiadnova et al., 1998a, b, 1999), members of a family of evolutionarily 
conserved and developmentally regulated transcription factors, especially important 
in neurogenesis (Stuart et al., 1994). The PAX3 homozygous mutation in mice 
produces profound defects in neurogenesis and limb muscle development, whilst the 
heterozygotes have a Splotch phenotype characterised by pigmentary disturbances 
(Epstein et al., 1991,1993; Vogan et al., 1993). PAX3 gene mutations in humans are 
associated with Waardenburg syndrome, an autosomal dominant disorder presenting 
with pigmentary disturbances, craniofacial abnormalities, and sensorineural deafness 
(Baldwin et al., 1992; Bober et al., 1994). Pax6 plays a key role in eye 
morphogenesis, neuronal differentiation and configuration of synaptic connections. 
PAX6 mutations result in aniridia and Peters anomaly in human, small eye in mouse 
and rat, and the eyeless phenotype in Drosophila melanogaster (Hill et al., 1991; 
Glaser et al., 1994; Li et al., 1994; Quiring et al., 1994). A microsatellite 
(CA)m(GA)n structure in intron 2 of the HLA-DRB genes has been shown to bind a 
zinc-dependent protein and form a non-B DNA-structure (Maueler et al., 1999). 
The transcription factor SP1 along with MAZ has been reported as 
participating in regulation of the serotonin la receptor in the brain which contains a 
TATA-less promoter (Parks and Shenk, 1996). Other similar reports also suggested 
that SP  sequences in the brain would affect TATA-less gene expression in the type-
JI subunit of cAMP-depedent protein kinase and presenilin-1 (Clegg et al., 1996; 
Mitsuda et al., 1997). Due to the developmental delay in the cerebellum of ERCCJ 
knockout mice (Chapter 7), we suspect similar regulatory events may modulate the 
activity of ERCC 1 protein with important functional consequences in neurogenesis. 
Loeb has proposed a 'mutator mutation' hypothesis that an early event in 
tumorigenesis might be a mutation that elevates the mutation rate and therefore the 
likelihood of changes in multiple genes relevant to tumour development (Loeb, 1991; 
Jackson and Loeb, 1998). This hypothesis was supported by the finding of 
widespread microsatellite instability in HNPCC patients, as well as in a number of 
other familial and sporadic cancers (Ionov et al., 1993; Thibodeau et al., 1993; 
Paulson et al., 1996; Steiner and Sidransky, 1996; Fleisher et al., 1999). 
Microsatellite sequences have been associated with gene rearrangement and similar 
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Figure 3.6 Physical linkage between human ERCCJ and neighbouring genes 
A genetic map of human chromosome 19q13.2-q13.3 region shows ERCCJ 
and neighbouring genes. Mapping data was compiled from (Ashworth et al., 1995; 
Brandriff et al., 1994; Lamerdin et al., 1996; Martin-Gallardo et al., 1992; Smeets et 
al., 1990; Smeets et al., 1991; Stubbs et al., 1996). The ERCCJ 3'-flanking region 
overlaps with ASE-1. The 10 exons of ERCCJ and 3 exons of ASE-1 are indicated 
by Roman numerals. Three arrows indicate the localisation of a (CA) 1 3 (GA)5 repeat 
(Sl), a (CA) 7 repeat (S2) and a (TGC) 4 repeat (S3) in ERCC]. The Alu repeat 
adjacent to Si is underlined. FOSB is similar to the dimerisation and DNA binding 
domain of the cFOS gene, and PHOS has 48.7% identity over 236 amino acid 
residues with the rat type 2C phosphatase gene. NSPL-1(neuroendocrine-specific 
protein like-1) has a similar expression patterns to that of the dystrophin gene, and 
CKJt'IM ( muscle-specific creatine kinase) gene, which is the nearest proximal 
polymorphic marker for myotonic dystrophy. The exact position of RAI, RelA 
associated inhibitor gene, has not been determined. 
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GGTTGCAGTGAGCCGAGATTGTGCCATGCATCCAGCCTGGCCACAGCAGATGTCT (CA) 13  
AAAAAG (GA) CCTGTCCATGTGCCTGGCTCACACCTGTAATCCCAGCACTTTGGGAAGG 
S2 
GCAGGGAGATGGGGAAGGTTAATGGGTAC (CA) 7 AAGAAAGAATGAATAAGACATACTAT 
S3 
AGTTTCCCGGGGGCAGACTACACAGGC (TGC) 4 GCGCTTCTTCCGCTTCTTGTCCCGGCC 
CA repeats have been shown to stimulate extrachromosomal recombination 3-20 
fold and to affect the intervals used for recombination between vectors (Stringer, 
1985; ; Bullock et al., 1986; Boehm et al., 1989; Wahls et al., 1990). Recent reports 
also revealed that mutations in the S. cerevisiae RAD2 7 gene, a member of large 
family of endonucleases and exonucleases including human XPG and FEN-i, cause 
increased rate of short and long repeat DNA instability and may act as a new imitator 
(Johnson et al., 1995; Tishkoffet al., 1997). Although so far there is no evidence of 
microsatellite instability in ERCCJ-deficient cell lines (David Melton, personal 
communication), it cannot be concluded that ER CC] does not participate in a process 
causing tissue-specific instability, like the Msh2 gene in the colon. 
The mouse ERCCJ transcript is expressed in all tissues at low levels as a 1.1 
kb band (van Duin et al., 1988). Two transcripts of 3.4 and 3.8 kb, derived from 
differential polyadenylation, have also been reported in human cell lines, whilst the 
72 bp exon VIII is often missed out due to alternative splicing (van Duin et at., 
1987). Moreover, a novel 1.5 kb transcript in mouse skin has been identified and 
characterised in this laboratory (Selfridge, unpublished data). Three close bands of 
ERCC1 protein have also been found to be present in liver tissue (see Chapter 8, 
Figure 8.6). We also found a set of putative GC, CAAT, and TATA boxes localised 
at base -882 to -783 upstream of the reported transcription initiation site. It is not 
unreasonable to predict new ER CC] transcripts in different tissues since alternative 
initiation of transcription in 5'-flanking regions can be found in several genes such as 
PAX6, a-Dystrobrevin and presenilin-1 (PS-1) gene (Mitsuda et al., 1997; 
Okladnova et al., 1998; Holzfeind et a!, 1999). 
The 3 '-flanking regions of the ERCC] gene overlap the ASE-] gene (Figure 
3.6). Indirect immunofluorescene analysis has indicated that ASE-1 co-localised 
with rDNA throughout the cell cycle and implied that it may be a member of the 
RNA polymerase I (pol I) transcription complex (Whitehead et al., 1997). In 
mammalian cells, CPD removal from RNA pol I transcribed rDNA is very slow and 
without strand specificity (Christians and Hanawalt, 1993; Fritz and Smerdon, 1995; 
Fritz et al., 1996); however, the mechanism of rDNA repair remains unclear. 
Although the relationship of ASE-1 and ERCC1 has not yet been characterised, it is 
of interest to note that contiguous gene syndromes, caused by deletions or 
VR 
duplications of unrelated genes physically contiguous on a chromosome, have been 
found such as Prader-Willi/Angeriman syndrome and DiGeorge/velo-cardio-facial 
syndrome (Ledbetter and Ballabio, 1995). In this context it is possible that the 
protein or mRNA of ERCC 1 and ASE- 1 might hybridise or otherwise interfere with 
the gene function of each other. 
In summary, we have cloned and characterised the 129/01a mouse ERCC1 
locus and subcloned BamHI and KpnI fragments into pBluescript Sk II (+). These 
plasmids contain the isogenic sequence homology necessary for the construction of 
targeting vectors. The 5'-flanking sequences provided useful information for further 
investigation of transcriptional regulation. 
Chapter 4 
Targeted disruption of the mouse ERCC1 gene 
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This laboratory generated the first ERCCJ-deficient mice by the insertion of a 
neo cassette into exon 5, which resulted in the first mouse model of defective NER. 
The ER CC] null mice were born severely runted, weighed only 20% of the control 
wild-type littermates, and died before weaning at the age of three weeks. 
Histopathological and flow cytometric analysis showed a number of enlarged hepatic 
nuclei, with polyploid and aneuploid DNA profiles which may be associated with the 
cause of early death. Elevated levels of p53 were also noted in the liver, brain and 
kidney of ER CC] knockout mice, implicating persistence of DNA damage in these 
tissues (McWhir et al., 1993). Recently, we have indeed found that nuclear levels of 
8-oxoguanine are elevated 10-fold in ERCC]-deficient livers, implicating that 
oxidative DNA damage may cause the p53 response (David Melton, personal 
communication). A group in Holland have also produced two additional ER CC] 
knockout lines, in one line the gene was interrupted by the insertion of a neo cassette 
into exon 7, and in the other line a more subtle mutation was achieved by the 
introduction a premature stop codon at residue 292, which removed the last seven 
amino acids of ERCC I. The first Dutch ER CC] nulls survived for up to 78 days and 
those carrying the subtle mutation survived up to 6 months (Weeda et al., 1997). 
One explanation of the different survival profiles between our mice and the Dutch 
knockout mice may be as a result of the different genetic backgrounds, 129/Ola 
crossed with Balb/C in our laboratory and 129/Ola mated with C57B116 or FVB in 
the Dutch group. A further possibility may be due to the nature of the targeted 
inactivation in the ERCC1 C-terminal region resulting in a residual activity in the 
Dutch nulls. In addition to the phenotypes previously demonstrated by our 
laboratory, the Dutch nulls also showed an absence of subcutaneous fat and infertility 
in both lines. They also exhibited an early onset deposition of ferritin in the spleen 
and aberrant nuclei in kidney accompanied with eosinophilic proteinaceous 
materials in the dilated renal tubules. These additional findings are likely to be as a 
consequence of the extended lifespan in the Dutch nulls relative to our knockouts. 
Aiming to further investigate the difference between the fully inactivated 
ERCC1 knockout mice and also produce a foxed ERCC] allele via a two step 
double-replacement gene targeting strategy in the same region, we replaced the 
exon3 -5 region with a hypoxanthine-guanine phosphoribosyltransferase (HPRT) 
+1- 
minigene resulting in a newly inactivated ERCC1 allele. The novel ERCCJ ES 
cells were used to generate a new knockout line (Section 4.5) and a second round of 
gene targeting was carried out to introduce two loxP sites into the same region 
(Chapter 5). 
4.1 Construction of the ERCC1 targeting vector 
The vector used here was designed to introduce a selectable marker in place of 
the ERCC] exon 3-5 region. This provided a convenient allele structure for the 
second targeting step for the foxed ERCCJ. This vector consisted of three main 
components: an HPRT minigene as a positive selectable marker, a herpes simplex 
virus thymidine kinase (HSV-TK) module as a negative selectable marker and 
isogenic sequences homologous to the regions flanking the 129/01a ERCC] exons 3 
and 5. 
The 5.2 kb HPR T minigene, derived from the vector pBT/DWM1 10 consists of 
exons 1-9, 5' and 3'untranslated region and introns 1, 2, 7 and 8 from the mouse 
HPRT locus [Magin, 1992 #144]. The minigene was driven by its own promoter 
and was used to replace a 4.85 kb BglII fragment containing the ERCC1 exon 3-5 
region in pKpnl_9.3. The isogenic DNA flanking this region to the 5' and 3' ends 
were 1.9 and 2.55 kb, respectively. The negative selectable marker, PGK-TK gene, 
was driven by a mouse Pg/c-i (phosphoglycerate kinase I) promoter and contained 
Pgk-i 3' untranslated region (Selfridge et al., 1992). This selectable marker, which 
was positioned upstream of the 5' flanking sequences, enabled negative selection 
against random integration events and therefore enrichment for homologous 
recombination. 
A three step cloning procedure was used to construct the ER CC] targeting 
vector and is described in Figure 4.1. The restriction map of this vector is shown in 
Figure 4.2. 
4.2 Introducing the ERCC1 exon 3-5 region deletion in HM-1 ES cells 
The ERCC] targeting vector was linearised with NotI, which cleaved at the 
6 
5 'end of the HSV-TK gene in pBluescnpt II SK (+). Approximately 30 x 10 HM-1 
ES cells at passage 13 were electroporated at 850 V, 3 tF (GenePulser, BioRad) in 
Figure 4.11 ERCCJ targeting vector construction 
The ERCCJ targeting vector was constructed as described below and the final 
vector consists of a mouse HPRT minigene flanked by 1.9 kb of 5' and 2.55 kb of 3' 
ERCC1 homologous sequences. A 2.7 kb PGK-TK module was placed upstream of 
the 5' flanking homology. 
Step 1: Two BglII fragments (0.85 and 4.0 kb) were removed from pKpnl_9.3, and 
subsequently this plasmid was purified from agarose and re-ligated at the 
BgIH site to product the vector A. The three BglII sites in the 4.85 Bglll 
fragment are boxed. 
Step2: A 5.2 kb HPRT minigene, isolated from the vector pBT/DWM1 10 and 
modified by the addition of BamHI linkers, was inserted into the Bglll site of 
the Vector A to form the Vector B. In this thesis we used an orientation of 
the HPRT minigene opposite to the target gene. 
Step3: The Vector B was linearised by NotTJClaI double digestion and ligated to a 
Not IIClaI fragment bearing the PGK-TK cassette. The final construct was 
the ERCCJ targeting vector and a restriction map is shown in Figure 4.2. The 
vector has a unique Nod restriction site at its 5'end for vector linearisation. 
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Figure 4.2 Restriction map of the ERCC1 targeting vector 
A restriction map of the ERCCJ targeting vector was determined by single and 
double digestion of plasmid DNA. All sizes in kb. Fragments marked * contain 
pBluescript II SK (+) DNA. This vector was linearised at a unique 5' NotI site prior 
to electroporation. 
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0.8 ml 1xHBS with 200 p.g linearised targeting vector. Cells were plated in ES cell 
medium supplemented with LIF and antibiotics. Positive selection with HAT for 
HPRT activity was started 24 hours after electroporation and four days later negative 
selection against HSV-TK activity was initiated by the addition of medium 
supplemented with gancyclovir (GCV) and HAT. 
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4.3 PCR screening for gene targeted ERCC1 ES cell clones 
PCR screening for homologous recombinants is provided for by the detection 
of the targeting specific juxtaposition of HPRT minigene sequence with a region of 
ERCCJ locus outside the targeting vector (Figure 4.3). ES colonies were picked 10-
14 days after electroporation and genomic DNA was isolated to screen for 
homologous recombination events by PCR amplification with primer pair T7471 and 
262W. Targeted colonies were identified by the presence of a targeting specific band 
of 2.6 kb. Eight out of 153 colonies (5.23 %) gave a positive PCR signal (Figure 4.3 
and Table 4.2). 
4.4 Southern analysis of PCR positive ES clones 
PCR positive clones were further investigated by Southern analysis for the 
presence of targeting-specific changes to ERCCJ and to confirm the integrity of the 
targeted allele. The targeting vector replaced a 4.85 kb ERCCJ Bglll exon 3-5 
region with a 5.2kb HPRT minigene containing two EcoRI sites. The targeted 
introduction of the HPRTminigene into the the ER CC] exon 3-5 region was detected 
by the introduction of these novel EcoRI sites at the predicted positions. The 
predicted targeting-specific changes to restriction patterns around the ERCC1 exon 
3-5 region were detected in EcoRI, BamHI and Barn flhIEcoRI double digested ES 
genomic DNA (Figure 4.4). The EcoRI digest of seven PCR positive clones 
produced one 2.95 kb diagnostic band when hybridised with the mouse ERCCJ 
cDNA probe. The other predicted 4.5 kb band was not detected by this analysis, 
presumably because this band contains only exon 6 as homology (Figure 4.5). The 
BarnHI digest produced a 17.2 kb diagnostic band from the targeted allele due to the 
loss of BamHI sites in this allele. A 2.95 kb diagnostic band from the targeted allele 
was detected in BamHL/EcoRI double digests, which is 200 bp smaller than the wild- 
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Figure 4.3 PCT screening of ES cells for gene targeting events 
ES cell lysates were amplified by PCR with primers T7471 and 262W. T7471 
corresponds to the ERCCJ 5'-flanking region (at base -165 to -141, see Chapter 
3) and 262W corresponds to the HPRT minigene 3 'UTR. The primer pairs 
T7471 and 262W and the cycling parameters of 94 C (1 min), 66 C (I min) and 
72C (1mm 30s) x 35 cycles were used to amplify a 2.6 kb fragment. 
An aliquot of this PCR product was electrophoresed on a 1% (w/v) agarose gel 
stained with ethidium bromide. A targeting specific band was present at 2.6 kb 
(arrow) in correctly targeted colonies surviving HAT and gancyclocir selection, 




-Ø 	2 6k 	





_____ 2.6 kb 
2_ 40 
[5- 
Figure 4.4 ER CCI inactivation 
The HPRT minigene replaces a BgllI fragment of ERCCI containing the exon 3- 
5 region and results in the introduction of two EcoRI sites into the ERCCJ 
allele. 
Map of the wild-type (WT) ERCC1 allele and the inactivated (K/O) ERCCT 
allele. This is demonstrated by the presence of diagnostic bands (underlined) in 
the targeted allele following Bami-Il, EcoRI and BarnHJIEcoRI double digestion 
and hybridisation to a mouse ERCCJ cDNA probe. Note that the 4.5 kb 
predicted band in EcoRl and BanHIIEcoRI digests was not detected by Southern 
analysis. All sizes of ERCCJ homology are in kb and the selectable marker is 
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Figure4.5 Southern analysis of ERCC1' ES cell DNA digested with EcoRI 
EcoRI digests of genomic DNA from HM-1 and seven targeted ES cells were 
separated on 1% agarose and hybridised to a mouse ERCCJ cDNA probe. The 
targeted allele contains an HPRT minigene bearing two EcoRl sites resulting in one 
2.95 kb diagnostic band (arrow); however, the other predicted targeting-specific 4.5 
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Figure4.6 Southern analysis of ERCC1' ES cell DNA digested with BamHI and 
Barn HI/EcoRI 
Single (BamHI) and double (BarnHIIEcoRI) digests of genomic DNA from 
HM-1 and the targeted ES clone #209 (KIO) were separated on 1% agarose and 
hybridised to a mouse ERCC/ cDNA probe. 
A 17.2 kb Ba,nHJ diagnostic band (arrowhead) occured in the targeted allele due 
to the loss of BarnHI sites. 
As in the EcoRI digests, a 2.95 kb diagnostic band was detected in the 
Barnl-II/EcoRI targeted allele, which is 200 bp smaller than the wild-type band. 
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type band due to the introduction of an EcoRl site in the HPRT minigene (Figure 
4.6). 
4.5 Testing the germline potential of ERCCt' ES clones and the generation of 
ERCCJ-deficient mice 
The main objectives of this research were the generation of ES cells and mice 
with targeted alterations to the ERCCI exon 3-5 region, and subsequently a second 
round of gene targeting in which the same region was to be reconstructed with two 
flanking loxP sites. This requires the prolonged in vitro maintenance of ES cells, 
which is known to reduce their ability to contribute to the germline. The suitability 
of ERCC[' ES clones for further gene targeting work was assessed by their ability 
to contribute to the germline after this initial round of gene targeting. 
The introduction of an HPRT minigene to inactivate an ERCC1 allele in the 
first step endows HPRT deficient HM-1 ES cells with an HPRT' phenotype and 
resistance to HAT selection. In the second step HPRT is replaced with an ERCCJ 
coding region bearing two loxP sites (Chapter 5). Selection for the second step 
utilised loss of HPRT function, while the non-targeted HPRTH  ES clones would be 
sensitive to the toxic purine analogue 6-thioguanine (6-TG). ES clones with low 
spontaneous levels of 6-TG resistance (6TGR)  are required for the second gene 
targeting step, since a high level of spontaneous 6-TG resistance would make it very 
difficult to identify gene targeted colonies amongst the non-targeted ES cells. Table 
4.1 summarises the results of the spontaneous 6-TG ' analysis and Southern 
hybridisation of seven positive clones. 
Clones #83, #209 and #257, with a low frequency of spontaneous 6-TG 
resistance and the predicted restriction patterns, were selected and injected into 
Balb/C blastocysts, which were then transferred to pseudopregnant females. Seven 
chimaeras were generated and assessed for germline transmission of the targeted ES 
cell allele by test- breeding. A chimeric female from #209 line gave germline 
transmission of the mutated ERCCI gene as determined by the presence of the 
diagnostic 2.95 kb EcoRI fragment. EcoRI digests of tail DNA from F 1 mice 
hybridised with a mouse ERCCI cDNA probe showed different restriction patterns 
due to polymorphic differences in 129/01a and Balb/C DNA. Whereas HM-1 ES 
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cells (129/01a background) showed single 6.0 and 2.6 kb EcoRI fragments, the 
mouse tails had doublets at both these positions, reflecting polymorphisms between 
129/01a and BalbIC. In addition, the tail DNA showed a novel 4.3 kb fragment. The 
reduced intensity of the 5.5 kb fragment in the mouse tail samples indicated that the 
4.3 kb fragment was the Balb/C polymorphic equivalent of the 5.5 kb 129/01a band 
(Figure 4.7B). The DNA polymorphism has also been noticed in comparing our 
ER CC] phage genomic DNA, with published results (see Chapter 3). The germline 
mice were mated with Balb/C and maintained as an outbred line for further 
experiments, which are described in the following chapters. 
Table 4.1 The suitability of ERCC1 +1— ES clones for the second round of gene 
taretin 
Clone No. 6-TG 	i 
(petri dish) 
Southern Blot 
(B1 c RI) 
Blastocyst 
rnirolnJLLtlotl 
83 0;0;0;0 	Av=0 OK * 
209 1;1;0;0 	Av0.5 OK * 
213 9;10;4;4 Av=7 OK 
218 4;4;3 	Av4 
221 3;3;31 	Av2.5 
228 1;0;0;0 	Av0.25 
257 3;2;2;1 	Av2 OK * 
? These clones were suspected to have additional random integration events due to faint bands in 
EcoRl digestion. 
* The predicted structure of the targeted allele in these clones was further confirmed by Southern 
hybridisation with BamHI and BamHI/EcoRI double digestion, and they were subsequently 
utilised for blastocyst microinjection. 
4.6 Discussion 
Four ERCC] knockout lines have been generated, two from our laboratory and 
two others from a Dutch group. Excepting the new strain described here, in which 
HPRT-deficient ES cells are used in conjunction with an HPRT minigene, all of the 
others utilised insertion of Neo cassettes into different regions to bring about 
inactivation of the ER CC] locus. The final structure of each of the targeted alleles is 
shown in Figure 4.8. We assume that the new knockout line would fully inactivate 
Figure 4.7 Test-breeding and Southern analysis of germline genomic DNA 
ES clone #209 was used to produce 3 male and 2 female chimaeras, and #257 
gave rise to 2 male chiameras. These chimaeras were test-bred with Balb/C to 
ascertain contribution of the ES cells to the germline. A single chimeric female 
from KT#209 line gave germline transmission of the mutated ER CC] gene. The 
mutation is labeled with " ". 
The genomic DNA from tails of two female germline pups (#2 and #3) gave rise 
to the diagnostic 2.95 kb EcoRI band (arrow). The other differences between 
the tail samples and HM-1 are due to DNA polymorphisms at the ERCCJ loci in 
the 129/01a and Balb/C genomes. 
109 




Non-Germline pup 	 Non-Germline pup 	Germline pup 	 Non-Germline pup 
(BaIbC x BaIbC) (129/01a x BalbC) (I 29/01a x BaIbC) 	(BaIbC x BalbC) 
2.3 - 
Figure 4.8 A Comparison of ERCC1 mutant allele structure 
Alignments of all reported ERCCJ mutant alleles showing the extent of 
flanking homology, the position and type of selectable markers used. All sizes of 
ER CCI homology are in kb, but the selectable markers are not drawn to scale. 
The mutant generated by Selfridge et al. resulted from the insertion of a 2.7 kb 
MT-Neo module into the PstI site in exon 5. 
The first mutant constructed by Weeda etal. utilised a 1.3 kb MCI -Neo cassette 
inserted into an artificial C/al site in exon 7. 
The second mutation by Weeda et al. resulted in the insertion a selectable marker 
into an artificial Clal site in intron 9 and introduction of a premature stop codon 
at residue 292 into exonlO, removing the last seven amino acids. 
The knockout in this thesis resulted in the removal of the ERCC 1 protein N-
tenninal coding region by the replacement of a 4.85 kb Bg[1I fragment of the 
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the ERCC 1 protein function due to a huge change in the ERCC 1 N-terminal region. 
A comparison of the targeting efficiency in different experiments is summarised in 
Table 4.2. 
Table 4.2 Comparison of ERCC1 knockout lines 
Strain Positive., 	selecftthle 	marker .Neg6the:sefrctaNeAtarlthr 7'ar1lng 
'drug selection /drug seleiction frequencj? 
Selfridge et al., 1992 2.4 kb MT-Neo/G418 (exon 5) 2.7 kb PGK-TKIGCV 1/100(1%) 
McWhir et al., 1993 2.8 kb PGKIDWM1/HATb 
Weedaetal., 1997 1.3 kb MCI-Neo/G418 (exon Not used 8/170(5%) 
7) 
Weeda et al., 1997 1.3 kb MC1-Neo/G418 (intron Not used 23/172 
9) (13%) 
Hsia et al. 5.25 kb DWM1 10/HAT (exon 2.7 kb PGK-TK / GCV 8/153 
3-5 region) (5.3%) 
gene targeting frequency is defined as the number of targeted colonies divided by the number of 
drug resistant colonies surviving selection screened 
Selfridge et al. (1992) also utilised single PGK-TKJG418/or PGK-DWM1/GCV as counter-
selection. 
GCV 	gancyclovir 
HAT hypoxanthine, aminopterin, thymidine 
HSV 	Herpex simple virus thymidine kinase gene driven by its own promoter 
HPRT hypoxanthine phosphoribosyltransferase minigene 
MCI 	synthetic mutant polyoma enhanced HSV-TK promoter 
MT metallothionein promoter 
Neo 	 neomycin phosphotransferase 
PGK mouse phosphoglycerate kinase promoter 
Generally two major variables, the choice of an insertion or replacement vector 
and the amount of homology in the vector, can influence the targeting frequency. 
Moreover, we also need to consider other factors such as position effects and the 
different promoters driving expression of the selectable marker. All ER CC] 
knockout mice reported to date utilised replacement vectors. The first knockout 
model produced in our laboratory used a vector bearing 0.55 kb of 5' homology, 1.85 
kb of 3' homology and a 2.4 kb MT-Neo module. A lower targeting frequency may 
arise from a shorter 5' homology and steric hindrance from two negative selectable 
markers, albeit this selection system resulted in higher enrichment than a single 
negative selectable marker (Selfridge et al., 1992). Hoeijmakers and colleagues 
generated two ER CC] knockout lines, in which both targeting vectors used a Neo-
cassete driven by the MC-1 promoter as a positive selectable marker (Weeda et al., 
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1997). A higher gene targeting frequency obtained with these vectors was probably 
due to the presence of 9.5 kb long homology outside a shorter 1.3 kb Neo-cassette; 
further, they did not use counter-selection which would have presumably augmented 
the targeting efficiency. 
The HM-1 ES cells and HPRT/HAT selection system described here, has been 
used to inactivate a wide range of genes in this laboratory, including mouse a-
lactalbumin (Stacey et al., 1994), cytokeratin-10 (Porter et al., 1996), DNA ligase I 
(Bentley et al., 1996)and prion protein gene (PrP) (Moore et al., 1995)with similar or 
even higher gene targeting frequencies. In this thesis we used a targeting vector 
bearing a 5.2 kb HPRT minigene and a 2.7 kb PGK-TK cassette as the positive and 
negative selectable markers. Although the targeting locus was interrupted by a 
longer selectable marker pBT/DWM 110 in reverse orientation, it still conferred an 
acceptable targeting efficiency. Only a few cases have been reported where the 
positive selectable marker was not expressed in ES cells when in the opposite 
orientation to the target locus (Koller and Smithies, 1989), and we presume that the 
orientation of the HPRT minigene in our case did not cause any interference with 
expression. 
Although the HM-1 ES line is derived from 129/Ola male embryonic stem 
cells, female chimeras are not uncommon from male ES cells and can contribute to 
the germline in this laboratory (Jim Selfridge, personal communication). A female 
chimaera from ES clone #209 has been successfully used to transmit the targeted 
ER CC] allele. Sex conversion in XY-XX chimaeras presumably arises from XY 
ES cells not in the dominant portion of sex organs. Another possible explanation 
may be attributed to the loss or silencing of all or part of the Y chromosome, which 
effectively results in XO cells. Sometimes incomplete sex conversion results in an 
infertile hermaphrodite or gynandromorph (Papaioannou et al., 1993). 
In summary, ERCCJ +/_ ES clones have been generated by the targeted 
disruption of the ERCCJ exon 3-5 region, which is replaced with an HPRT minigene. 
R 
Clones with low levels of 6-TG and correct restriction fragment patterns were tested 
for their ability to contribute to the mouse germline for further experiments. These 
clones also concluded the first stage of the two-step gene targeting strategy to 
introduce two loxP sites into the ER CC] gene. 
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Chapter 5 
Cre-mediated recombination at the ERCC1 locus 
112 
At the time this project was started, this laboratory had presented ERCCJ- 
deficient mice, bearing a neor  cassette in exon 5, as the first mouse model of 
defective NER. The ER CC] nulls were severely runted and died before weaning at 
the age of three weeks, presumably due to liver failure (McWhir et al., 1993). This 
premature death limits the scope for further analysis of the role of ERCC 1 in various 
somatic compartments of the adult organism and of other concealed consequences 
such as behaviour and predisposition to cancer. One goal of this project was to 
bypass these phenotypic constraints and to investigate ER CC] deficiency in adult 
mice. We decided to adopt the strategy of conditional gene targeting to overcome 
this obstacle. Generally these methods have taken advantage of refined selection 
procedures and/or particular enzymatic systems initially discovered in other 
organisms, which have the ability to act upon the process of DNA recombination. 
Among these, the CreIloxP system has proven extremely useful in providing a very 
versatile system. Cre-recombinase is a 38-kDa protein which is able to carry out 
site-specific recombination between a pair of unique 34-bp DNA sequences (loxP 
sites) in the absence of any cofactors or additional proteins (Sauer and Henderson, 
1988). By appropriately positioning the two loxp sites into the gene of interest 
(termed 'floxing'), Crc-mediated recombination can be used to excise loxP flanked 
DNA and hence delete the 'foxed' gene. This system can also be used with other 
transgenic strategies such as removing a foxed STOP signal to activate toxic or 
reporter genes (Lakso et al., 1992; Lakso et at., 1996; Jacob and Baltimore, 1999), 
targeted chromosomal translocations (Ramirez-Solis et al., 1995; Smith et al., 1995; 
Lewandoski and Martin, 1997; Herault et al., 1998), gene replacements (Kondo et 
al., 1998; Zc,u et al., 1994), insertions (often called "knock-ins") (Kitamoto et al., 
1996; Araki et al., 1997; Kolb et al., 1999), and point mutations (Reichardt et al., 
1998; Wang et al., 1999). 
The novelty of the CreIloxP system clearly lies in the ability to modify 
specifically targeted genes in a tissue and/or developmentally regulated fashion. 
Mice containing the foxed gene are crossed with mice expressing a Cre-transgene 
from which Cre recombinase is expressed in a cell-type-specific or inducible manner. 
Use of these Cre-mediated recombination strategies is likely to have a profound 
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impact on developmental biology and the generation of useful animal models 
corresponding to human diseases. 
This chapter describes the introduction of two loxP sites into the ER CC] locus 
by means of a double replacement gene targeting strategy. This two step method can 
be used to produce a series of mouse strains bearing different subtle alterations, 
either point mutations or loxP sites, to endogenous genes. This laboratory has used 
this method to replace the murine a-lactalbumin gene with its human counterpart 
(Stacey et al., 1994) and to produce a subtle change in the mouse Pm-P gene (Moore 
et al., 1995). Moreover, the method has been used successfully to introduce two loxP 
sites into the Ligi locus in this laboratory and further to generate Lig] °°" mice. 
The LigJfbxfb(  mice were then crossed with transgenic mice expressing Cre 
recombinase under the promoter control of the ovine 3-lactoglobulin (BLG) gene. 
The expression of this milk protein gene is restricted exclusively to mammary 
secretory epithelial cells in a developmentally regulated pattern (Whitelaw et al., 
1992), and it was reported that Cre-mediated recombination occurred in 70-80% of 
the cells in the mammary glands (Selbert et al., 1998). 
The two-step process of gene targeting was carried out in the ES cell line HM-
1. The first step has been described in Chapter 4, in which the ERCCJ exon 3-5 
region was replaced by an HPRT minigene resulting in an inactivated ER CC] allele. 
ERCCt' ES clones were used for a second round of gene targeting in which the 
ER CC] exon 3-5 region was reconstructed with loxP flanked ER CC] homology. 
5.1 Construction of a second step gene targeting vector 
A second step gene targeting vector was generated for use in the targeted 
reconstruction of a functional ERCC] allele. The plasmid pKpnl_9.3 containing 
exons 1-7 (Chapter 3) provided the basis of the novel targeting vector. 
Due to technical difficulty obtaining the same Bglll fragment by means of 
partial digestion that was deleted in the first targeting step (see Chapter 4, Figure 
4. 1), we chose a shorter BamHI fragment for this strategy. This internal BamHI 
fragment, containing the exon 3-5 region, was isolated from pKpnl_9.3 and inserted 
into pBT/loxP to introduce two loxP sites flanking the BamHI fragment, one site 
between exons 2 and 3 and the other downstream of exon 5, forming vector C. A 
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blunt-ended Nod-Clal fragment containing the foxed gene fragment derived from 
vector C was ligated into the Bg[lllblunted site of vector A (Chapter 4), forming the 
second step gene targeting vector p1oxPERCC]. A schematic illustration of the 
construction of this targeting vector is presented in Figure 5.1 and restriction map of 
this vector is shown in Figure 5.2. 
5.2 Introducing the targeting vector ploxP_ERCC1 into ES cells 
5.2.1 ES cell culture 
1.2x 106  ERCCI' ES cells (clone #209) at passage 19 were electroporated with 
200 jig of NotI linearised ploxP_ER CC] in 800 p.1 of HEPES-phosphate buffered 
saline (PBS), pH 7.05 at 910 V, 3 jiF (BioRad gene pulser) in sterile BioRad 
electroporation cuvettes. The cells were then incubated at room temperature for 10 
2 	 S 
minutes before plating out onto eight 75 cm flasks at a density of 1.2 x 10 ES 
cells/flask without drug selection. Cells were maintained for 5-7 days without 
selection to enable HPRT decay in targeted cells and then plated out onto 90 mm 
6 
dishes at a density of 1.5 x 10 cells/dish in ES cell medium supplemented with 5 jig 
/ml 6-thioguanine. Drug resistant ES colonies were picked 11 days later and half of 
each colony was screened by PCR analysis for the targeted alteration. The remainder 
of each colony was grown in 24 well dishes in ES medium without selection. 
5.2.2 Detection of ES cells with foxed ERCC1 alteration 
The second step gene targeting vector used to reconstruct a functional ER CC] 
allele with two loxP sites utilised a gene fragment carrying the exon 3-5 region 
almost identical to the region which had been replaced by an HPRT minigene in the 
first step (refer to Figure 5.4). Introduction of the two loxP sites flanking a 4.2 
BamHI fragment resulted in the foxed ER CC] allele being distinguishable from the 
wild-type allele. Furthermore, the 3' loxP site was tagged with two novel restriction 
sites-BamHI and EcoRI. 
PCR analysis of the wild type allele with primers 432E and 529N for exon 5 
and 6 respectively resulted in a 1.8 kb band and the foxed allele gave a 1.4 kb band. 
Three clones (#27, #55, #90) were found to be heterozygous and have one wild type 
and one reconstructed allele (Figure 5.3). Analysis by Southern blotting of BamHI, 
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Figure 5.11 Construction of the foxed IERCC1 targeting vector 
The vector ploxP ERCCJ was constructed via two cloning step as follows: 
Stepi: A 4.2 kb BamHI fragment containing the ERCC1 exon 3-5 region was 
isolated from the vector pKpnl_9.3 and inserted into vector pBT/loxP to form 
the intermediate vector C. 
Step2: A ClaI-NotI fragment containing the foxed ERCC1 gene fragment was 
subsequently isolated and ligated with vector A (Figure 4.1) to form the 
foxed ERCCJ targeting vector ploxP_ERCCJ. Due to the inefficiency of 
blunt end ligation, only two out of 144 (1.4%) bacterial colonies showed the 
desired insertion. Note that using a smaller BamHI fragment in this 
reconstruction step created size discrepancies of 200 bp and 450 bp in introns 
2 and 5, respectively, compared to the wild type gene. 
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Figure 5.2 Restriction map of ploxP_ERCCJ 
A restriction map of the foxed ER CC] targeting vector ploxP_ER CC] was 
determined by single and double digestion of plasmid DNA. All sizes of ER CC] 
homology are in kb. Fragments marked * contain pBluescript II SK (+) DNA. This 
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Figure 5.3 TPCR screening of ES cell colonies for the 11oxed ERCCJ alteration 
ES cell lysate was amplified by PCR with primers 432E and 529N, which 
correspond to ERCCJ exon 5 and exon 6 respectively. The cycling parameters 
were 94 C (1mm), 66 C (1mm) and 72 C (1mm 30s) x 35 cycles. PCR products 
from the wild type allele gave a 1.8 kb band and the foxed allele presented a 1.4 
kb band. 
An aliquot of the PCR product was electrophoresed on a 1.0% (w/v) agarose gel 
stained with ethidium bromide. A positive colony containing one foxed allele 
(#90) was detected showing both 1.8 and 1.4 kb bands. HM-1 DNA and no 





















EcoRI and BamHTJEcoRI double digested DNA, probed with the mouse cDNA 
probe, was consistent with the proposed structure of the foxed ER CC] allele (data 
not shown here, it will be discussed further in section 5.3.2.2 in conjunction with 
Gre-mediated recombination). It was therefore concluded that all three clones were 
heterozygous for the foxed ERCCI allele and had undergone the desired 
homologous recombination event. 
5.3 Selection for ERCC1 ° clones after site-specific recombination 
5.3.1 Conditional deletion of ERCC1 in vitro by transient expression of Cre 
recombinase 
To test whether Cre-mediated recombination could be induced between the 
two loxP sites in a genomic context, Cre recombinase was transiently expressed in 
ES cells bearing the foxed ERCC] allele: 2 x 10 ERCC1+/fbx  ES cells (clone #90 at 
passage 35) were electroporated with 200 tg of the circular Gre expression vector, 
pMC/CreN, in 800 il of HEPES-PBS, pH 7.05 at 950 V, 3 pF. After a 10 mm 
incubation at room temperature the cells were plated out in a large flask. Two days 
later, the cells were split and half were taken for genomic DNA preparation and the 
remainder were used to carry out a second round electroporation, again using 200 .tg 
pMC/CreN, at 1,000 V, 3 jtF and plated out in a large flask. The ES cells were 
allowed to proliferate for two days, DNA samples from these cells were screened for 
the presence of a Cre-mediated recombination event. 
5.3.2 Molecular analysis for specific excision of DNA from foxed ERCCJ allele 
Figure 5.4 shows Cre-mediated recombination between two loxP sites in the 
foxed ER CC] allele following two-step gene targeting. Since the ER CC] exon 3-5 
region is flanked within two loxP sites prior to being excised, it will effectively be 
deleted and form a small circular DNA molecular by Gre-mediated recombination. 
This molecule lacking elements necessary for maintenance and propagation within 
the cell will be prone to nucleolytic degradation, and hence will be lost. Deletion of 
the exon 3-5 region should disrupt gene function in a manner similar to the first step 
gene knockout. Furthermore, removal of the intervening sequences will bring exon 2 
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Figure 5.4 Schematic representation of two- step double replacement strategy 
for the introduction of two loxP sites into the ERCCI locus and further Cre-
mediated recombination 
The foxed ERCCI allele was generated by two distinct steps. In the first step 
the ERCC/ exon 3-5 region was ablated by targeted replacement with an HPRT 
minigene. A second homologous recombination step was subsequently used to 
reconstruct a functional allele with the introduction of two loxP sites flanking the 
exon 3-5 region. 
In the first step, positive and negative selection for HPRT and HSV-TK were 
achieved by supplementing the ES medium with HAT and gancyclovir. For the 
second step, the HPRT minigene was replaced by an intact exon 3-5 region, flanked 
with two loxP sites. Selection against HPRT function with the toxic purine analogue 
6-thioguanine is sufficient to enrich for targeting events. 
Abbreviations: 
HAT 	hypoxanthine, aminopterin, thymidine 
HSV-TK 	Herpes simple virus thymidine kinase gene 
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and 6 into close proximity, in a manner unique to the deleted ERCCI allele. In this 
section we discuss the structural changes in the different gene-targeting steps. 
5.3.2.1 PCR analysis 
ES cells from the second sequential round of pMC/CreN electroporation were 
plated out at single cell density to allow colony formation. When clones were 
sufficiently large, 36 colonies were picked at random and screened for the presence 
of the ERCCIdCI  allele by PCR. Individual colonies were harvested by scraping and 
mechanically disaggregated in a small volume of medium. Thereupon one half of 
each cell suspension was deposited into a well of a 24-well plate for continued 
expansion of the colony, whilst the other half was used for the rapid colony screening 
procedure. Cells were pelleted by brief centrifugation and resuspended in 1 x PCR 
buffer with proteinase K. After 2 hours digestion, the proteinase was inactivated by 
heating, whereupon a small aliquot was used in the PCR assay specific for the 
ERCCJ allele. 
The presence of a specific product for the deleted allele was verified by PCR 
amplification between exons 2 and 6 using two oligonucleotide primers-A09, 
complementary to the 5' end of intron 2, and 529N,complementary to the 3' end of 
o 
exon 6. The cycling program was 94 C (1mm), 66 C (1mm) and 72 C (1mm 30s) x 
35 cycles. Prior to recombination, the distance between these two primer binding 
sites was too long (nearly 7.15 kb) for efficient amplification. Thus the wild type 
and foxed alleles did not give a product from this reaction. Only after Cre-mediated 
recombination had excised the intervening region were the two primer binding sites 
close enough for a product to be amplified. Hence, the 2.3 kb product spanning the 
Cre-induced deletion was the diagnostic band for the ERCC1 allele. Five (#8, #11, 
#12, #20, #21) out of 36 colonies produced positive signals in this screening. 
Analysis of two of the five clones is shown in Figure 5.5. 
5.3.2.2 Southern blotting analysis 
The predicted structures shown in Figure 5.6 comprise the wild-type, knockout, 
foxed, and the deleted ERCCI allele arising from Cre-mediated recombination of 
the foxed allele, along with the predicted DNA fragments arising from digestion 
121 
Figure 5.5 Detection of ES cells with Cre-mediated recombination events 
This panel shows part of the wild-type mouse ERCCJ locus, reconstructed allele 
with two loxP sites and the allele following Cre-mediated recombination. The 
primer pair A09 and 529N corresponds to exon 2 and exon 6 respectively. In the 
wild-type and foxed alleles the distance between these two primer binding sites 
was too long (nearly 7.15 kb), so a product was not detected using this reaction. 
Gre-mediated recombination excised the intervening region and gave a 2.3 kb 
Cre-induced band. 
An aliquot of the PCR product was electrophoresed on a 1.0% (w/v) agarose gel 
stained with ethidium bromide. Two positive colonies containing one allele 
having the Cre-mediated recombination event (#90) presented the 2.3 kb band. 
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Figure 5.6 A restriction map of different ERCCJ allele structures 
A restriction map depicting the structures of the parental, gene targeted, foxed 
and deleted (following Cre-mediated recombination) ERCCI alleles. All sizes are in 
kb and drawn to scale except the HPRT selectable marker in the knockout allele, 
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with BarnHI, EcoRI and BarnHL/EcoRl restriction enzymes,which should hybridise 
to a mouse ERCCJ cDNA probe and be detected by Southern blotting. 
DNA was prepared from the original ES cell line HM-I, a clone with a 
targeted knockout allele (ERCC1' # 209), a clone heterozygous for the foxed allele 
(ERCCI
+fflox  #55) and a clone which had given a positive result from the PCR 
analysis specific for the deleted allele (ERCCJ 1' #8). Following digestion with 
BarnHl, EcoRl and BarnHL/EcoRI restriction enzymes, the DNA was subjected to 
Southern blot analysis (Figure 5.7). 
In BarnHI digestion, previous work had shown that 4 bands were detected in 
wild-type and ERCCt' samples (17.2, 7.3, 5.35 and 4.2 kb). The 17.2 kb band was 
derived from the knockout allele which lacks two of the endogenous Barn HI sites, 
and the other bands were derived from the wild-type ER CCI allele and would thus 
be unaffected by targeting. ERCCI' °' ES cells exhibited the expected 3 bands (7.3, 
5.35 and 4.2 kb) from the wild-type allele. Moreover, there are two novel bands 
(9.35 and 6.85 kb) in the reconstructed allele arising from the introduction of a new 
BarnHI site. The 9.35 kb band gave a strong signal and the 6.85 kb band formed a 
doublet with the wild-type 7.3 kb band. Cre-mediated recombination of the foxed 
ERCCJ locus deletes the exon 3-5 region and thus juxtaposes exon 2 with exon 6. 
The deletion results in two doublets, one which has been mentioned above (7.3 and 
6.85 kb), and the other (5.35 and 5.15 kb) is generated from a 200 bp discrepancy 
between the original and deleted allele. 
Wild-type DNA digested with EcoRI and hybridised to the ER CCI cDNA 
fragment had given three bands (6.0, 5.5 and 2.6 kb) in Southern analysis. Generally 
the 0.95 kb EcoRI predicted band between exon 3 and 4 in HM-I ES cells was 
difficult to detect due to the low content of homology to the cDNA (see Chapter 4). 
Apart from these three bands, a 2.95 kb EcoRI band appeared as a diagnostic band in 
the knockout allele. As already discussed in Chapter 4, the 4.5 kb predicted band 
was not detected. In EcoRl digests of the ERCC1+ff0x  ES cells, the 5.3 kb band in 
the reconstructed allele could not be resolved from the wild-type 5.5 kb band and 
three bands (1.3, 1.05 and 0.95 kb) were also difficult to detect by Southern analysis. 
Although a new 3.05 kb EcoRI band was detected in the allele following Cre- 
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Figure 5.7 Southern analysis of ERCC1', ERCC1' , ERCC1+0X , and 
4-/de ERCCI l ES cell clones 
Southern analysis of genomic DNA from different ES cells using a variety of 
restriction digests and an ERCCJ cDNA probe. 
Panel (A) depict BamHI digests. 
Panel (B) depict EcoRI and Ba,nHIlEcoRl double digests. 
The same loading order was used in both panels: 
HM-1, 129/01a ELM-i ES cells, encoding two wild-type ERCCI' 4- alleles. 
KJO, 129/01a ERCCJ' ES clone #209. 
foxed, 129/Ola ERCC1' t1° ES clone #55. 
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mediated recombination, it appeared only slightly different from the null allele due to 
a similar 2.95 kb band in this allele. 
In BamHlIEcoRI double digestion, there were six predicted bands (5.8, 3.15, 
2.3, 1.65, 1.0, 0.95) from the wild-type ES cells, but the 1.65 and 0.95 kb bands were 
not readily detected. The 2.95 kb band in knockout allele and the 5.3 kb band in 
foxed allele could be thought of as a diagnostic band in each case. It was difficult to 
differentiate the deleted foxed allele from the null allele for the same reason as with 
the EcoRI digests. Table 5.1 summarises a comparison of predicted bands following 
digestion with BamHT, EcoRI and BamHIIEcoRI restriction enzymes and actual 
bands observed in Southern analysis. We conclude that these alleles all have the 
predicted structure. 
5.4 Generation of mice carrying the foxed ER CC] allele 
Following the confirmation that the foxed ERCCI allele had the correct 
structure and that Cre-mediated recombination could be induced between the two 
loxP sites in vitro, 	 ES cells were used to produce mice bearing the 
foxed ERCCJ allele. The breeding strategy is shown in Figure 5.8. ERCCI +/flox  ES 
cells clones (#27, #55, #90) were injected into host blastocysts, and the resulting 
chimaeric mice were mated with Balb/C mice to produce mice heterozygous for the 
foxed allele. These animals were interbred to generate mice homozygous for the 
floxltlox 	 fiox/flox ERCCJ 	mice. To date we have produced ERCCI 	mice (Figure 5.8 
panel C) and they have developed normally and no abnormalities have been observed 
(Jim Selfridge, personal communication). These mice will be used to study the Cre-
mediated recombination in vivo. 
5.5 Discussion 
The targeted inactivation of a gene is a powerful tool to investigate gene 
function in the intact organism. However, a large number of mice carry null 
mutations that lead to obvious developmental defects and frequently cause early 
embryonic lethality. Moreover, the commonly used procedure may still allow the 
expression of proteins with deletions or truncations that have residual function or 
exhibit transdominant activity. Our original and new ERCCI nulls were viable but 
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Table 5.1 Predicted and observed ERCC1 restriction fragments in different ES cells 
Wild type Knockout Floxed Cre-mediated 
recombination 
predicted observed predicted observed predicted observed predicted observed 
17.2 17.2 
9.35 9.35 
7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 
BarnHI 6.85 6.85 6.85 6.85 
5.35 5.35 5.35 5.35 5.35 5.35 5.35 5.35 
5.15 5.15 
4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 
6.0 6.0 6.0 6.0 6.0 6.0 6.0 6.0 
5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 
5.3 5.3 
4.5 - 
EcoRl 3.05 3.05 
2.95 2.95 
2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 
1.3 - 1.3 - 
1.05 - 
0.95 - 0.95 - 0.95 - 0.95 - 
5.6 5.6 5.6 5.6 5.6 5.6 5.6 5.6 
5.3 5.3 
4.5 - 
3.15 3.15 3.15 3.15 3.15 3.15 3.15 3.15 
3.05 3.05 
Ba,nHlIEcoRl 2.95 2.95 
2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 
1.65 - 1.65 - 1.65 - 1.65 - 
1.3 - 
1.05 1.05 
1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
0.95 - 0.95 - 0.95 - 0.95 - 
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Figure 5.8 CreIIoxP mice breeding schemes 
A ligand activated site-specific recombination: A conditional tamoxifen-
inducible Crc recombinase produced by fusing it with the ligand-binding 
domain of the human oestrogen receptor (Crc-ER T) that binds tamoxifen but not 
oestrogen. This fusion protein is made under the control of a tissue-specific 
promoter. The chimaeric protein is only activated in the presence of 4-OH-
tamoxifen which causes release of the inhibitor, heat shock protein I-Isp90. The 
free form,Cre-ER T, enters the nucleus and excises the intervening DNA flanked 
by two loxP sites 
The breeding strategy between Cre-transgenic mice and foxed ERCCJ mice: In 
the first step, ERCCI -'-/flox 	 floxltlox mice are interbred to produce ERCC1 	mice, and 
in the near future these mice will be crossed with Cre ERCCI' mice to 
generate Cre ERCC10x  mice. The next generation from the mating of the 
established ERCC1' mice and Cre ERCC10x  mice will contain some Cre 
ERCC1IlO mice which will be treated with tamoxifen to produce tissue-specific 
knockouts. 
PCR analysis of ERCC1 1° ''° mice: An aliquot of the PCR product from mouse 
tail DNA amplified in the same way as described in Figure 5.3 was 
electrophoresed on a 1.0% (w/v) agarose gel stained with ethidium bromide. 
Two mice homozygous for the foxed ERCCI allele presented the 1.4 kb band 
only. HM-1 DNA (WT) with the 1.8 kb band only and flox/+ ES cells DNA 
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died before weaning at the age of three weeks [(McWhir et al., 1993) and Chapter 6 
in this thesis]. To circumvent lethality in this early stage as well as allow the analysis 
of later functional roles of ERCC1 during development and maintenance of 
individual tissue, we chose to use the Cre/loxP recombination system. Cre 
recombinase mediates site-specific recombination between 34 bp sequences termed 
loxP sites. This system, which was derived from bacteriophage P1, has been adapted 
to function in ES cells and shown to be a powerful system to mediate both subtle and 
large scale mutations. 
We have developed a double replacement gene targeting strategy based on the 
use of only one selectable marker, the HPRT gene. This selectable marker can be 
selected for, by culturing in HAT, as well as against by culturing in 6-TG. It 
provides at least two advantages over other methods. In the simpler one step 
approach the loxP sites are introduced along with a flanking selectable marker which 
may have deleterious effects on neighbouring genes. Recent studies have suggested 
that PGK-NEO (a hybrid gene consisting of phosphoglycerate kinase I promoter 
driven neomycin phosphotransferase gene), a widely used cassette employed as a 
selectable marker for homologous recombination in ES cells, can deregulate 
neighbouring targeted loci even up to 100 kb distant, presumably by competing for 
regulatory sequences (Fiering et al., 1993; Rijli et al., 1994; Pham et al., 1996) . It is 
possible that a number of mouse phenotypes might arise from the effects of the 
retained selectable markers. The potential for confusion is likely to be exacerbated 
by the common arrangement of mammalian genes into gene families such as Hox 
gene clusters. Around 40 such genes have been isolated that are located in four 
relatively short clusters (the HoxA to HoxD complexes), and all genes in each cluster 
have the same 5'-to-3' transcriptional orientation with a similar function in 
developing axial structures (Kostic and Capecchi, 1994; Koran et al., 1995). 
Following the second step in our strategy, the gene targeted allele has no foreign 
sequence and differs from the wild-type allele only with respect to the engineered 
subtle alterations. 
A second advantage of this targeting strategy is that several subtle 
modifications at the same locus can be generated by using an initial gene-targeted 
cell line as a substrate for subsequent replacements. In contrast, the "hit and run" or 
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"in-out" strategy requires that each mutation is separately targeted to the gene of 
interest, and then the targeted cell line is expanded and fortuitous intrachromosomal 
recombination is relied on. It results in the frequent loss of the introduced altered 
sequence, rather than its endogenous homology, leaving the locus unmodified. Our 
strategy can be used to provide future ER CCI gene modifications bearing subtle 
mutations in specific domains. 
Some parameters are thought to influence the efficiency with which gene 
targeted clones are retrieved with this two step gene targeting step. This HPRT 
based strategy depends on the efficiency of 6-TG selection killing any HPRT 
expressing cells after the second targeting step. However, at least three classes of 
cell may be selected in 6-TG: (1) HPRT deficient cells, HM-1, carried over from the 
first targeting step as a minor contaminant, (2) cells which have spontaneously lost 
HPRT function and (3) cells which contain the desired subtle alteration from the 
second homologous recombination event. The problems associated with HM-1 
carry-over can be circumvented by generating a number of independent clones in 
step one and performing second step in ES cells lines with low levels of spontaneous 
6-TG resistance. Cells which have spontaneously lost HPRT function can arise for a 
number of reasons such as minigene deletion, gene conversion and methylation of 
the minigene promoter. We have found that it is difficult to retarget step 1 Lig]' 
lines due to methylation silencing the HPRT minigene (Melton et al., 1997). The 
PGK-1 promoter for the Ligi targeting used to drive this minigene was methylated, 
which results in a high rate of 6-TG resistance and consequentially precludes the 
efficient retrieval of targeted clones in the second targeting step. For this reason we 
used a more appropriate promoter (HPRT) to drive the selectable marker in this 
study, which is not methylated to the same extent. Three clones which showed low 
spontaneous 6-TG resistance in step 1 gene targeting and had been validated by 
Southern analysis were considered suitable for this strategy (data shown in Chapter 
4). 
Since our laboratory had previously and successfully utilised the double 
replacement gene targeting strategy for different gene loci, we employed this strategy 
to introduce two loxP sites into the endogenous ER CC] locus. The first step 
involves a replacement recombination event allowing the introduction of an HPRT 
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cassette into the ERCCJ exon 3-5 region, as with conventional gene targeting. 
Correctly targeted ES clones were then identified among the HAT resistant clones. 
In a second step, a foxed ERCC] targeting vector, consisting of sequence 
homologous to the target gene, reconstructed the disrupted allele and introduced two 
loxP sites. Clones with the desired modification were identified among the 6-TG 
resistant clones. Since we had inserted two loxP sites flanking a smaller BamHI 
fragment, this provided a straightforward means of screening by PCR without further 
restriction enzyme digestion to distinguish between wild-type and foxed allele. 
Southern blotting confirmed that five ES cell clones identified by PCR had 
undergone the correct homologous recombination event. Despite small deletions of 
introns 2 and 5, we presume the ERCC 1 transcript and encoded protein from the 
foxed allele to be functionally equivalent to the wild-type allele. To date 
ERCC]fb)flb( mice have developed normally to adulthood and no abnormalities have 
been observed in these mice. 
A PCR-based assay was devised to detect in vitro Cre-mediated recombination 
at the ERCCJ locus. This assay was used to screen ES cells into which a Cre-
expression plasmid had been introduced. Five clones exhibited positive signals in 
this experiment and Southern analysis confirmed all clones had undergone Cre-
mediated deletion of the exon 3-5 region of the foxed ERCCJ allele. The structure 
of this deleted ER CC] allele, determined by Southern blotting, matched the 
predictions made from the known structure of the foxed allele. The data from in 
vitro studies implied that Cre-mediated recombination between the two loxP sites at 
the ER CC] locus could be successfully utilised in mice and this study is presently 
being carried out in our laboratory. 
Since foxed genes will be present in every cell of the organism, the ability to 
perform tissue- and developmentally specific recombination is then dependent on the 
choice of promoter used to drive the expression of Cre recombinase in vivo. To date, 
most researchers have used either tissue-specific Cre or inducible Cre to achieve 
their goals. The first report of tissue-specific recombination in a mouse model 
demonstrated transgenic mice carrying the Cre gene under the control of a T-cell 
specific ick (lymphocyte creatine kinase) promoter could delete a foxed DNA 
polymerase 13  (polfi) gene in a subset of mouse T cells (Gu et al., 1994). Tsien et al. 
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used the promoter from the a-calcium-calmodulin-dependent kinase II ((xCaMKII) 
gene to drive Cre expression to exclusively inactivate a foxed N-methyl-D-aspartate 
receptor l(NMADRJ) gene in the CAI region of hippocampus (Tsien et al., 1996a b). 
The inducible expression system can be used to direct temporal expression of the Cre 
recombinase driven by a ligand-dependent promoter. In the case of Mxl-Cre mice, 
Cre expression was placed under control of the interferon-induced Mx] promoter and 
high efficiency recombination of the foxed polfi gene among multiple cell types of 
adult animals was achieved after administration of the interferon agonist 
polyinosinic-polycytidylic acid (Kuhn et al., 1995). Transgenic mice in which the 
Cre-recombinase has been placed under the control of a tetracycline(Tc)-controlled 
promoter have been also reported (St-Onge et al., 1996). In this system a fusion 
protein (Ic-controlled transactivator, tTA) consists of the Tc repressor (tetR) and the 
activating domain of the herpes viral protein VP 16. In the absence of the effector 
molecule Tc or doxycyline (Dox), this transactivator is active to bind an array of 
cognate tet-operator (tetO) sequences in front of a minimal human cytomegalovirus 
(hCMV) promoter and further activates transcription of the desired gene . Addition 
of Tc or Dox prevents tTA from binding and thus the initiation of transcription 
(Baron et al., 1997, 1999). A similar system with mutated tTA (rtTA), in which Tc 
or Dox acts as an inducer of transcription, has also been reported as operating in a 
highly tissue-specific way when it was employed in mice (Kistner et al., 1996). To 
achieve breeding simplicity in obtaining the mouse genotype desired, the use of a 
single transgene construct harbouring both functional cistrons (i.e. tissue-specific 
tTAIor rtTA expression and tetO-CMV regulated Cre expression) may be desirable. 
In this study we will utilise transgenic mice (kindly provided by Dr. Alan 
Clark, Department of Pathology, University of Edinburgh) carrying a conditional 
tamoxifen-inducible Cre recombinase, Cre-ER T, a fusion protein consisting of Cre 
and the G521R mutant form of the human oestrogen receptor ligand-binding domain. 
This domain no longer binds oestrogen but does bind the antagonist 4-OH-tamoxifen 
(Littlewood et al., 1995). In the absence of the ligand, the chimaeric protein Cre-ER T 
is bound and inactivated by the heat shock protein Hsp90 and retained in the 
cytoplasm. Exposure of cells to this ligand releases CreERT  from Hsp90, it 
tranlocates into the nucleus where it can recognise loxP sites and excise the 
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intervening DNA (Scherrer et al., 1992). The Cre recombinase, in combination with 
different tissue-specific promoters, can generate a wide range of conditional/and 
inducible knockouts (Figure 5.8 panel A). Indeed, a recent paper has demonstrated 
that the Cre-ER fusion protein driven by a human keratin K14 promoter was 
successfully expressed in the mouse skin (Vasioukhin et al., 1999). The proposed 
breeding strategy between Cre-transgenic mice and foxed ER CC] mice has been 
presented in Figure 5.8 (B). The scheme described here can be used to generate 
fox/fox ER CC] mice from interbreeding floxl+ heterozygous mice, and we have 
recently produced these mice. These mice will soon be crossed with Cre-ER T 
transgenic mice or other transgenic mice under the control of a tissue-specific 
promoter to acquire Cre floxl+ mice. Since it is easier to achieve a single Cre-
mediated recombination event in required cells, we will then cross Cre flox/+ mice 
with the established ERCCJ' mice (Chapter 4) to generate the tissue-specific 
knockouts. Because many of the major symptoms and signs in NER-deficiency 
diseases such as XP, CS and TTD have presented in skin, we will try to set up a 
Cre/loxP model, using an established transgene expressing the chimeric recombinase 
under the control of the keratin 5 (K5) promoter that is selectively active in 
epidermal proliferating basal keratinocytes, to investigate the role of ER CC] in skin 
disease' (Brocard et al., 1997). Moreover, the Cre-mediated recombination system 
can provide a convenient pathway to study the correlation between polyploidy and 
liver failure in ER CC] knockout mice. This offers a great opportunity to study the 
consequence on internal organs of NER-deficiency. 
In summary, the ERCCI +Iflox ES cells have been produced and successfully 
employed in in vitro transient Cre-mediated recombination. The generation of mice 
bearing foxed alleles will allow the production of a number of different ERCCI-
deficient mouse models in the near future. It should be possible to answer a series of 
questions concerning the importance of ERCC 1 in DNA repair and other novel 
functions. 
Cells from the basal layer of the skin epidermis undergo a well-defined program of differentiation, 
coordinated with vertical migration from suprabasal layers (spinous and granular layers) and a 
protective cornified layer of enucleated and keratinized cells, which is eventually shed. Thus, 
epidermal cells are continuously renewed throughout life, utilising reservoirs of stem cells lacated in 
the basal layer and outer root sheaths of hair follicles. Because the keratin 5 promoter directs gene 
expression in the basal layer of the skin,; therefore, all skin cells would be expected to be ERCC1 
negative if the Cre/loxP system is working efficiently. If the expected tissue specificity of Cre 
expression is obtained then only the skin will be ERCCI-deficient. 
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Chapter 6 
Liver changes in the ERCC1-deficient mice 
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In Chapter 4, we have described a new ERCCJ-deficient line, designated as 
KT#209, which was generated by deleting the exon 3-5 region. We suspected that it 
was a complete knockout due to the removal of the region encoding amino acid 36 to 
175 (see Figure 8.1). In order to acquire more information about ERCC 1 function, it 
became important to investigate any differences between the original and novel 
(KT#209) ERCC] -deficient mice. This chapter describes fatty change, 
mitochondrial damage and hepatocyte polyploidy/aneuploidy in the livers of these 
mice. It also discusses the expression of some proteins in liver extracts. 
6.1 Growth retardation and anatomical changes in the new ERCC1-deficient 
mice 
As mentioned in Chapter 4, the heterozygous ERCC1 mice were outbred to 
obtain homozygous mutants. The new ER CC] knockout mice, similar to the original 
line, were severely runted from birth and died before weaning at 20 days. Since we 
were unable to detect any obvious changes in the gross appearance and behaviour 
between the wild-type and heterozygous ERCC] mice, even in a long time 
investigaation, in this section we categorised them both as the control group. At 
embryonic day 16.5 (E16.5), the average body weight of the mutant mice were 
moderately lighter than the control group (84% of the control group); thereafter the 
mutant mice exhibited severe growth retardation and were only 30% body weight of 
the control group at postnatal day 19 (P19) (Figure 6.1). We examined several 
organs (liver, thymus, spleen, heart, lung, kidney, brain, intestine and stomach) of the 
new ERCCJ knockout line at P3, P8, P13, P16 and P19. Except for the brain, these 
organs were consistent with the reduced size observed for the whole body (data not 
shown). We also noted that some homozygous mutant livers showed white 
discolouration (data not shown). 
6.2 Histological analysis and fatty changes in the ERCC1 knockout livers 
On microscopical examination of several organs of KT#209 ER CC] mutants, 
using hematoxylin and eosin (H&E) staining, the most significant change, as with the 
original ER CC] knockout mice, was the aberrant nuclear sizes in the liver . Some 
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Figure 6.1 Growth retardation in the KT#209 ERCC1 -deficient mice 
Homozygous wild type (ER CC] 
+1+ 
) and homozygous mutant (ER CC]
-I- 
 ) 
littermates at postnatal day 16 (P16) are shown. 
Growth curve of the KT#209 mutants (ERCC] ' ) and control littermates 
+1+ 	 +1- 
(ER CC] and ERCCJ ). Animals were weighed at the indicated days and the 
weights plotted against age in days. Except embryonic day 16.5 (E16.5), all 
other mice were postnatal pups. Each point is the mean of two ER CC] mutants 
or three control littermates. 
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large nuclei could be found at embryonic day 16.5 (E16.5). In addition to this 
finding, it was evident that hepatocytes in both our ER CC] knockout lines contained 
a number of lipid-like vacuoles, that leave the nucleus in the centre of the cell. 
Severe damage of hepatic architecture and focal and mild necrosis of hepatocytes 
were also noticed in some older mutants (Figure 6.2). The frequency of apoptotic-
like cells showed no significant changes in the ERCC] null liver (data not shown), 
although we did not further confirm this by TUNEL (terminal deoxynucleotidyl 
transferase-mediated dUTP nick-end labelling) staining. We considered two 
possibilities for the content of these vacuoles: glycogen and/or lipid. The periodic 
acid-Schiff (PAS) staining did not show a strong reaction on liver sections from both 
ERCCJ-deficient lines and the wild-type littermates (data not shown), implying that 
these vacuoles did not contain hepatic glycogen. After ruling out the possibility of 
abnormal glycogen metabolism, we examined the second possibility of lipid within 
these vacuoles with an oil red 0 staining, which reveals lipid droplets as red-
coloured deposits. Intriguingly, a lot of small, or sometimes slightly larger, lipid 
vesicles were found in the whole liver section from mice of both ER CC] knockout 
lines, whereas the control littennates did not show any evidence of this lipid 
accumulation (Figure 6.3). These lipid droplets were present in the liver cell 
cytoplasm and did not displace the nucleus. 
6.3 Electron-microscopic examination of the ERCC1 null livers 
To further explore whether lipid droplets in the ERCC1 null livers correlated 
with changes in specific organelles, an electron-microscopic method was applied in 
this tissue. This work was carried out with the help of Mr. John Findlay, Biological 
Sciences Electron Microscope Facility, University of Edinburgh. 
A low power electron micrograph (2,850x) showed that the cell boundaries of 
some hepatocytes from the new knockout line were not easy to detect (Figure 6.4). 
Meanwhile, numerous lipid droplets were found in the cytoplasm of null hepatocytes 
and the nuclei of these hepatocytes remained centrally located. The size of the lipid 
droplets observed were often as large as the nucleus. The variant nuclear sizes were 
consistent with those seen after the H&E staining. Except for a few cells with a 
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Figure 6.2 TH[istopatholiogical analysis of mouse livers (THII&E staining) 
Sections through the liver of wild-type (A and C) and ER CC] ' (B, D, E and F) 
mice at embryonic day 16.5 (E16.5, A and B) and postnatal day 16 (P16, C, D and E) 
and 19 (P 19, F). In the embryonic stage, some large nuclei (arrowhead) can be found 
in the ERCC 1 null livers. Both wild-type and knockout livers contained numerous 
islands of erythropoietic cells (bracketed). At P16, the arrangement of hepatocytes 
within the wild-type liver can be readily seen (C). The hepatocytes form flat, 
anastomosing plates usually only one cell thick between which blood passes 
sluggishly towards the centre of the lobule. This arrangement maximises the contact 
between hepatocytes and blood. V; central vein. Compared with the wild-type 
control littermates, the ER CC] null livers showed a large nuclei and aberrant nuclei 
(arrowheads in D and E). A vacuolar appearance (arrow) was also evident in the 
ERCC] null hepatocytes (D and E). At P19, in spite of large nuclei, a focal necrotic 
area (star in F) was also present in the liver of an ERCC] ' mouse. A, B and E x 400; 
C and Dx200;Fx 100 
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Figure 6.3 Accumulation of intracellular lipid in the liver of ERCCJ-deficient 
mice 
Photomicrographs demonstrating the histologic appearance of the livers of 
+I- -I- control group (ERCCJ ) and mutant (ERCCJ ) mice. Frozen tissue sections were 
prepared from the livers and stained with oil red 0. The red droplets indicate 














protruding nuclear envelope (data not shown), this structure was intact in most 
hepatocytes. A striking finding was the abnormalities of mitochondria in the null 
hepatocytes, especially in the sites near lipid droplets. The misshapen and enlarged 
mitochondria were only seen in the null hepatoctyes. Higher power views (1 1,000x 
and 37,000x) showed that some mitochondrial membranes were disrupted, although 
the cristae remained intact. Some lipid droplets also had a "secondary vesicle" 
structure (Figure 6.5). No fibrin deposition or viral particles were seen in these 
sections. 
We also examined the original ER CC] knockout mice, and found that some 
mitochondria had moderate structural disruption (Figure 6.5). Although we did not 
find lipid droplets in these specimens, we suspected that there might be similar 
findings to the new knockout line, as the oil red 0 staining also indicated fatty 
changes in the original knockout line. 
A comparison of the disruption of mitochondrial membranes in the wild-type, 
original and KT#209 ERCCJ null livers is presented in Figure 6.6. Obviously, the 
novel ERCCJ-deficient line showed severe damage in the liver cell mitochondria. 
We also noticed that the mitochondria near lipid droplets showed a higher frequency 
of disruption than at other sites. 
6.4 Polyploidy in the ERCC1-dificient livers 
Polyploidy is a characteristic feature of mammalian hepatocytes (Brodsky and 
Uryvaeva, 1977). In new-born mammals, nearly all hepatocytes are dipolid. After 
several days a significant fraction of the mitotic hepatocytes fail to undergo 
cytokinesis (acytokinetic mitosis) in the growing liver, resulting in the formation of 
binucleated hepatocytes which markedly increase in numbers after a few weeks. 
Then mononucleated tetraploid (4C) cells emerge, followed by binucleated cells with 
two tetraploid (2x4C) nuclei and finally by mononucleated octoploid cells (8C). The 
succession of hepatocyte cell classes has been established by early cytophotometric 
studies (Brodsky and Uryvaeva, 1977; Nadal and Zajdela, 1966)and more recently by 
flow cytometric studies (Gerlyng et al., 1993; Saeter et al., 1988). The entire process 
of hepatocyte polyploidisation is considered to be a mechanism of evolutionary 
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Figure 6.4 Low power electron micrographof ERCC1
-I- 	 +1+ 
and ERCCJ liver 
(x2$5©) 
Ultrastructural analysis of liver cells from littermates showed that a lot of lipid 
droplets were located in the vicinity of the KT#209 ERCCJ ' hepatic nucleus. Note 
the lack of a significant cell boundary in some hepatocytes of the ERCC1 knockout 
mice. 
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Figure 6.5 High power electron micrograph of ERCCJ ' livers showed 
disruption of the mitochondria. 
Mitochondria near lipid droplets in the KT#209 ERCCI ' hepatocyte showed 
atypical appearance (B), whereas in the wild-type control littermates the 
mitochondria were intact (A) (x 11,000). Note that "secondary vesicle" (star) in 
some lipid droplets. A comparison of the wild-type (C), original (D) and KT#209 
(E) ERCC/ ' null livers indicated that some hepatic mitochondrial membranes in the 
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Figure 6.6 Disruption of mitochondrial membrane was elevated in the ERCC1 
null livers 
Three to four hundred mitochondria of age matched wild type, original and 
KT#209 ERCCI null hepatocytes were counted. The values represent normal 
(good), semi-conserved (semi-) and fully disrupted (bad) mitochondrial membrane in 














adaptation, reflecting an increasing degree of irreversible hepatocellular 
differentiation adopted to decrease the high risk of genomic damage to which the 
liver is exposed (Brodsky and Uryvaeva, 1985). Sigal et al. have demonstrated using 
FACS analysis that the frequency of synthetic (S) phase hepatocyes in the fetal, 
neonatal and adult rodent liver were 33.8%, 4.9% and 1.0% respectively and that the 
tetraploid frequency was raised from 0% (foetal) to 44% (adult), confirming that 
polyploid hepatocytes are terminally differentiated end-stage cells with a low 
proliferative capacity (Sigal et al., 1995). 
Interestingly, previous reports of livers of the ERCCI-deficient mice, either 
from our original nulls or from Hoeijmakers' group, showed similar nuclear 
abnormalities with increased nuclear size and anueuploidy at an early age (McWhir 
et al., 1993; Weeda et al., 1997). As mentioned above, we have noticed that the 
aberrant nuclei occurred in the embryonic stage (E16.5). In order to compare the 
variations in different knockout lines, FACScan analysis was performed on liver 
cells of wild-type littermates, original and KT#209 ERCC1 nulls. The FACScan 
profiles present the number of cells plotted against the DNA content of the nuclei as 
measured by the fluorescence of the propidium iodide stained nucleic acid. The 
FACScan profile representative of the wild type animals showed a distinct peak 
corresponding to normal diploid cells (2C). Conversely, a high population of 4C 
nuclei emerged in both ERCCI-deficient lines, 31.93% from the original nulls and 
21.89% from the KT#209 line. Meanwhile, the populations of 8C nuclei in the 
original and new knockout lines were 12.87% and 8.24% (Figure 6.7). This result 
supports the histological observations of increased incidence of abnormally large 
nuclei in the hepatocytes of both ERCCJ-deficient mice. Furthermore, the FACScan 
profiles of brain, kidney, lung and spleen from the KT#209 ERCCJ-deficient mice 
have shown no significant changes in comparison with the wild-type control (data 
not shown), suggesting that the increased liver ploidy is a specific feature in the 
ERCCI knockout mice. 
65 Expression of proteins in the ERCCJ null hepatocytes 
6.5.1 Introduction 
Figure 6.7 Flow cytometric analysis of liver nuclei 
Representative FACScan profiles of postnatal day 16.5 livers from wild type, 
original and KT#209 ERCCJ-deficient mice. The relative number of cells (vertical 
axis) are plotted against the DNA ploidy (horizontal axis). The percentage of total 
nuclei with elevated DNA content is also shown'. 
In this figure, wild-type and original ERCC I-deficient livers were derived from littermates and were 
analysed at the same time. The KT#209 ERCC I null liver was analysed separately with slightly 
different counting conditions. The key point is that both null sample show polyploid DNA peak 
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Reactive oxygen species (ROS) are implicated in the pathogenesis of a wide 
variety of human diseases. To develop a better understanding of the exact 
mechanisms that underlie ROS-dependent disorders in biological systems, recent 
studies have investigated the regulation of gene expression by oxidants, antioxidants 
and other determinants of the intracellular reduction-oxidation (redox) state. At least 
two well-defined transcription factors, NF-KB and AP-1 (c-fos and c-jun) have been 
identified to be regulated by the intracellular redox state (Sen and Packer, 1996). 
The c-fos and c-jun or related family members may dimerize to form the nuclear 
transcription factors of the AP-1 family (Curran and Franza, 1988). We have found 
four potential AP-1 binding sites and three NF-KB binding sites in the ERCCI 
promoter region (see Chapter 3). Further, we suspect that ROS may be the causative 
factor of the ERCCJ null liver phenotype. Here we also describe c-fos changes in 
the ERCCI-deficient livers. 
Although NER normally protects the genome by removing bulky base adducts 
caused by UV radiation or other environmental mutagens, this pathway is also 
implicated in the repair of many nonbulky base lesions (Sancar, 1996). A recent 
report has pointed out the S. pombe NER system possesses a predominant role in 
correcting C.0 mismatches and probably also has a relevant role in the correction of 
other mismatches (Fleck et al., 1999). Genetic and biochemical studies have also 
shown that S. cerevisiae. RAD1-RADIO and MSH2-MSH3 complexes act together 
in some recombination events (Ivanov and Haber, 1995; Sugawara et al., 1997). 
Further, studies on Drosophila MEI9, a homologue of human XPF, indicated that 
this protein is involved in both NER and BER pathways in some cases (Bhui-Kaur et 
al., 1998). 
PCNA has been suggested to be involved in both DNA excision and mismatch 
repair—that is in addition to its essential role in cellular DNA synthesis and cell 
cycle regulation (Jonsson and Hubscher, 1997; Kelman, 1997). PCNA has a toroidal 
structure made up of three subunits that assembles around DNA as a sliding clamp 
which links the polymerase to the DNA template. In S-phase cells, PCNA is in close 
association with DNA replication foci in a detergent-insoluble form. The C-terminus 
of the flap structure-specific endonuclease (FEN-1) also binds PCNA in replication 
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to act as an exonuclease, in contrast to its endonuclease activity in DNA repair. 
Upon DNA damage, p21 competes with FEN- 1 for binding to PCNA through its C-
terminus to stall the replication fork. Surprisingly, this interaction with PCNA does 
not inhibit excision repair, which also utilises PCNA (reviewed in (Kelman, 1997; 
Kelman and Hurwitz, 1998; Lieber, 1997; Tsurimoto, 1998; Warbrick, 1998) 
Based on this understanding, some experiments have been carried out to test 
the possible relationship between ERCC1 and MSH2, PMS2 and PCNA. We 
hypothesise that the polyploidy and aneuploidy of ERCCJ-deficient liver cells may 
have arisen by altering cell-cycle checkpoint controls. Checkpoint control 
mechanisms identify crucial regulatory networks that act to ensure the dependency of 
cell cycle events on the successful completion of the previous stage (Hartwell and 
Weinert, 1989; Paulovich et al., 1997). Checkpoint-induced arrests delay the cycle 
progression and allow time for cellular recovery from various types of damage, 
thereby preventing the propagation of mutant, possibly transformed cells, or 
activating apoptosis in those cells which failed to pass the check and are thereafter 
selectively eliminated. Thus some proteins correlating to cell cycle and 
mitochondrial apoptotic pathways were investigated in this study. 
6.5.2 Western blot analysis of protein levels in the ER CCI null liver extracts 
In order to investigate the possible response to oxidative stress, cell cycle arrest 
and apoptosis and the relationship with other repair proteins in the ERCCJ null 
livers, we used liver extracts from the wild-type and both our ERCCI-deficient lines 
to evaluate the alteration in the steady state levels of the proteins being studied. 
Protein extracts (80 jtg) were electrophoresd on a 12.5% SDS-PAGE, transferred to a 
nitrocellulose membrane and detected with various antibodies. 
The expression of c-fos was found to be induced in both ERCCJ-deficient 
lines, and the elevated level was especially high in the KT#209 line; conversely, no 
signals could be found in the wild-type track. This might be an indication that these 
knockout livers incurred large amounts of damage from reactive oxygen species. We 
next addressed the question of whether ERCC 1 has a role, either co-operative or 
coripetitive, in other repair pathways. Interestingly, two components of MMR, 
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Figure 6.8 Immunoblot analysis of c-fos, MSH2, PMS2 and PCNA in the ERCCJ 
null liver extracts 
To test the possible alteration in levels of c-fos, components of MMR and 
PCNA in the ER CCI null liver extracts, western blot analysis was carried out using 
amounts of whole cell extracts corresponding to 80 .tg of total protein from livers to 
assay the steady state level of each protein. 
wild-type original 	KT#209 
c-fos 
40000 O"Waawft 	MSH2 
PCN 
PMS2 
MSH2 and PMS2, were found to be elevated in the ER CC] null livers. Meanwhile, 
PCNA, a dual function protein in DNA repair and replication, was also raised 
significantly in both knockout livers (Figure 6.8). It is worth noting that the 
predicted molecular weight of PCNA (261 a.a.) is 29 kDa, but it migrated at 36 kDa 
on SDS-PAGE which might arise from a structural flexibility between residues 128-
150 (Liang et al., 1992). 
Differentiation of cells requires withdrawal from the cell cycle and induction of 
a novel program of gene expression leading to elaboration of a specialised phenotype 
(Duronio and PH, 1994; Lassar et al., 1994). This process requires inductive signals 
from the environment, coincident with, or after cell cycle withdrawal. Failure to co-
ordinate growth arrest and differentiation may result in a failure to form normal 
tissues because cells either continue to proliferate (Kipreos et al., 1996), or undergo 
apoptosis (Boudreau et al., 1996). A lot of proteins have been shown to be involved 
in cell-cycle checkpoint response to DNA damage and apoptosis. Here, we tested the 
expression of cell cycle regulatory protein p15, p21, p53, pRB family (pRB, p107, 
p130), cyclin Al, cyclin Dl and cdc2. Unfortunately, we did not find any significant 
change or any detectable signal from these proteins (data not shown). Also, we did 
not find alterations in the level of mitochondria-related apoptotic proteins, Bax and 
Bcl-2 (data not shown). However, from the BrdU labeling data we have found 
evidence of lower replication indices in the ERCC 1 null livers than normal wild-type 
animals, consistent with the growth retardation in the ERCC 1-deficient mice (Nunez 
et al., in press) 
6.6 Discussion 
6.6.1 Fatty change and mitochondrial defects in the ERCCJ-deficient mice imply 
that oxidative stress may be a major cause of hepatic failure 
As mentioned above, remarkable lipid droplets were found in hepatocytes of 
both our ERCC]-deficient lines. A lot of reports have demonstrated that excessive 
accumulation of lipid in hepatocytes occurs in certain disease states and a variety of 
experimental conditions, such as the well-known alcoholic or drug-induced liver 
disease (review in Farrell 1994; Hall, 1995). Lipid storage liver diseases are 
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characterised by the deposition of either phospholipids and/or triglycerides in the 
liver. Depending on the size and number of lipid droplets in a hepatocyte, it can be 
further divided into macrovesicular and microvesicular subtypes, although there are 
frequent associations and both may be present in the same liver. 
Macrovesicular steatosis (or fatty change) is the most common form, and the 
hepatocyte contains a single, large fat vacuole (mainly triglycerides) which fills up 
the hepatocyte and displaces the nucleus to the periphery, resulting in the so-called 
signet-ring appearance of the cell. The most frequent causes of macrovesicular 
steatosis are alcohol abuse, obesity, diabetes and some dyslipemias. In the absence 
of other liver lesions, macrovesicular steatosis is a relatively benign condition, at 
least in the short term. Conversely, microvesicular steatosis presents numerous small 
lipid droplets in the cytoplasm, which do not push the nucleus to the side and gives 
the hepatocytes a "foamy" or "spongiocytic" appearance. Microvesicular steatosis is 
seen in conditions where there is continued toxic insult (chemical, anoxic or hypoxic) 
to the liver, and is further related to severe impairment of the mitochondrial 3-
oxidation of fatty acids. An oil red 0 stain can confirm the small reddish lipid 
vesicles that fill the hepatocytes. 
Due to findings similar to microvesicular steatosis in our ERCCJ-deficient 
mice, it is reasonable to assume that some metabolic disturbances in fatty acid 
oxidation may lead to the liver phenotype in these animals. In humans, some 
patients with steatosis develop steatohepatitis, which is a progressive liver disease 
and is associated with liver dysfunction including jaundice and coagulopathy. 
Mortality rates as high as 50% have been reported in patients who were hospitalised 
with clinically overt alcohol-related steatohepatitis (Carithers et al., 1989). 
Furthermore, progression to cirrhosis is relatively common in patients with alcoholic 
or non-alcoholic steatohepatitis, developing in 20% to 40% of such individuals 
within 5 years (Pares et al., 1986; Powell et al., 1990) Mahler et al. also reported 
that a diffuse microvesicular steatosis was found in a 17-year-old boy who died from 
fulminant liver failure associated with an emetic toxin (Mahler et al., 1997). 
The liver phenotype in the ERCCJ-deficient mice raises the interesting 
question of has the deficiency of a DNA repair protein, generally functioning in the 
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nucleus, could lead to the cytoplasmic events. Although it remains unclear at this 
moment, we will attempt to put forward some hypotheses here to link the abnormal 
fatty acid metabolism and mitochondrial disorders in the ERCC1 null livers. 
It is now recognised that the liver is a major target organ in inherited 
mitochondrial disorders. Impairment of mitchondrial functions can induce liver 
lesions such as steatosis, cholestasis, fibrosis and necrosis (Goncalves et al., 1995; 
Cormier-Daire et al., 1997). Even in the absence of liver cell necrosis, extensive 
microvesicular steatosis is a serious condition. Often, but not always, signs of 
involvement of other organs, most notably the central nervous system, sensory 
organs or muscle, are associated and may be an early clue to the diagnosis. For 
instance, neonatal liver failure has been reported in association with deficiency of 
mitochondrial complexes I and III in several infants (Bioulac-Sage et al., 1993; 
Cormier-Daire et al., 1997) and of complex IV in several others (Vilaseca et al., 
1991). Liver biopsy specimens typically show microvesicular and macrovesicular 
steatosis, and mitochondrial swelling on electron microscopy. Further, there is 
obvious and severe neuromuscular involvement in infancy (seizures, hypotonia). 
Taanman et al. analysed 29 children associated with a severe depletion of 
mitochondrial DNA (mtDNA) and found most of these patients presented soon after 
birth with hepatic failure, muscle weakness and renal tubulopathy (Taanman et al., 
1997). Bakker et al. reported that three infants with the mtDNA depletion syndrome 
all suffered from liver failure soon after birth and death in the first 3 months of life 
(Bakker et al., 1996). Maaswinkel-Mooij et al. also described a similar infant who 
had vomiting, hypotonia, lactic acidemia and liver dysfunction and died by 7 months 
of age (Maaswinkel-Mooij et al., 1996). Neurological abnormalities developed in 
these children before death; however, the predominant clinical symptoms were 
hypoglycaemia, acidosis and liver failure. Because our ERCCJ-deficient mice also 
showed developmental disorders in the cerebellum (see Chapter 7), they provide a 
good clue to investigate an ERCCJ-correlated human disease. 
Oxidation of lipid, known as lipid peroxidation, is a complex, free-radical-
initiated event that leads to both the destruction of proximal lipid membranes, and 
the formation of a multitude of toxic lipid breakdown products, including alcohol, 
aldehyde (e.g., malondialdehyde), alkanes and alkenes that can cause irreversible 
151 
marcromolecular damage, including adduct formation and the oxidation of DNA and 
proteins and can further cause damage to subcellular organelles (Halliwell, 1991, 
1994). It is well known that disturbance of mitochondrial fatty acid n-oxidation, 
resulting from exposure to CC1 4, amineptine, cocaine, or choline deficiency, or in 
other conditions such as alcoholic liver damage, causes fatty liver deposits (Farrell, 
1994; Hall, 1995). From the observations of microvesicular steatosis and 
mitochondrial defects in the ERCCJ-deficient mice, we suspect that the ERCC1 
protein might play a role in mitochondrial DNA repair and thus further affect 
mitochondrial fatty acid 3-oxidation. 
Because the mitochondrial genome contains very few noncoding sequences, no 
introns and is not protected by histones, damage to mtDNA can be expected to have 
a greater impact on cell function than damage to nuclear DNA as the probability of 
damaging coding sequences is much greater. If damage accumulates, electron 
transport chain function will diminish with a concomitant fall in cell bioenergetics 
and subsequent cellular dysfunction. Several human diseases such as Leber's 
syndrome, Pearson's syndrome and some cases of chronic progressive external 
ophthalmoplegia have been discovered to arise from the defects in the mitochondrial 
genome. Additionally, accumulations of mutations and deletions in mtDNA with 
their associated defects in oxidative phosphorylation have been implicated in 
diabetes, ischemic heart disease, Parkinson' disease, demyelinating polyneuropathy, 
cancer and ageing (reviewed in Nagley and Wei, 1998; Schapira, 1999; Simon and 
Johns, 1999; Wallace, 1999). We suspect that one possibility for the growth 
retardation in the ERCC 1-deficient mice may be defects in oxidative phosphorylation 
and consequent energy exhaustion, although we cannot exclude other possibilities, 
such as reduced growth hormone or other growth factors. ER CC] heterozygous mice 
have no overt phenotype. Since a 4,977-bp deletion of human mtDNA is very 
common in some mitochondrial disorders, we have designed a long-range-PCR assay 
to investigate possible mutation events in the ERCCJ-deficient mtDNA. 
Despite an increasing amount of information describing the reaction of 
chemicals with mtDNA, it is unclear whether this increased incidence of damage is 
due to increased susceptibility to damage and/or lack of appropriate repair pathways. 
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Recently, however, a number of reports have begun to shed light on DNA repair 
pathways in the mitochondria. Some mitochondrial-specific DNA repair enzymes 
have been identified, such as methyl transferase (Myers et al., 1988), uracil-DNA 
glycosylase (Domena et al., 1988; Caradonna et al., 1996), apurinic/apyrimidinic 
endonuclease, ultraviolet endonuclease (Tomkinson et al., 1988), DNA polymerase y 
(Longley et al., 1998) and DNA ligase III (Lakshmipathy and Campbell, 1999). 
Most of the identified mtDNA-specific repair enzymes are associated with the BER 
pathway, suggesting it is the major repair pathway in mitochondria coping with many 
types of mtDNA damage. No MMR pathway has yet been directly shown in 
mitochondria of higher eukaryotes, although it clearly exists in yeast. However, two 
genes of S. cerevisiae encoding MSH1 and MSH2 have distinct mitochondrial and 
nuclear homologues (Reenan and Kolodner, 1992). Disruption of the MSHJ locus 
results in an increased rate of mtDNA mutagenesis and rearrangement (Reenan and 
Kolodner, 1992). Whether or not a recombination repair mechanism occurs in 
mitochondria is controversial. Some interstrand cross-links such as cisplatin are 
thought to be repaired by recombinational repair in mitochondria (LeDoux et al., 
1993) while other interstrand cross-links such as psoralen are not (Croteau and Bohr, 
1997). Campbell and colleagues suggested that mammalian mitochondria possess a 
similar DNA end-binding activity to nuclei, suggesting a recombination repair 
pathway might exist in this organelle ( Thyagarajan et al., 1996; Lakshmipathy and 
Campbell, 1999). 
To date there is no strong evidence for a NER mechanism in the mitochondria. 
Clayton et al. reported that UV-induced lesions were not repaired in mtDNA. A lack 
of NER in mitochondria of yeast and of some higher eukaryotes was also 
demonstrated by several groups, and they suggested that mitochondria of these 
species do have the ability to repair UV lesions by photolyase activity. Surprisingly, 
the UV mimetic mutagen 4-nitroquinoline 1-oxide (4NQO), which is thought to be 
repaired by NER, was removed from mtDNA of CHO cells (71% within 24 h), albeit 
4NQO also induces oxidative lesions such as 8-oxo-dG (Snyderwine and Bohr, 
1992). Furthermore, a recent in vitro study has shown that the human NER system 
can remove oxidative DNA damage such as 8-oxo-dG and thymine glycol (Reardon 
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et al., 1997). Klungland et al. also suggested that XPG can activate the BER 
mechanism in the repair of oxidative DNA damage using a reconstitution assay 
(Klungland et al., 1999). Several lines of evidence also indicated that the 
ERCC1/XPF complex and their yeast homologues are involved in recombination 
events (Davies et al., 1995; Sargent et al., 1997; Bhui-Kaur et al., 1998; Melton et al., 
1998). Since we found some mitochondrial defects in our ERCCJ-deficient mice, it 
is not unreasonable to suggest that ERCC 1 might have a function in mitochondrial 
DNA repair. 
Most mitochondrial proteins are encoded by nuclear genes, synthesised as 
preproteins in the cytosol, targeted to the mitochondria, and imported into the 
organelle. Mutation in nuclear genes can also exert their phenotypic effects by 
indirectly inactivating oxidative phosphorylation (OXPHOS) or destabilising the 
mtDNA. For instance, the mtDNA depletion syndrome has been reported in muscle 
and in some infants with hepatopathy and nephropathy. Numerous imperfect 
mitochondria and ragged-red fibres are found in muscle of infants with mtDNA 
depletion. This syndrome is likely to be caused by a nuclear mutation that disrupts 
the regulation of mtDNA copy number during development, resulting in random loss 
of the mtDNA (Larsson and Clayton, 1995). Regarding these events, we cannot 
exclude the possibility that some nuclear-encoded mitochondrial proteins may be 
affected as a consequence of ERCC I deficiency. Future studies will address this 
possibility and investigate any phenotype in ERCCJ-deficient muscle. 
Both ERCCJ-deficient lines generated in our laboratory died before weaning 
and, in light of phenotypic findings in these animals, it could be considered 
reminiscent of clinical reports about acute liver failure (ALF) in neonates and infants 
(Caraceni and Van Thiel, 1995). Generally the aetiologies of ALF in paediatric 
patients can arise from congenital infections, vascular damage, drugs, toxins and 
metabolic disorders. The major cause of metabolic disorders in ALF include 
galactosemia, tyrosinemia, hereditary fructose intolerance, orrnithine carbamoyl 
transferase deficiency, 6-3 -oxosteroid-5 --reductase deficiency, mitochondrial 
respiratory-chain disorders and fatty acid oxidation disorders (reviewed in Lee and 
Williams, 1997). A growing body of evidence has emphasised that ALF is attributed 
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to abnormalities of mitochondrial structure or function (Bioulac-Sage et al., 1993; 
Mei et al., 1993; Saibara et al., 1994; Mahler et al., 1997). We suspect that a major 
cause of death in our mice is ALF arising from metabolic disturbance, either as a 
direct or indirect consequence of the disturbance of the DNA repair system, although 
we cannot ignore other possibilities. 
One such possibility is that ERCC1 is directly involved in fatty acid 
metabolism, although there is no evidence to support this. An increasing number of 
proteins known as moonlighting proteins are found to have two or more different 
functions, varying as a consequence of changes in cellular localisation, cell type, 
oligomenc state, or the cellular concentration of a ligand, substrate, cofactor or 
product (Jeffery, 1999). For instance, in the DNA repair systems, the uracil-DNA 
glycosylase as a monomer is important for removal of uracil that is incorrectly 
present in DNA due to inappropriate use of dUTP during DNA synthesis or 
deamination of cytosine residues; however, as a tetramer it become a 37 kDa subunit 
of glyceraldehyde-3 -phosphate dehydrogenase to convert glyceraldehyde 3-
phosphate to 1,3-diphosphoglycerate (Meyer-Siegler et al., 1991). Also, the mouse 
PMS2 gene, a mismatch repair enzyme, can be recruited by some blood cell types for 
use in somatic hypermutation of antibody variable chains (Cascaiho et al., 1998). 
Another striking example is Ref-1, also designated APE and HAP1, which has 
bifunctionality in the initiation of repair of apurinic/apyrymidinic (AP) sites in BER 
and in stimulating the DNA binding activity of AP-1 protein (e.g. c-fos and c-jun) 
by a redox-dependent mechanism (Xanthoudakis et al., 1996). Although to date 
there is no evidence that the ERCC1 protein possesses a new function in addition to 
DNA repair, this would not preclude a direct effect of ERCC1 in the fatty acid 
metabolic pathway. 
6.6.2 The hepatocytes of ERCC1 null livers increase in DNA content 
Polyp loidisation is a feature of virtually all organs, including blood, muscle, 
cornea, thyroid, pancreas, endometrium, placenta, urinary bladder and neural tissues 
(Harris, 1971; Brodsky and Uryvaeva, 1985; Mitaka et al., 1992; Kudryavtsev et al., 
1993). Furthermore, polyploidy is associated with hypertrophic responses in tissues, 
e.g., vascular muscle cells in hypertension, acinar cells in the lactating breast, 
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endometrial cells in the gravid uterus, peripheral lymphocytes in human 
immunodeficiency virus infection, and with cell ageing, as observed in cultured 
fibroblasts undergoing senescence (Printseva and ; Tjurmin, 1992; Biesterfeld et al., 
1994; Katz, 1994). Normal liver development is characterised by a progressive 
polyploidisation, which represents a route of cellular differentiation with a gradual 
reduction in proliferative potential (Epstein and Gatens, 1967; Saeter et al., 1988). In 
new-born mammals such as mice or rats, the parenchyma are mainly diploid cells 
that divide intensively, whereas the adult liver contains approximately 40-50% 
polyploid (mainly tetraploid) hepatocytes, nearly two thirds of which are binucleated 
(Gerlyng et al., 1993; Kudryavtsev et al., 1993). 
Although the biological role of polyploidisation is not entirely clear, polyploid 
hepatocytes are considered to be fully functional and terminally differentiated cells 
with a low proliferating potential. A differentiated feature in liver is the generation 
of tetraploid cells, implying that there is a block in normal cytokinesis following 
DNA replication, leading to the generation of DNA tetraploidy and a higher ploidy 
population. The increased hepatocyte DNA content in the liver of our ERCCJ-
deficient mice at such an early age is a striking event. Megakaryocytes constitute 
another lineage where polyploidy is normally observed. However, no differences in 
the frequency or appearance of megakaryocytes were observed in the bone marrow 
and spleen of ERCC 1-deficient mice compared to controls (data not shown). 
Meanwhile, the findings in this project seem to indicate that these mice may be 
enduring accumulated oxidative DNA damage. It has been suggested that the 
polyploid genome may provide defence against oxidative stress, which might be 
helpful in an organ as heavily engaged in detoxification as the liver (Burdon, 1995; 
Nakatani et al., 1997). Also, it has been reported that intracellular antioxidant 
defence systems, such as glutathione, play a modulating role in DNA synthesis (Sanz 
et al., 1996; Sanz et al., 1995). Thus we suspect that the increase of DNA content in 
our ERCCJ-deficient livers may be an adaptive response to the endogenous toxic 
injury. 
In this study we only employed propidum iodide (PT) in flow cytometric 
analysis to determine the DNA content of ERCC1 null hepatocytes, which has its 
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limitations to precisely assign a cell population in each subclass (i.e. 2N, 2x2N, 4N, 
2x4N, 8N and 2x8N and so on) and in each phase of the cell cycle. Since both 
nongenotoxic and genotoxic experiments have demonstrated that the determination 
of hepatocyte subclasses may dictate hepatopathogenic potential (Melchiorri et al., 
1993; Madra et al., 1995; Goolsby and Rao, 1996; Miller et al., 1996; Hasmall and 
Roberts, 1997), two modifications might be useful to acquire more information about 
the polyploidy and/or aneuploidy formation in the ERCCJ -deficient mice. Firstly, a 
cell sorting into ploidy classes and further BrdU labelling of each class can determine 
the proportion of mononucleated and binucleated cells within the diploid, tetraploid 
and octaploid populations. In combination with the ploidy profile, the data will 
enable the determination of the nuclearity profile. Secondly, recent reports have 
demonstrated the expression of particular proteins at specific phases of the cell cycle. 
For instance, monoclonal antibody TG-3 has been utilised in flow cytometry to 
detect the mitosis-specific antigen nucleoin (Anderson et al., 1998). 
Increased cell ploidy could be deleterious and may cause organ failure, 
especially when imposed chronically upon tissues, such as during congestive heart 
failure. Furthermore, aneuploidy or chromosome imbalance is the most massive 
genetic abnormality of cancer cells (Duesberg et al., 1998; Lengauer et al., 1998). 
The histopathological patterns in the ERCC1 knockout liver bring to mind the large 
liver cell dysplasia, which is characterised by cellular enlargement, nuclear 
pleomorphism with hyperchromatia, and multinucleation and is frequently associated 
with hepatocellular carcinoma and cirrhosis (Cohen and Berson, 1986; Thomas et al., 
1992). A high frequency of hepatocellular adenomas also occurred in the aged XPA 
mice, implying that high levels of lesions normally repaired by NER readily induce 
tumour formation in the liver (de Vries et al., 1997). In normal liver tissue the loss 
of stem cell potential would imply that polyploid hepatocytes can only undergo a 
limited number of divisions. However, this limit may never be reached and liver is 
characterised by a progressive polyp loidisation undergone throughout the lifespan in 
normal livers. In hepatocellular tumours the turnover of cells is significantly higher, 
allowing for a much larger number of successive cell generations than in normal 
liver. We have not yet determined the proliferative activity of the different ploidy 
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classes of ERCCJ null hepatocytes and it might provide information about 
hepatocellular tumour formation which is not readily available from studies of 
normal liver growth. 
6.6.3 Expression of c-fos and DNA repair proteins MSH2, PMS2 and PCNA 
The early response transcription factors AP-1(c-fos and c-jun) rapidly increase 
in cellular stimulation with mitogens or growth factors (Loyer et al., 1996). Certain 
forms of ROS such as H202  also act as signal transduction messengers to induce AP-
1. Several studies have demonstrated that superoxide produced by xanthine/xanthine 
oxidase system and hydrogen peroxide in tissue culture cells can alter c-fos and c-jun 
expression (Lakshminarayanan et al., 1998; Huang et al., 1999; Wenk et al., 1999). 
These transcription factors function as critical regulators of cellular growth and 
differentiation. Moderate concentrations of intracellular ROS have been shown to 
influence gene expression through transcriptional or post-translational pathway (Sies, 
1997). Recent studies have shown that c-fos and c-jun were overexpressed in 
hepatocytes when stimuli trigger the G 0/G 1  transition of quiescent normal rodent 
hepatocytes, although the mechanism by which these factors control this transition 
remains poorly understood (Loyer et al., 1996). Furthermore, Ref-1, as mentioned 
above, has been identified as a dual function protein involved in BER and 
transcriptional regulation to stimulate AP-1 by a redox activity (Xanthoudakis et al., 
1996). Since we believe that the findings in our ERCCJ-deficient mice liver are 
closely correlated with oxidative damage, it is not surprising to learn that the 
expression level of c-fos from the null liver extracts was elevated. 
An increasing body of evidence indicates that the NER system may perform 
alone or together with MMR components to remove some specific types of DNA 
lesions (Moggs et al., 1997; Kirkpatrick and Petes, 1997). From E. coli to human, 
several reports have shown MMR proteins can act in concert with NER to promote 
more rapid removal of transcription-blocking lesions in the transcribed strand of 
active genes (Mellon and Champe, 1996; Cooper et al., 1997). The human NER 
complex can recognise and excise G.G and GsA mismatches in vitro (Huang et al., 
1994). Furthermore, S. pombe NER proteins Rhpl4, SwilO and Radl6, the fission 
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yeast homologues of human XPA, ERCC 1 and XPF respectively, have a role in C.0 
mismatch correction that is independent of MMR proteins Msh2 and Pins 1 (Fleck et 
al., 1999). Conversely, MMR proteins are known to recognise DNA damage caused 
by u.v. light and cisplatin, which are normally repaired by NER (Duckett et al., 1996; 
Yamada et al., 1997). 
Recent analysis has suggested that, as on the distal side of a double strand 
break, one strand is degraded 5' to 3', producing long single-strand tails in the single 
strand annealing pathway (Wu et at., 1997). Removal of the nonhomologous DNA 
strand tails, arisen as intermediates of HO endonuclease-induced recombination, 
appears to occur by an endonucleolytic cleavage of the tail at its junction with paired, 
homologous sequences (Fishman-Lobell and Haber, 1992). In S. cerevisiae, this 
depends on two proteins from the NER pathway (RAD i/RADiO) and two proteins 
from MMR pathway (MSH2/MSH3); however, none of the many other proteins in 
these two pathways is required (Ivanov and Haber, 1995; Sugawara et at., 1997). It 
appears that the MMR proteins MSH2IMSH3 recognise branched structures such as 
would be formed between the old region and the newly synthesised DNA, allowing 
the RAD1-RADIO endonuclease to clip it off (Alani et al., 1997). In cells lacking 
RAD1, mating-type switching is delayed for several hours until an apparently 
redundant, but inefficient process, removes the old region (Holmes and Haber, 
1999a, b). 
Kolodner and colleagues have described a physical interaction between the 
MSH2 and all of the NER repair proteins by biochemical and genetic experiments 
(Bertrand et al., 1998). In Drosophila, in vitro studies have demonstrated that MEI9, 
a homologue of XPF, is required for nick-dependent repair of the mismatches G.G 
and T.G (Bhui-Kaur et al., 1998). 
Interestingly, the levels of MSH2 and PMS2 were elevated in the ERCC 1 null 
liver extracts. As mentioned above, ERCC1-XPF and their homologues in other 
species may cooperate or compete with components of MMR in removing some 
DNA lesions. Since the mechanism remains to be elucidated, a collaboration with 
Dr. Alan Clark, Department of Pathology, University of Edinburgh, has been 
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proposed using the ERCCJ/MSH2 double knockout mice to investigate the 
relationship between these components of the two repair systems. 
In addition to its role in replication, several studies support the involvement of 
PCNA in repair processes. For instance, it has been reported that if cells are 
irradiated with u.v. light, DNA repair reactions occur in cell nuclei with PCNA 
accumulation, even though the cells are not in S phase (Toschi and Bravo, 1988). 
Studies of in vitro nucleotide excision repair, base excision repair and mismatch 
repair have all indicated indispensable roles of PCNA as part of the repair machinery 
(Aboussekhra and Wood, 1995; Umar et al., 1996; Kiungland and Lindahi, 1997; 
Shivji et al., 1998). Since we just mentioned that NER and MMR might compete to 
repair certain types of DNA lesions in some situations, it is not unreasonable to 
imagine that components of other repair systems such as MSH2, PMS2 and PCNA 
would be raised in the ERCCJ-deficient mice. Furthermore, several studies have 
shown that some proteins involved in DNA replication and/or repair bind to the 
same, or partially overlapping sites on the PCNA protein. For instance, p21 and 
FEN-1 share a sequence motif in their PCNA-binding regions (Gulbis et al., 1996). 
Other proteins sharing the same motif, such as XPG and MCMT [DNA-(cytosine-5) 
methyltransferase], can be expected to bind to the same region as well (Chuang et al., 
1997). Although no report has suggested that ERCC 1 or XPF could bind PCNA at 
this moment, we cannot exclude the possibility of direct protein interaction between 
these proteins. 
6.6.4 ERCC1, cell cycle arrest and apoptosis 
Primary events after exposure of eukaryotic cells to DNA damaging agents 
include activation of certain signalling pathways that may eventually result in cell 
cycle arrest and/or apoptosis. We also believe that increased DNA content in the 
hepatocytes of the ERCC1 null liver is closely related to cell cycle arrest. Although 
no significant changes of some proteins relating to the cell cycle control have been 
found in liver cell extracts from both ERCCJ-deficient lines in this study, we still 
consider that there is a cell cycle arrest in livers of these mice and there are some 
possible reasons to explain the findings in this study. 
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First, cell division is closely regulated by complex interactions of multiple 
proteins that control particular phases of the cycle. Due to protein redundancy, we 
cannot exclude that other redundant gene products in the cell cycle would affect the 
liver specific phenotype in the ERCCJ-deficient mice. Indeed, we have found 
evidence of G2 cell cycle arrest in the ER CC] null hepatocytes using centromeric 
staining (Nunez et al., submitted). 
Second, expression and activity of cell-cycle regulatory protein is timed and 
turnover rates for cyclins are very rapid, e.g. 20-30 min for D cyclins (Sherr, 1993), 
thus it was difficult to determine the kinetics in the in vivo studies. 
Third, although we have previously reported that the p53 level was raised in 
ERCC]-deficient liver by using immunohistochemistry staining, a recent study of 
ERCC11p53 double knockout livers in this laboratory (Nunez et al., submitted) 
demonstrated that p53 is not responsible for the accelerated increase in ERCC] null 
liver DNA content. We suspect that p53 might have a protective role in some 
subclasses (e.g. binucleated cells) as well as reducing replication in other cells in 
ERCCJ null livers. 
Fourth, several reports have shown the p21 protein level to be low in normal 
tissues, only lung expressed detectable p21(Wu et al., 1996). Indeed, p21 levels are 
not easily to be detected in our liver extracts. However, the study in ERCC]1p53 
double knockout mice has shown that p21 mRNA level in the original ER CC] null 
livers was 2-times that of the wild-type livers (Nunez et al., submitted). 
Furthermore, a recent in vitro study has demonstrated that p21 protein was expressed 
at later times after the nuclear binding of PCNA, reducing nearly to basal levels 
during DNA damage (Savio et al., 1998). This might be consistent with elevated 
level of PCNA and low level in p21 in the ER CC] null liver extracts. 
There are two general mechanisms of cell death: necrosis and apoptosis. 
Although we did not utilise TUNEL to detect apoptosis in the ERCC]-deficient liver 
sections, it seemed that there were no significant changes in apoptosis from 
observations in H&E staining. The Dutch group have also indicated that there are no 
apoptotic changes in their ERCC] null livers (Weeda et al., 1997). Harrison and 
colleagues also indicated that p53 can regulate cell cycle arrest but not lead to 
apoptosis in DNA-damaged hepatocytes (Bellamy et al., 1997). Since necrosis is 
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always the Outcome of severe and acute injury and we have found necrosis in some 
regions of ERCCJ null livers, we suspect that necrosis might be responsible for the 
early demise in our case. Further, the increasing of mitochondrial membrane rupture 
in the ERCCJ null hepatocytes is consistent with necrotic findings. Thus it seems 
reasonable in our case that Bax and Bcl-2 were not elevated even in the event of 
mitochondrial damage. 
Because it is difficult to utilise the perfusion technique in our runted animals, 
we cannot acquire good hepatocyte cultures at this moment. We are awaiting the 
availability of foxed ERCCJ mice for the cultured hepatocytes in the near future and 
it may provide valuable information about regulation in the cell cycle and the 
formation of polyploid cells. Furthermore, we have generated a novel anti-mouse 
ERCC 1 antibody (see Chapter 8), which might be useful in immunoprecipitation-
western blot studies to pull-down more related proteins. 
6.6.5 Future prospects for studies in the ERCC1 null livers 
A recent study has demonstrated that oval cell proliferation was found in the 
liver of p21 transgenic mice after hepatectomies when p21 overexpression resulted in 
liver growth retardation (Wu et al., 1996). Since oval cells are the progeny of 
potentially pluripotential stem cells and are activated when hepatocyte proliferation 
is blocked (Thorgeirsson, 1996), it is worth tracing these cell changes in our ERCCJ-
deficient mice and testing whether these cells contribute to the polyploid patterns. 
Korver et al. have reported that the mice lacking the winged-helix transcription 
factor Trident also showed polyploidy in the embryonic hepatocytes and 
cardiomyocytes. They suggested that Trident might have a cell-cycle specific gene 
regulation function (Korver et al., 1998). Since the winged-helix motif can be 
classified as a variant of the helix-turn-helix motif, we cannot discount the possibility 
that ERCC 1, which has a helix-hairpin-helix motif (see Chapter 8), might have 
similar functions in liver development. 
Because we found microvesicular steatosis in the ER CC] null livers, it is 
interesting to know whether the lipocyte, synonymously termed the hepatic stellate 
cell (HSC), retinoid-storing cell and Ito cell, is also affected in the fatty acid 
metabolism pathway (Grinko et al., 1995). This non-parenchymal liver cell body is 
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located in recesses between the adjacent parenchymal cells in the perisinusoidal 
space of liver and cellular projections embrace the sinusoidal endothelial cell. The 
transition of HSC to myofibroblasts is thought to be the core pathogenic event in 
liver fibrosis, since it results in a largely expanded pool of myofibroblasts capable of 
the production of virtually all matrix components (collagens, proteoglycans, 
glycoproteins and hyalurocan) (Olaso and Friedman, 1998). Although we suspect 
the majority of lipid contents in our ERCC] null livers is triglyceride, we cannot 
exclude the possibility of retinoid metabolic disorders. The foxed ERCCJ mice will 
bea good model to investigate the metabolic dysfunction under the Cre-recombinase 
control. 
It is noteworthy that peroxisomes (microbodies), the single-membrane bound 
organelles, also participate in n-oxidation (reviewed in Fujiki, 1996; Waterham and 
Cregg, 1997; Kunau, 1998; Titorenko and Rachubinski, 1998). Each hepatocyte has 
approximately 200 peroxisomes, or one peroxisome for every four mitochondria. In 
animal cells, peroxisomes as well as mitochondria degrade fatty acids via 3-
oxidation. The mechanism of n-oxidation in both organelles is similar, however, the 
enzymes in each system are different gene products and whereas mitochondrial fatty 
acid metabolism generates energy, the peroxisome n-oxidation system produces 
H202 in the first oxidation step, which is lost as heat. Further, an important 
distinction between the substrate spectra of both organelles is that mitochondria 
catalyse the 3-oxidation of the bulk of short (<C8), medium (C8-C 12) and long chain 
(C 1 4 -C20) fatty acids, whereas peroxisomes are involved preferentially in the 
metabolism of very long chain (>C20) fatty acids that can be shortened for further 
oxidation in the mitochondria. In humans, defects in the structure and/or function of 
peroxisomes give rise to a group of genetic diseases. These include Zellweger 
syndrome (or cerebrohepatorenal syndrome), infantile Refsum's disease and neonatal 
adrenoleukodystrophy, which are characterised by an impairment of the peroxisomal 
n-oxidation pathway with a decreased number or absence of morphologically 
distinguishable peroxisomes in liver, brain and other tissues. Since some specific 
substrates such as 3, 3'-diaminbenzidine can be utilised to detect cytochemical 
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localisation of peroxisomes, it will be interesting to investigate whether this 
organelle is also affected in future studies. 
In summary, the histopathological findings in the ERCCJ null livers, such as 
microvesicular steatosis and mitochondrial damage, suggest that oxidative stresses 
may be responsible for ERCC1 dysfunction either directly or indirectly. It may also 
provide a reasonable explanation that the polyploidy and aneuploidy in the livers of 
ER CC] knockout mice is adapted to this high risk of genomic damage. The 
sequential overexpression of immediate early gene product c-fos also supports this 
suspicion. Interestingly, elevation of other repair proteins MSH2, PMS 1 and PCNA 
was also found in the ER CC] null liver extracts. 
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Chapter 7 
Histogenesis of the cerebellum is delayed in the mice lacking ERCC1 
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DNA repair is expected to be of particular importance in the brain as neurones 
in the adult can not be usually replaced. Indeed, approximately 20% of XP patients 
(XPA>XPB=XPD=XPG) suffer from neurological abnormalities including 
hyporeflexia, sensorineural deafness, mental retardation and microcephaly (Cleaver 
and Kraemer, 1995). The severity of neurological dysfunction seems to correlate 
with the degree of repair deficiency. Since p53 levels were raised in the brain of our 
original ERCCJ null mice, we were interested to see whether brain structures have 
been changed in both the original and KT#209 ERCCJ knockout lines we have 
generated. This chapter describes the developmental delay observed in the 
cerebellum of these mice. 
7.1 Introduction 
The cerebellum contains a large cortical region within which distinct cell types 
are positioned in a layered fashion. This section briefly discusses the histogenesis 
and genetic control of this tissue (reviewed in Altman and Bayer 1997; Goldowitz 
and Hamre, 1998; Oberdick et al., 1998; Hatten, 1999). The model for histogenesis 
and anatomy of the cerebellum is presented in Figure 7.1. 
7.1.1 Cells comprising the cerebellum 
In the mouse cerebellum morphogenesis begins at embryonic day 7.5 (E7.5) as 
the anterior portion of the neural tube becomes subdivided into three prospective 
vesicles: the prosencephalon, the mesencephalon and the rhombencephalon. 
Subsequently, at E9 the dorsolateral parts of the alar plates of the neural tube bend 
medially and form the rhombic lips. In the caudal portion of the metencephalon (a 
subdivision of the rhombencephalon) the rhombic lips are widely separated, but 
immediately below the mesencephalon they approach each other in the midline to 
create a curved, sausage-shaped pontine flexure. At E10- 11,  the cerebellar anlage 
establishes itself as two bilateral thickenings in a cephalocaudal direction called the 
cerebellar plates. These thickenings increase considerably during development up to 
El 5. This feature has been interpreted as resulting from either progressive fusion of 
the cerebellar plates at the midline or differential growth of the medial part of the 
cerebellar primordium. This plate develops a small midline portion, the vermis, and 
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Figure 7.11 The Ilfistogenesis and anatomy of the cerebellum (adapted from 
Sadler, 11995) 
(I) The cerebellar pnmordium (dorsal view). 
(A) Left panel shows the mesencephalon and rhombencephalon, from which the 
roof of the 4th ventricle has been removed. (B) Right panel shows the choroidal 
fissure and lateral and medial apertures in the roof of the 4th ventricle. 
Cytodifferentiation of the cerebellum. 
A sagittal section through the roof of the metencephalon shows development of 
the cerebellum. Note formation of the external granule layer on the surface of 
the cerebellar plate (A and B). During late stages, cells of the external granular 
layer migrate inward to mingle with Purkinje cells and thus form the definitive 
cortex of the cerebellum. 
Cellular organisation of the adult cerebellar cortex. 
The cerebellar cortex shows the molecular, Purkinje and granule-cell layers on 
top of the white matter. Note the Purkinje-cell dendritic trees extend up to the 
meningeal surface of the cortex. 
See text for detail. 
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two lateral portions, the hemispheres. A transverse fissure soon separates the nodule 
from the vermis and the lateral flocculus from the hemispheres. This flocculonodular 
lobe is phylogenically the most primitive part of the cerebellum. 
All cells in the cerebellum arise from a germinal matrix region. The initial 
germinal matrix, which is bounded by the isthmus (the constriction between the 
mesencephalon and metencephalon) anteriorly and the choroid plexus posteriorly, 
consists of a typical neuroepithelial ventricular zone and a more caudal rhombic lip 
region (also called the germinal trigone). The Purkinje cell layer (PCL) and Golgi 
cells within the granular cell layer are sequentially produced from the primary 
germinal epithelium of the cerebellum analge between E12 and E1 5. Meanwhile, 
cells originating from the rhombic lip invade the cerebellum anlage rostrally to 
produce a secondary germinative layer, the external granular layer (EGL). As these 
EGL cells migrate over the cerebellar surface in a subpial position, the Golgi 
neurones are born from the diminishing ventricular zone. The deep cerebellar nuclei, 
such as the dentate nuclei, reach their final position before birth. Until postnatal day 
15 (P15), the EGL produces the granular cells of the internal granular layer (IGL), 
which reach this deep position after migration along the Bergmann glial fibre 
processes. It is during this time that the cerebellum is transformed from a curved, 
sausage-shaped structure into one with deep fissures and large finger-like 
appendages called folia, and the cerebellum increases >1,000-fold in volume. This 
period also sees the maturation of the two major extrinsic inputs to the cerebellar 
cortex: the inferior olive's climbing fibres to the Purkinje cells and the spinal and 
reticular mossy fibres to the granule cells. 
7.1.2 A genetic analysis of the cerebellum 
The analysis of both naturally occurring and induced mutations affecting 
cerebellum have implicated numerous genes in cerebellar development and 
maintenance. Table 7.1 summarises some of these genes which might correlate with 
our findings in the cerebellum. 
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Gene Name Gene function Primary cerebellar defects of mutant mice Reference 
Reelin extracellular protein reeler mice with Purkinje cell ectopia and granular cell reduction (G and Curran, 1998) 
disabled-] (Dab]) phosphotyrosine binding domain reeler-like mice; cerebellar hypoplasis with Purkinje cell ectopia; granule cell reduction (Rice et al., 1998) 
Ma/hi bHLH transcription factor devoid of EGL (Ben-Arie et a)., 1997) 
NeuroD bHLH transcription factor granule cell depletion (Miyata et al., 1999) 
Ziprol (Ru491Zfp38) zinc-finger protein increased cell death in the IGL of mice with overexpression of Ziprol (Yang et al., 1999) 
Zici zinc finger transcription factor Purkinje cell reduction, hypoplastic cerebellum, a lobule of the ant. lobe missing; ataxia (Aruga et al., 1998) 
ROR-a; retinoid-related orphan receptor; staggerer mice; Purkinje cell reduction and ectopia (Hamilton et al., 1996) 
cdk5 (cyclin-dependent sequence homology to cdc2, found lacking cerebellum foliation (Ohshima et al., 1996) 
kinase 5) predominantly in the brain 
cdk5r (p35) brain specific activating subunit of defects in neuronal migration (Chae et al., 1997) 
cdk5 
cyclin DI promote progression ofGl phase hindleg clasping (Sicinski et al., 1995) 
G1RK2 K-channel subunit weaver mice; EGL is persistent and filled with apoptotic cells until at least P28 (Surmeier et al., 1996) 
ErbB3 protein tyrosine kinase of the class I lethal mutation; the midbrain/hindbrain regions were strikingly affected with little (Erickson et al., 1997) 
EGFR family differentiation of the cerebellar plate 
CXCR4 chemokine receptor ectopic granule cells migration (Zou et al., 1998) 
GluRö2 fast excitatory synaptic transmission lurcher mice; apoptosis of Purkinje cells during the second postnatal week (Heintz and De Jager, 
1999) 
Pax6 paired box gene; granule cell migration disturbance (Engelkamp et al., 1999) 
Unc5 netrin receptor rostral cerebellum malformation (rcm) mice; abnormal granule and Purkinje cell migration (Ackerman et al., 1997) 
SCA I expanded CAG repeat gait ataxia; ectopic Purkinje cells in the adults (Burright et al., 1995) 
BDNF neurotrophin increased death of granule cell; stunted growth of Purkinje cell dendrites; a persistent EGL is (Schwartz et al., 1997) 
detectable at P21 
Pafahibi (Lisi) n-subunit of PAF misplaced Purkinje cells (Hirotsune et al., 1998) 
EGFR: epidermal growth factor receptor; bHLH: basic helix-loop-helix; SCA1 type 1: spinocerebellar ataxia; BDNF: brain-derived neurotrophic factor; GIRK2: 0-protein-activated, inwardly 
rectifying K channel protein; GluR62. ö 2-glutamate receptor; PAF: platelet-activating factor acetylhydrolase 
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7.2 ERCCJ '  mice display some phenotypic abnormalities linked with the 
cerebellum 
It is known that the cerebellum is involved in motor regulation, motor learning, 
spatial orientation and spatial learning and memory, as demonstrated by the ataxia 
resulting from cerebellar disorders in animals and humans (Tan et al., 1993; Joyal et 
al., 1996; Le Marec et al., 1997; Caston et al., 1998). In order to examine cerebellar 
function, the behaviour and cerebellar morphology of both ER CC] knockout mice 
have been investigated over the age range from embryonic day 16.5 (E16.5) to 
postnatal day 21 (P21). 
Although the behaviour phenotype is inadequate for genotypic determination 
under the age of P9, we found the hindlimbs of older ERCCJ nulls (KT#209 line) 
were clasped when the mice were lifted by the tail, suggesting cerebellar defects in 
these mice (Sicinski et al., 1995; Andre et al., 1998; Aruga et al., 1998); whereas the 
wild-type mice extend their legs (Figure 7.2). However, this behavioural 
abnormality did not manifest in the original ERCCJ knockout mice. At P16, 
ERCCJ and ERCCJ pups were able to turn over easily within a few seconds 
when they were placed on their backs. In contrast, it took KT#209 ER CCF mice 
longer (-20 seconds) to turn over. The gait of these mice also showed imbalance, 
revealed by the patterns of paw prints (Schwartz et al., 1997), as they Often dragged 
their hindlimbs behind them (data not shown), presumably due to exhaustion. 
Furthermore, we have noticed that some of KT#209 ER CC] ' mice kept their eyelids 
closed and both knockout lines showed kyphosis (data not shown), implicating the 
possibility of neuromuscular and/or skeletal disturbance. The gross morphology of 
brain looked normal (data not shown). There were no apparent discontinuities 
between the anterior and posterior aspects of the cerebellum, and the foliation 
appeared normal with no observable alterations in the number of fissures (data not 
shown). 
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Figure 7.2 Abnormal leg-clasping reflex in the ERCC1 ' mice (KT#209 line). 
When the mice were lift by their tails, mutant mice often crossed or clasped 
their hindlimbs, whereas the wild-type mice respond by extending their legs . On the 






7.3 The ERCCJ-deficient mice exhibit developmental delay in the external 
granule layer 
As mentioned previously, the precursors of the granule cells are first located 
embryonically in the rhombic lip in the dorsal hindbrain. They migrate to form the 
EGL of the cerebellum postnatally, and then undergo massive proliferation before 
differentiating and migrating into the underlying cerebellar cortex to form the 
internal granule cell layer. This section describes the examination of morphologic 
changes in the cerebellum of ERCCJ-deficient mice (KT#209 line) and control 
animals from E16.5 to P21, the time period when the migration process occurs 
(Figure 7.3). The cerebellar structure has been visualised by hematoxylin and eosin 
(H&E) staining, and by processing with a monoclonal calbindin D-28K antibody, a 
specific marker for Purkinje cells. We also checked the cerebellum of original 
ERCCJ nulls at P13, P16 and P21. The observations in the original ERCCJ null 
cerebella indicated that there were no significant changes between two knockout 
lines (data not shown). The work presented in this section was carried out in a 
collaboration with Dr. Liz Jamieson. 
Histological analysis of E16.5 ERCC1 null embryos revealed the normal 
location of the developing cerebellum; however, its overall size was reduced slightly 
in the nulls [Figure 7.3 (A) and (B)]. At P4.5, there were no significant morphologic 
changes between genotypes except a smaller size in the null cerebellum than the 
wild-type and heterozygous mice. At this time, the cerebellum was arranged as 
normal in a highly ordered structure, and the distinct layers-EGL, ML, PCL and IGL 
could be found in all sections (data not shown). At P8, the developing cerebellum is 
characterised by the presence of a very robust population of rapidly proliferating 
granule cells, which expand beneath the pial surface to create an EGL approximately 
8-10 cells thick. Some cells during this period have completed their migration via 
Begmaim glial guides to the developing IGL. Interestingly, the ERCCJ null IGL 
appeared thinner than the control littermates and the PCL in the nulls also showed 
irregular alignment. At this stage the PCL in the control littermates (ERCCJ +/+ and 
+1- 
ERCCJ 	mice) normally lied in a monolayer [Figure 7.3 (C) and (D)]. 
Immunostaining with the Purkinje cell marker calbindin revealed occurrence of the 
irregular alignment in the PCL up to P14 in the null cerebellum [Figure 7.3 (E) and 
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Figure 7.3 Layer formation is disrupted in the cerebellum of ERCC1 '  mice 
Sagittal cerebellar sections of ERCC] ' and ERCCJ ' mice were stained with 
H&E to visualise the cellular layers. At E16.5 [(A) and (B)], the primordium of 
-I- 	 +1+ 
ER CC] cerebellum (B) is nearly the same as ER CC] littermates (A) (x4). At P8, 
the molecular layer is thinner in the ERCC]
-I- 
 mice (D) than in ERCC]
+1+ 
 mice (C); 
meanwhile, Purkinje cell also shows irregular alignments in the ERCC] ' mice 
(arrow) (x200). Calbindin labelling for Purkinje cells was employed in the P14 
+1+ 	 -I- 
ERCC] (E) and ERCCJ (F) cerebellum, showing some Purkinje cells (star) in 
ERCCI' mice had an irregular alignment (x200). At P16.5, the EGL retains 3 or 
more cell thickness (arrowhead) in the ERCCJ ' cerebellum (H), whereas the EGL 
has disappeared in the ER CC]
+1+ 
 mice (G) (xl 00). At P19, morphological features in 
both ERCCJ
+1+ 
 (I) and ER CC]
-I- 
 (J) seem similar (x200). Cb: cerebellum; EGL: 
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(F)]. In the wild-type, most neurogenesis was observed to be completed in the EGL 
at P 16.5, and the size and density of the IGL had begun to assume normal values and 
the folia were well-defined. By comparison, development in the two ER CC] 
knockout lines lagged behind the control littermates, with both retaining an EGL 3 or 
more cells thick. Histological analysis showed that this developmental delay in the 
cerebellum of both ERCCJ-deficient lines was maintained until P19 [Figure 7.3 (G) 
and (H)]. At P19, except for size, there was no significant morphological difference 
between both ERCCJ-deficient lines and the control littermates. The EGL has 
disappeared in all sections at this stage [Figure 7.3 (I) and (J)]. 
7.4 An in vitro study of cerebellar cells 
In order to measure the electrophysiological variations and observe in vitro 
migration of the ERCCJ null cerebellar cells in future studies, a tissue cultural set up 
for these cells has been designed. This has enabled a morphological comparison 
between the ERCCJ-deficient and control cells. Intriguingly, the mixed culture 
cerebellar cells from a younger age (P8) could survive for a long time in the 10% 
foetal calf serum without addition of any growth factor. Conversely, the cells from 
P12 or older cerebellums did not grow very well, presumably these cells have 
reached the terminal differentiation stage. 
Although we did not utilise antibodies to differentiate cell types, some 
morphological changes seem interesting, especially stellate-like cells. Reflective of 
their name, stellate cells exhibit numerous elongate dendrite-like processes extending 
like a star's points from their cell bodies (Geerts et al., 1993; Grinko et al., 1995). In 
liver cell culture, the quiescent  hepatic stellate cell (i.e., not activated), also called Ito 
cells or lipocytes, display multiple thin elongate processes that extend radially from 
the cell body, as well as prominent perinuclear retinoid droplets. They can be 
induced by growth on glass in the presence of serum, and are distinguished by the 
development of prominent cytoplasmic fibres, loss of pennuclear droplets, and cell 
spreading (i.e., increasing size). Additionally, activation in culture is marked by the 
loss of dendntic processes. These activation-associated morphological changes are 
an integral component of the stellate cell's injury response (Kawada et al., 1996; 
Ikeda et al., 1999). In the adult cerebellum, glial cells transform into stellate 
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astrocytes after the cell migration is completed (Schmechel and Rakic, 1979). Both 
hepatic and cerebellar stellate cells can be recognised by their abundant expression of 
glial fibnilary acidic protein (GFAP) (Buniatian et al., 1996). 
Figure 7.4 illustrates both quiescent and activated stellate-like cells. The non 
activated ERCCJ ' stellate-like cell has a flattened, angular appearance and shows 
abundant lipid droplet-like patterns in the cytoplasm. Unlike the activated form in 
+1+ 
both hepatic stellate cells and stellate-like cells from the ER CC] cerebellum, the 
activated ER CC] ' stellate-like cells still have a lot of droplets albeit an uneven 
pattern. In comparison with the control groups, all dishes from different ERCCJ '  
cerebellum showed many stellate-like cells, either quiescent or activated form, and 
sometimes formed huge cells. 
Programmed cell death (apoptosis) plays a major role in the differentiation and 
development of central nervous system and ensures balanced cell development 
(Johnson and Deckwerth, 1993; Raff et al., 1993). Since granule cells are the most 
numerous elements in the cerebellum cortex and in the brain as a whole (80-85% of 
all human neurones), apoptotic cell death may be a key factor in regulating the final 
number of neurones. The TUNEL (terminal deoxynucleotidyl trans ferase-medi ated 
dUTP nick-end labelling) technique was applied to probe the apoptotic change in 
these cultured cerebellar cells. We found that there was no significant changes 
-I- 
between the ERCC] cerebellar cells and the ERCC]
+1+ 
 control group (data not 
shown). TUNEL staining of the tissue blocks has not yet been determined. 
7.5 Discussion 
7.5.1 The abnormal behaviour in the KT#209 ERCC1-deficient mice 
The cerebellum is essential for motor control, and its dysfunction disrupts 
balance and impairs control of speech, limb and eye movements. Clasping of 
hindlegs has been reported in several mouse mutants as an early symptom of 
developmental or functional problems of the nervous system (Sicinski et al., 1995; 
Andre et al., 1998; Aruga et al., 1998). The abnormal limb reflex observed in the 
KT#209 ER CC] knockout mice is presumably an abnormality in function(s) of the 
cerebellum. Although the original ER CC] nulls also showed developmental delay in 
the cerebellum , we have not yet learned why the two ER CC] knockout lines differ 
175 
Figure 7.4 Representative phase contrast of cerebellar cells 
an activated stellate-like cell (star) without vesicle formation in the ERCCt'  
cerebellar cell culture. 
quiescent (left) and activated (right) stellate-like cells in the ER CC] ' cerebellar 
cell culture. Note a lot of vesicles in both cells. 





in this behavioural phenotype. Furthermore, we also noticed that some knockout 
mice of the novel ER CC] line showed gait disturbance and kept their eyelids closed 
(data not shown). It remains to be determined whether other neurological defects 
such as spinocerebellar path dysfunction, which have escaped our attention, might 
suffice to cause the neuromuscular abnormalities. 
Evidence from XP patients indicates that the major neuropathological 
disruption is neuronal degeneration, particularly of the cerebral cortex and 
cerebellum (Johnson and Deckwerth, 1993). Since mammalian brain cells are not 
exposed to u.v. light, the neurotoxic DNA damage presumably results from an 
endogenous source (Robbins, 1989). XPA cells are known to be repair-deficient for 
certain type of oxidative damage (Satoh et al., 1993). Reardon et al. have recently 
shown in the brain tissue that the NER system can repair several oxidative lesions 
including 8-oxo-dG and thymine glycol (Reardon et al., 1997). Recent evidence 
suggests that some neurological degenerative diseases, such as Parkinson's disease, 
may derive from defects in mitochondrial DNA (Zhang et al., 1999). Several lines of 
evidence also indicate that the mitochondrial encephalomyopathies are a 
heterogeneous group of diseases which are mostly caused by inborn errors of 
oxidative phosphorylation (reviewed in Larsson and Clayton, 1995). Although the 
mechanism(s) underlying the developmental delay observed in ER CC] null cerebella 
remains to be determined, the observed mitochondrial abnormalities in the liver 
suggests that oxidative damage might give rise to this developmental defect and/or 
other unknown subtle changes. Furthermore, hepatic encephalopathy, defined in 
broad terms as changes in neurological function that result from liver disease, has 
demonstrated a wide range of neuropsychiatric signs and symptoms in humans that 
are associated with both acute and chronic liver failure (Cordoba and Blei, 1996). 
Since in our ERCCJ-deficient mice there are strong indications of acute hepatic 
failure (see Chapter 6), it is possibe that the developmental delay and/or functional 
abnormalities in the ERCC1 null cerebellum originate from liver cell damage. 
7.5.2 Migration delay of the external granular layer in the ERCC1-deficient 
mice 
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The EGL of the cerebellum is a transient structure during development of the 
mature cerebellum. After exiting the cell cycle, granule cell precursors begin their 
inward migrations at P3 to form the internal granule layer (IGL). This process 
continues until about P15 at which time the EGL is no longer present (Hatten and 
Heintz, 1995). At P16.5, the EGL in both ERCCJ null lines still had 3-4 cell 
thickness, whereas that of the wild-type and heterozygous littermates had 
disappeared. Since EGL cells only give rise to cerebellar granule cells and may 
represent the single source of granule cells, the number of granule cells can be 
determined by the extent of cellular proliferation in the EGL as well as by cell death 
at a later stage. Thus, it is possible to speculate on how ERCC 1 may be involved in 
the cerebellar development. 
Firstly, it is important to note that granule cell neurite extension and migration 
are closely linked process (reviewed in Hatten, 1999). Bergmann glia can guide the 
Purkinje cells and granule cells from their origin in the ventricular matrix and the 
external granular layer, respectively, to their final position in the cerebellar cortex. 
Therefore, the delay of EGL cell migration could be a consequence of the 
malformation of Bergmann glia cells. In this process, Bergmann cells provide a 
scaffold for neuronal migration. The perpendicular migration of EGL cells may 
occur by a reciprocal interaction between the granule neurones and Bergmann glia 
cells. The cultured mouse cerebellar granular precursor cells have been observed to 
extend their mitotic behaviour when grown in reaggregates, while the addition of glia 
or glia membrane functions to the cultures halts division of the precursors, indicating 
a role for specific cell-cell contact in neuronal proliferation and growth arrest (Gao et 
al., 1991). It seems that some glycoproteins, such as the anachronism gene product, 
might be responsible for the arrest of neuronal proliferation imposed by cerebellar 
glia cells (Ebens et al., 1993). Furthermore, several molecules have been proposed to 
influence granule cell migration. For examples, neuregulin, which is expressed in 
granule cells, can bind to erbB4 on the glial cell surface to regulate the migration 
(Rio et al., 1997). Studies on the disposition and role of thrombospondin show that 
thromobospondin is expressed on the granule cell axons. Antibody perturbation 
experiments in explant cultures of cerebellar cortex demonstrated reduced granule 
cell migration (Shea et al., 1990). Similar studies also suggested that brain-specific 
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lipid-binding protein (BLBP) and axonal glycoproteins, such as neuron cell adhesion 
molecules (NCAM), TAG-i and Li, are thought to play a critical role in radial glia 
guidance (Furley et al., 1990; Anton et al., 1997; Rio et al., 1997). Furthermore, the 
characterisation of mouse mutants resulting from genetic abnormalities of neuronal 
migration has provided insight into some of the molecular pathways guiding this 
process. For instances, reeler mice, or mice with disruption of the genes Mdab 1, 
cdk5 and cdk5r (P35) display similar migration abnormalities (Ohshima et al., 1996; 
Chae et al., 1997; Rice et al., 1998). In this study, a non-typical stellate cell 
(transformed glial cell) in the ERCCJ '  cerebellar cell cultures has been found, 
suggesting that we need to pay much attention to this cell and other factors that 
might affect granule cell migration and interfere with EGL cell differentiation. 
Secondly, programmed cell death describes the stereotypic loss of individual 
cells at specific times during development. This process, like proliferation, 
differentiation, and growth control arrest, is thought to play an essential role in 
controlling the balance among cell populations throughout animal development. Cell 
death is often controlled by survival promoting signals from other cells, but is 
executed in a cell autonomous manner (Raff, 1992). A direct induction of cell death 
by the removal of trophic factors or the inhibition of mitosis may be included in this 
process. In the cerebellum, it appears that the number of Purkinje cells in large 
measure determines the size of granule cell population. When Purkinje cells are 
eliminated by experimental perturbations, there is a concomitant reduction in the size 
of the granule cell population (Feddersen et al., 1992; Hen-up and Kuemerle, 1997). 
Furthermore, an increased granule cell death generally occurs together with 
compensatory granule cell proliferation. This has previously been described in 
irradiated wild-type mice and mice lacking brain-derived neurotrophic factor 
(BDNF), in which a persistent EGL was even detectable at postnatal day 21 (Altman 
and Anderson, 1972; Schwartz et al., 1997). Although the nature of this relationship 
is yet to be determined, we found an irregular Purkinje cell layer in the P8 ERCCJ 
null cerebellum, implicating that there might be an non-concomitant connection 
between the Purkinje cells and granule cells. 
Thirdly, Kuida et. al. have demonstrated that the EGL of mice lacking CPP32, 
also named caspase 3 and an apoptotic effector, persists to P16 with decreased cell 
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death and a supernumerary cell population. They also found that this mutation 
caused hydrocephalus and subsequently elevated intracranial pressure, presumably 
from the obstruction of the cerebral aqueduct by the excessive celluarity of the 
brainstem (Kuida et al., 1996). Further, insulin-like growth factor-i (IGF-1) has an 
important anti-apoptotic role in cerebellar development, and it has been shown to 
stimulate neurite outgrowth and promote survival of neurones in culture (Torres-
Aleman et al., 1994; Tanaka et al., 1998). A recent study has also demonstrated that 
transfection of the insulin receptor enhances the expression of ERCCJ mRNA in 
Chinese hamster ovary (CHO) cells while conferring resistance to UV-induced 
damage (Perfetti et al., 1997). In contrast to the previous suspicion, a similarly anti-
apoptotic pathway might also be considered in our ERCCJ knockout mice, which 
would alter cerebellar structure. 
Finally, in the granule cell proliferation stage, there may be particular adverse 
consequences of cell division in the absence of ERCC 1. Perhaps the drain on the 
pool of nucleotide precursors, or abnormal ionic fluxes such as calcium, cannot be 
tolerated by the cell (Whitaker and Patel, 1990). Meanwhile, the disorganisation of 
chromatin that must accompany DNA replication in an unrepaired cell may lead to 
genetic imbalances that cannot also be tolerated. In this regard, it is noteworthy that 
there are specific cell cycle checkpoints in both S phase and in G2 phase of the cell 
cycle (Earnshaw and Pluta, 1994). These may halt further progression of the cell 
cycle until the genome has been repaired. The elevated p53 level in the ERCCJ null 
brains, which can perturb cell cycle regulation by activation of p21, appears to be 
one possibility to explain the developmental delay. 
7.5.3 Future prospects for studies in the ERCC1 null cerebellum 
Since we suspect that the developmental delay in the EGL in both lines of our 
ERCCJ '  mice might arise from migration defects, a direct measurement of neuronal 
migration in the cerebella seems a useful index. The protocols for the in vivo BrdU 
labelling and an in vitro cerebellar granule cell migration assay have been 
demonstrated by several groups (Hirotsune et al., 1998; Engelkamp et al., 1999), so 
we can utilise these methods and improve our cultural techniques in the near future 
to investigate whether cerebellar cells from the ER CCJ ' mice would migrate behind 
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the control group and the possible mechanisms to explain the delayed neural 
migration. 
There is increasing evidence to suggest that stellate cells play an important role 
in the production of hepatic fibrosis (Olaso and Friedman, 1998). The main features 
of the activation process of hepatic stellate cells, including enhanced expression of 
type I collagen and active proliferation, have been clearly demonstrated in 
experimental models of liver fibrosis (Geerts et al., 1993; Grinko et al., 1995). In the 
ERCC] ' cerebellar cell culture, we have found a lot of stellate-like cells and an 
abnormal droplet pattern in comparison with the control group. We have not yet 
learned if a similar fibrosis mechanism of stellate cell changes occurs in the 
cerebellum; however, from previous reports about the correlation between glia cells 
and stellate cells, we suspect the function of stellate cels (or glia cells) in the 
cerebellum would be changed after tissue injuries (or DNA damage) and further 
affect the cell migration. Moreover, lipid droplets have also been noticed in the 
ERCCJ ' mice liver (see Chapter 6), implicating irregular lipid metabolic pathways 
in some specific cell types of the ERCCJ-deficient mice. Because foxed ERCCJ 
mice are now available (see Chapter 5), a conditional ER CC] knockout mouse, in 
which ERCCJ expression is disrupted only in neurones during development, 
becomes a possible route to investigate the role of ERCC 1 in the cerebellum or other 
brain structures and behaviour changes. 
In the in vitro study, we did not find a significantly increased level of apoptosis 
in the cultured ERCCJ ' cerebellar cells in comparion with the wild-type controls. 
However, these cultures are mixtured neuronal and glial cultures, and we have not 
yet characterised any in vivo apoptotic changes in particular cell types. Conversely, 
altered anti-apoptotic functions might delay the EGL cell migration in the ERCCJ-
deficient cerebella. Since available evidence suggests that several regulators, such as 
caspase 3, cyclin Dl and IGF-1, are involved in responses to apoptosis (Sicinski et 
al., 1995; Kuida et al., 1996; Tanaka et al., 1998), immunohistochemistry or in situ 
hybridisation with different markers and ERCC 1 probes (or anti-ERCC 1 antibodies) 
will be used in future to investigate whether apoptotic or anti-apoptotic effects are 
involved in the observed developmental delay in the ERCCJ-deficient cerebellum. 
Electrophysiological methods have been used widely to study the functional 
changes in the neurones. For instance, in developing and regenerating neurones, the 
growth cone located at the distal tip of a neurite is thought to be the site governing 
nerve growth and axon guidance (Goodman and Shatz, 1993). Several ions are 
implicated in various signalling pathways in nerve growth and growth cone 
behaviour. An optimal range of the concentration of intracellular Ca 
2+
in growth 
cones is required for proper nerve growth (Kater and Mills, 1991). A recent study 
also suggested that elevation in cytosolic Ca 
2+
and the subsequent activation of N- 
methyl-D-aspartate glutamate receptors would trigger the granule cell migration 
(Komuro and Rakic, 1993, 1998). Moreover, the control of granule cell survival is 
relative to depolarising activity of amino acid receptors and the potential role of Ca 
2+ 
 
in this process. Surmeier et. al. have demonstrated that the weaver mutants, which 
lack a G-protein-activated, inwardly rectifying iC channel protein, have granule cell 
degeneration (Surmeier et al., 1996). To study whether the electrical activity would 
be changed in the growth cones of the ER CC] ' mice and the cell death in granule 
cells and other events, a collaboration, with Dr. Heng-Sheng Lee, Department of 
Pathology, University of Edinburgh, has been proposed. 
In summary, the ERCCJ-deficient mice (KT#209 line) displayed an abnormal 
leg-clasping reflex and uncoordinated movements, suggesting that these mice have a 
certain level of impairment in the cerebellum. Both ER CC] ' lines also showed a 
developmental delay in the EGL and irregular cell alignment in the PCL. A 
nontypical stellate-like cell has been observed in cerebellar cell culture. 
181 
Chapter 8 
Evaluating the ERCC1 protein and its possible functions 
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Although the human ERCC1 (hERCCJ) and mouse ERCCJ (mERCCJ) genes 
were cloned in 1986 and 1988 respectively (van Duin et al., 1986, 1988), to date the 
knowledge about the predicted ERCC 1 protein structure still relies on site-directed 
mutagenesis research and sequence analysis strategies from different databases due 
to the lack of data from x-ray crystallography. Computer-based analysis is employed 
in this chapter to predict the ERCC 1 structure and its probable functions. 
Furthermore, to the best of our knowledge, all available human antibodies against 
ERCC1 could not efficiently recognise the mouse ERCC1 protein. Due to the 
necessity to study the mouse ERCC 1 protein in detail, a novel antibody to recognise 
the mouse ERCC 1 protein has been generated and successfully used in western 
blotting. Since recent reports have suggested that ERCC 1 may get involved in other 
repair systems, particularly those linked to recombination (Sargent et al., 1997; 
Melton et al., 1998), this has led to speculation that it might affect V(D)J 
rearrangement and also T cell maturation. Here we set up some experiments to test 
these possibilities. Finally, this chapter describes the response to u.v. light and 
mitomycin C in the primary embryonic fibroblasts derived from the KT#209 ERCCJ 
knockout mice. 
8.1 Analysis of the mouse ERCC1 protein 
In spite of 87% similarity between the human and mouse ERCC 1 protein, the 
estimated p1 in hERCC1 is 5.84 in contrast to 7.33 in mERCC1. The calculated 
molecular weight of hERCC1(297 a.a.) and mERCC1 (298 a.a.) are 32559.88 and 
32967.36 respectively. In mERCC 1 non-polar a.a. (44.15%) are in the majority and 
leucine is the most abundant a.a. (11.74%). The analysis of hydrophilicity showed 
that the mERCC 1 protein has a more hydrophobic structure in the central region than 
N- and C-terminal regions. Meanwhile, the analysis of secondary structure predicted 
the C-terminus of ERCC 1 might have several stretches of a-helix. [Figure 8.1(A)] 
(above predictions according to MacVector 4.5.1 software). 
Different software (Block, ProfileScan, Pfam) (Bateman et al., 1999; Henikoff 
et al., 1999) have given us the prediction that the C-terminal region, around a.a. 
residues 258-288 of ERCC1, contains a helix-hairpin-helix (HhH) motif, which is a 
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Figure 8.11 Sequence analysis of the mouse ERCC11 protein 
Analysis of hydrophilicity and secondary structure were performed using 
MacVector 4.5.1 software. The hydrophilicity plot was scaled by the Kyte-
Doolittle method, and secondary structure was predicted by Chou-Fasman (CF) 
and Robson-Gamier (RG) methods. 
Other protein sequences similar to the mERCC 1 protein were searched for using 
PSI-Blast software (NCBI). Also, illustrated is the position of the mERCC1 
exon 3-5 encoding region in this protein. 
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non-sequence-specific DNA binding domain to recognise both ss and ds DNA via 
the formation of hydrogen bonds between nitrogens in the protein backbone and 
phosphate groups in DNA (Doherty et al., 1996). A lot of proteins, which are 
essential for the protein-mediated synthesis and repair of DNA structure, such as 
nuclease, ligases, helicases, topoisomerases and polymerases, are also believed to 
possess HhH motifs (Doherty et al., 1996). 
A recent paper has reported that the XPF protein family shares similarity with 
Drosophila MEI-9, S.pombe Rad16 and S. cerevisiae RAD1 as well as the putative 
RNA-helicase superfamily 2 (SF2) in several archaebacterial genomes. This SF-2 
RNA-helicase superfamily contains the cellular eIF-4A transcriptional factor and 
many viral helicases (Sgouros et al., 1999). Interestingly, in addition to a role as a 
partner of ERCC1, XPF has a good alignment within the ERCC1 residues 100-175. 
The same software, an iterated PSI-BLAST non-redundant protein-sequence 
database (NCBI) (Altschul et al., 1997), was also utilised to search for other protein 
sequences similar to that of the mERCC1 protein. The setting is the same as the 
suggestion on the published paper: the scoring matrix on BLOSUM62 and the 
expect-value thresholds at 10 for reporting hits and at 0.001 for inclusion of hits in 
subsequent iterations. In the third iteration, it did not detect any high score in the 
mERCCI N-terminal region (residues 1-80). Between mERCC1 residues 80-295, 
the search showed —70% similarity with Lilium longJlorurn ERCC1, S. pombe SwilO 
and Drosophila melanogaster repair protein MUS210 (E value around 10
-80 
 ), 53% 
with an ERCC1-like sequence in Caenorhabditis elegans and 59% in Plasmodium 
-67 
falciparu,n (E value in the range of 10 ). In the same region, it also share —40% 
similarity with XPF and three putative ATP-dependent RNA helicases from 
Archeoglobus flilgidus, Met hanococcus jannaschii and Met hanoba cteriurn 
-50 	-20 
therrnoautotrophicurn (E value from 10 to 10 ). Further, mERCCI is 53% similar 
-34 
to S. cerevisiae RADIO (residues 80-210, E value=lO ) and 34% similar to 
-20 
Drosophila melanogaster MEI9 (E value=10 ). The C-terminal region (residues 
225-285) in mERCC1 showed 45-50% similarity to DNA ligases from several 
species such as Mycobacterium tuberculosis, Thermotoga maritirna, Rhodotherm us 
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inarinus and Chiamydia trachomatis (E value in the range of 10 
-6
),  thought to arise 
from sharing a similar HhI-1 motif. Figure 8.1 (B) shows the similarity between the 
mERCC1 protein and other proteins. It was apparent that the deleted ERCC1 exon 3-
5 coding region (a.a residues 36-175) in the KT#209 knockout mice constitutes a 
large part (47%) of the mERCC1 protein, although the exon 3-5 region is only 13% 
(2/15 kb) of the ERCCI gene. 
The PROSITE software search (Hofmann et al., 1999) detected an N-
glycosylation site at a.a. residues 246-249 and four casein kinase II phosphorylation 
sites at a.a. residues 59-62, 78-81, 201-204 and 267-270. Although the original 
paper describing the mERCC1 sequence predicted a nuclear localisation signal at a.a. 
residues 16-23 (van Duin et al., 1988), the PSORT software (Nakai and Horton, 
1999) has suggested that there might also be a second nuclear localisation signal in 
the C-terminal region (residues 279-285). 
8.2 Antibody recognition of the mERCCI protein 
This laboratory has produced a good mouse model to study ERCC1 function, 
but there is presently no antibody available against mouse ERCC1. To gain insight 
into the biochemical properties of ERCC 1, we intended to purify the protein by using 
an E. co/i overexpression system and subsequently generate an antibody raised 
against the mERCC 1 protein. For this purpose, fragments of the ERCC 1 gene were 
cloned into the vector pET-29c(+) (Novagen, Madison, WI) to produce fusion 
proteins. One recombinant protein was further used to raise antiserum against the 
mERCC1 protein. The whole strategy for the preparation of fusion protein and 
antibody against the mERCC 1 protein is shown in Figure 8.2. 
8.2.1 Expression of recombinant ERCC1 fusion proteins 
Two ERCC1 coding regions, one containing the full-length ERCC 1 protein and 
the other comprising exons 3-5, were amplified by PCR from the plasmid pTZME 
using primers designed to introduce NcoI and BamHI restriction sites at the 5' and 3' 
ends respectively. These PCR products were inserted into the pET-29c(+) vector and 
designated pET_ERCC 1 A (containing the full-length ERCC 1 protein, nucleotides 
Figure 8.2 The strategy for expression of ERCC1 recombinant protein 
The PCR products, containing restriction sites, amplified from eDNA clone 
pTZME were cut with NcoI and BamHI and inserted into pET-29c(+). After 
identifying positive clones with the correct reading frame, the plasmids were 
transformed into a host with the T7 RNA polymerase gene (XDE3). Addition of 
IPTG to a growing culture of the lysogen induces T7 RNA polymerase, which in turn 
transcribes the ERCC1 eDNA in the plasmid. The ERCC1 recombinant proteins 
were purified via column chromatography and subsequently sent to the Scottish 
Antibody Production Unit for preparing the antisera. 
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from cDNA 89-1,053) and pET ERCCIB (comprising ERCCJ exons 3-5, 
nucleotides from eDNA 204-623). Positive clones from each of these construcs were 
identified by restriction digestion of purified plasmids and further confirmed by 
DNA sequencing (data not shown). Three positive clones of each recombinant were 
used to transform E. coli strain BL21 (DE3) in order to produce the predicted 
recombinant protein in a small scale. The proteins were extracted from BL21 (DE3) 
cells after 1 mM IPTG induction at 37 °C and separated on an SDS-PAGE gel. By 
this method, the growth of host cells was blocked and the bulk of the cell's protein 
synthesis was derived from the fusion protein clones. As shown in Figure 8.3 (A) a 
clone with plasmid pET_ERCC1B, containing mERCCI exons 3-5, was expressed as 
a 15 kDa insoluble protein, whilst the soluble form was only present as a trace. The 
full length mERCC1 protein (pET_ERCCIA) failed to express in this experiment. 
We decided to use pET_ERCC I  for large scale purification. 
The pET-29c(+) vector is designed for expression of inserts as stable fusion 
proteins with a C-terminal hexa-histidine tag. The His-6-tag facilitates the 
purification of the fusion protein by specifically binding to an immobilised nickel 
2+ 
(Ni ) chelating agent. Since the fusion protein from the recombinant pET_ERCC1B 
was insoluble, this fusion protein was purified under denaturing conditions in 8M 
2+ 
urea using the Ni -charged resin to perform column chromatography. Elution was 
performed by stepwise gradients with increasing imidazole concentrations in PBS 
buffer [Figure 8.3 (B)]. Urea was removed from the purified protein by dialysis 
against PBS and the final yield of fusion protein was 1.025 mg/ml. 
8.2.2 Western blotting analysis of the ERCC1 protein 
Two rabbits (R539 and R540) were immunised with the fusion protein from the 
recombinant pET_ERCC I B (250.ig/rabbit/month) at the Scotish Antibody 
Production Unit (SAPU) to produce polyclonal antiserum. The sera were collected at 
one month intervals and tested by western blotting to check for an antibody response. 
After the third boost, the R540 rabbit had raised a high titre antiserum which 
continued for ten months. The antibody titre from the other rabbit R539 had not 
been raised and thus we did not study it further (Figure 8.4 panel A). 
Figure 8.3 The expression of ERCCI recombinant proteins cloned in the 
pET29c(+) vector 
Proteins from an approximately equal number of cells induced with I MM IPTG 
were run in each lane of a 12.5% SDS-PAGE gel and stained with Coomassie 
blue. The proteins of uninduced whole cell extract and soluble and insoluble 
fractions of induced total cell extracts are marked as U, S and I. The arrow 
indicates that a clone containing the pET_ERCC1B plasmid produced a 15 kDa 
fusion protein. 
The pET_ERCC1B-His6-tag fusion protein from E. co/i BL21 (DE3) was 
purified with His-tag affinity chromatography (Novagen, Madison, WI) in a 
large scale. The insoluble fractions of protein extracts were purified on Nickel 
resin beads, washed and eluted using an imidazole gradient under a denaturing 
condition with 8M urea. Lanes: W, whole cell extract from the pET_ERCCIB 
clone induced by 6 hr 1mM IPTG; 1, flow through of the resolubilised extracts 
after passing through affinity chromatography; 2 and 3, elutes obtained with 20 
mM and 40 mM imidazole, respectively; F, the final products eluted with 100 
mM imidazole. 
(B) 
pET ERCC1B pET_ERCC1A 









W 	1 	2 	3 	F 
116 - 
14- 
Due to the insoluble nature of the fusion protein from pET_ERCC1B, we could 
not utilise a column affinity-purification strategy to purify the antibody from our 
rabbit serum. Alternatively, a small scale purification using antigens immobilised on 
nitrocellulose membrane was employed in this experiment (Robinson et al., 1988). 
The affinity-purified antiserum purified against whole cell extracts from the 
+1+ 
immortalised ERCC1 	cell line PF20 was diluted 1:500, 1:1,000 and 1:2,000. 
Three dilutions of the secondary antibody (horseradish peroxidase linked Donkey 
anti-rabbit IgG, Amersham) were used at 1:2,500, 1:5,000 and 1:10,000. Results 
showed that 1:1,000 of the antiserum and 1:5,000 of the secondary antibody 
produced minimum background noise on the western blot (Figure 8.4 panel B), 
Therefore, these were adopted as the optimum dilutions required for further 
experiments. 
It was important for us to characterise the reaction of this novel antiserum 
against protein extracts from cultured cells. A panel of cultured cell lines, from those 
readily available in our laboratory, was screened by western blot analysis for the 
presence of ERCC 1 protein expression. Total whole cell extract was isolated from 
the transformed wild-type mouse embryonic fibroblast line PF20, the transformed 
original ERCCJ-deficient embryonic fibroblast line PF24, the transformed novel 
ERCCJ-deficient embryonic fibroblast line PFKT9, the wild-type Chinese hamster 
ovary cell line CH09, the ERCCJ-deficient Chinese hamster ovary cell line CH043-
3B, and the SV40 transformed wild-type human fibroblast line MRC5V1. The 
protein (35p.g) was electrophoresed on a 12.5% SDS-PAGE, transferred to a 
nitrocellulose membrane and detected using this novel antiserum (Figure 8.5). The 
expected ERCC1 protein expression was present in the PF20 lane. Several reports 
have demonstrated that the hERCC 1 protein migrated at about 39 kDa on SDS-
PAGE, which does not correspond to the predicted size (32.5 kDa) based on the 
amino acid sequence derived from the hER CC1 cDNA clone. Conversely, the 
mERCC 1 protein migrated slightly higher (0.5 kDa) than the predicted molecular 
weight (33 kDa). Furthermore, different size and intensity bands were also detected 
in the CH09 (32.5 kDa)and MRC5V1 (35 kDa) lanes. It was evident from this blot 
that the novel anti-mouse ERCC 1 polyclonal antiserum cross-reacted with other 
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Figure 8.4 Analysis of rabbit anti-mIERCCII polyclonal antibody by western 
blot. 
Two rabbits (R539 and R540) were immunised with the recombinant protein 
containing the ERCC 1 exon 3-5 coding region at 250 p.g /rabbit/month. After 
the third boost, R540 raised a high titre antiserum against the mERCC 1 in PF20 
(wild-type immortalised cell line) whole cell extracts. This rabbit continued to 
produce high titre antiserum and monthly injections were continued until 
terminal exsanguination. Pre: preimmune sera; T: test sera; #8-10: sera from the 
eighth, ninth and tenth boost, respectively. Arrow indicates the position of 
mERCC1. 
The affinity-purified anti-mERCC1 antiserum at 1:500, 1:1,000 and 1:2,000 
dilution was used against whole cell extracts from the PF20 cell line. The 
secondary antibody here was used at a 1:5,000 dilution. 
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Figure 8.5 ERCC1 protein expression detected in different cell lines 
Western blot analysis of protein samples from a range of cultured cell lines. 
Whole cell extracts were prepared from a wild-type mouse fibroblast line (PF20), an 
original ERCCI-deficient fibroblast line (PF24), a novel ERCC1 null fibroblast line 
(PFKT9), a wild-type Chinese hamster ovary cell line (CH09), an ERCCI-deficient 
Chinese hamster ovary cell line (CH043-313), and a SV40 transformed wild-type 
human fibroblast line (MRC5VI). Protein (35 g) was electrophoresed through 
12.5% SDS-PAGE, transferred to a nitrocellulose membrane and detected by the 
affinity-purified anti-mERCC1 antibody. The arrow indicates a 33.5 kDa band in the 
PF20 track. The size in the CH09 appeared lower (32.5 kDa) and the MRC5VI 
higher (36 kDa) than the PF20 track. 
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species. We could not find any positive signals in either of the ERCC1-deficient 
mouse lines (PF24 and PFKT9) or the CH043-3B lane, even though some 
alternatively spliced ER CC] transcripts have been identified in the original ERCCJ-
deficient cells by RT-PCR (Melton, unpublished results). 
We next investigated the pattern of ERCC 1 protein expression in different 
tissues from wild-type mice and ERCCJ transgenic lines. Due to different patterns 
of tissue transcripts observed in this laboratory (Jim Selfridge, unpublished data), we 
also tried to compare the ERCC1 expression in RNA and protein levels from 
different tissues. Total whole cell protein extract (80 p.g) from each of the tissues 
was detected by western blot analysis, and data were compared with northern 
blotting. 
In northern blot analysis of wild-type mouse tissue, the normal 1.1 kb ERCC 1 
transcript was detected in all tissue examined. The level of expression was lowest in 
the liver and generally low in all other tissues except for the testis, where expression 
was much more abundant. In addition to the normal ER CC] transcript, a novel 
larger transcript predominated in the skin track. In comparison with northern blot 
analysis, the level of ERCC 1 protein expression was very low in heart and muscle. 
The highest level of ERCC 1 protein expression was consistent with the high level of 
transcript in testis. There was no evidence for a second peptide in skin 
corresponding to the novel transcript, but intriguingly, three different protein bands 
were clearly evident in the liver track [Figure 8.6 (A)]. 
We have generated transgenic lines which gave high levels of hepatocyte-
specific ERCC1 transgene expression (Jim Selfridge, unpublished data). Northern 
blot analysis of a transgene positive ERCCJ-deficient mouse (original background) 
presented a high level transgene transcript in the liver and very much weaker signals 
in the brain, testis and skin, suggesting a very low level of transgene expression in 
the latter tissues. We found a similar pattern in western blot analysis, albeit there 
were still three bands in the liver track [Figure 8.6 (B)]. 
193 
Figure 8.6 A comparison of RNA and protein levels in different tissues from the 
wild-type and transgene positive ERCCJ-deficient mice (Northern blot analysis 
kindly provided by Jim Selfridge). 
Upper panel: total cell extracts (80 tg) were prepared from a selection of mouse 
tissues, electrophoresed on a 12.5 % SDS-PAGE, transferred to a nitrocellulose 
membrane and detected by the affinity-purified anti-mERCC 1 antibody. Middle 
panel: an identical tissue panel of RNA was hybridised with an ERCC1 cDNA 
probe. The position of 18S rRNA is indicated. Lower panel: the ethidium 
bromide (EtBr) staining to illustrate RNA loads. 
Upper panel: a similar procedure as above on a male transgene positive ERCC 1 
null mouse (original background). Middle panel: northern blot analysis. Lower 
panel: the ethidium bromide (EtBr) staining to illustrate RNA loads. 
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8.3 The possible role of ERCC1 in T cell development 
During recent years our knowledge about thymic T cell development has 
increased considerably. This is due to the development of assay systems which 
allow monitoring of T cell differentiation from precursors (reviewed in von Boehmer 
and Fehling, 1997; Glimcher and Singh, 1999; Mariathasan et al., 1999). The thymic 
rudiment becomes capable of supporting T cell development at gestation stage. In 
foetal life, the progenitor cells which seed the thymus via the peripheral blood are 
derived from the foetal liver at first and later from the bone marrow (Gale, 1987; 
Cahill et al., 1999). Since our ERCCJ-deficient mice have shown enlarged 
hepatocyte nuclei from embryonic day 16.5 (Chapter 6, Figure 6.2), it was interesting 
to investigate whether these mice also exhibit developmental defects in T cells. 
Furthermore, recent reports have indicated that the ERCC 1/XPF complex is involved 
in recombination events (Sargent et al., 1997; Melton et al., 1998), raising the 
possibility that ERCC 1 might have a role in the V(D)J recombination process and 
thus that ERCC 1 deficiency might affect B and/or T cell maturation. 
8.3.1 Introduction 
Thymocyte maturation is an inherently selective process that permits the 
differentiation of a small percentage of immature T cells. T-cell precursors in the 
thymus are initially negative for expression of the surface antigens CD4 and CD8, 
termed double negative (DN). DN cells are subdivided further into four distinct 
differentiation stages based on changes in the surface expression of CD44 and CD25 
in the following order: CD44CD25—*CD44CD25--CD44CD25--WD44CD25 -. 
At the third stage (CD44 CD25 ), DN thymocytes are selected for the expression of 
successfully rearranged T cell receptor (TCR) 1 3 chain, and progress to a 
CD4CD8 double positive (DP) stage (Godfrey and Zlotnik, 1993; Penit et al., 
1995). Thymocytes that reach the DP stage rearrange TCRct and express the mature 
form of the TCRc43, which is associated with CD3yc/CD36c and . These DP cells 
In order to discriminate T-cell receptor from transcription-coupled repair (TCR), in this thesis the 
former is designated as TCR. 
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are then subjected to a selection process based on the affinity of their TCRs for self-
MHC. MHC class IT-restricted thymocytes undergo positive selection to the CD4 
lineage and function in immune responses primarily as T-helper cells. In contrast, 
MHC class I-restricted thymocytes are positively selected to the CD8 lineage and are 
expressed in immune responses primarily as T-effector cells. Self-tolerance also 
occurs in the thymus through a process called negative selection (Sant'Angelo et al., 
1998; Singer et al., 1999). A model of thymocyte development and T cell receptor 
complexes is presented in Figure 8.7. 
V(D)J recombination plays a critical role in normal thymocyte development, as 
expression of functional TCR*  chains is required for both the DN to DP and further 
to single positive (SP) developmental transition. In this process, DNA breaks are 
initiated by the products of the recombinase activating genes (RAG) 1 and 2, 
followed by the action DNA repair enzymes and DNA-dependent protein kinase 
(DNA-PK) (Mombaerts et al., 1992). Furthermore, immunoglobulin genes are also 
modified through a similar V(D)J recombination process in pre-13 cells. For 
instance, the severe combined immunodeficiency (SCID) mice failed to generate 
significant numbers of functional TCR and Ig gene rearrangements because of a 
severe defect in V(D)J recombination (Lieber, 1998). 
8.3.2 T cell development in ERCC1 -deficient mice 
To investigate whether ERCC 1 is necessary for T cell development, we set up 
a pilot study to examine the expression of CD3, CD4 and CD8 in the ERCCJ null 
mice (KT#209 line) by flow cytometnc analysis. The following antibodies were 
used: anti CD3 fluorescein isothiocyanate (FITC)-labelled (Pharmingen); anti CD4-
phycoerythnn (PE) (Caltag); and anti CD-8 FITC (Caltag). The work presented in 
this section was carried out as part of a collaboration with Mr. Xing-Xing Zhang of 
the Institute of Cell, Animal and Population Biology (ICAPB), University of 
Edinburgh. 
The pups from crosses of heterozygous mice aged 14.5, 16.5 and 18.5 days 
respectively were killed. Thymus and spleens from ER CC] null animals were all 
Figure 8.7 Schematic representation of thymocyte development and T cell 
receptor complexes. 
Basic stages of thymocyte development (adapted from Sebzda et al., 1999; Wiest 
and Carleton, 1999). 
Thymocyte maturation can be devided into three broad categories based on 
coreceptor surface expression: 1. an early double negative (DN) CD4CD8 stage, 
2. a predominant double positive (DP) CD4CD8 stage, and 3. mature CD4 or 
CD8 single positive (SP) stage. Immature DN thymoctyes upregulate the 
coreceptors following TCR J3 locus rearrangement and preTCR or n-selection. 
TCR a chain rearrangement is initiated and TCR ap heterodimers are expressed 
on the cell surface at the DP stage. At this point, these thymocytes become 
eligible for both positive and negative selection. 
Pre-T cell receptor and T cell receptor complexes (adapted from van Oers, 1999). 
The immune tyrosine—based activation motifs are represented as darkened 
rectangles. The pre-TCR complex appears to have a very weak association with 
the TCR E subunits. 
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markedly smaller than those of wild-type or heterozygous littermate controls  with 
total cell numbers reduced approximately 5-fold in both tissues (data not shown). 
Flow cytometric analysis of both thymocytes and splenocytes at postnatal day 14.5 
showed no significant differences in the CD3, CD4 and CD8 between homozygous 
mutants (n=3) and their control littermates (n=2) (data not shown). Cells from the 
day 16.5 ERCCJ-deficient mice (n=2) showed similar profiles to the control group 
(n=2) in these tissues [Figure 8.8 (A); only showing FACScan profiles of 
thymocytes). Intriguingly, there are significant changes in the thymus from ERCCJ 
nulls (n=3) at the age of 18.5 days compared to their control littermates (n=2) [Figure 
8.8 (B)], although the profiles from ERCCJ-deficient spleens were similar to those in 
the control group (data not shown). As determined by flow cytometric analysis for 
the CD3 marker, there is an elevation in the ERCCJ nulls (51.85± 4.54%) compared 
to their control littermates (13.26±2.17%). In a comparison of the knockout mice 
and the controls in CD4/CD8 profiles, the DP thymocytes of ERCC1 ' were reduced 
from the control value of 84.32±4.53% to 51.66±3.32%; conversely, CD4 SP 
thymocytes in ERCC 1 / showed a remarkable increase (from the control value of 
2.21±1.79% to 30.25±3.75%) while ERCC1 CD8 SP thymocytes were essentially 
the same as in controls [Figure 8.8 (C)]. 
8.4 Primary embryo fibroblasts response to u.v light and mitomycin C 
This laboratory has previously reported that primary embryonic fibroblasts 
from the original ERCC]-deficient mice were hypersensitive to u.v. light, but only 
moderately sensitive to the DNA cross-linking agent, mitomycin C (Melton et al., 
1998). A Dutch group have made a similar observation from their ERCCJ knockout 
mice with a C-terminal ERCC 1 truncation (Weeda et al., 1997). In order to test 
whether KT#209 knockout mice show different patterns of sensitivity, we isolated 
primary embryonic fibroblasts from day 12.5 wild-type and ERCCJ-deficient mouse 
embryos and utilised similar conditions (at passage 2) as before to investigate 
2  From previous studies and this experiment, we found that there is no significant difference in the 
wild-type and heterozygous ER.CCI mice, either in appearance or thymus protein expression of 
ERCC I by western blotting (data not shown) and categorise them as the control group. 
Figure g•g  FACS analysis of T-cell specific surface antigens in the ERCCJ-
deficient thymus 
Thymuses were isolated from post natal day 16.5 (A) and 18.5 (B) mice, 
respectively, and stained with anti CD3 FITC, anti CD4 PE and anti CD8 FITC. In 
each case, 10,000 viable cells were collected and analysed on a FACScan (Becton-
Dickinson). The control group contain both the wild-type and heterozygous mice. 
(C) A comparison of T-cell surface antigens in the P18.5 thymoctyes between the 
































Figure 8.9 illustrates sensitivity to u.v. light in terms of the cells surviving each dose 
of u.v. irradiation as a percentage of untreated controls. The D 50 mean values (the 
dose giving 50% survival) for the ERCCJ wild-type and knockout mice are 10 and 
1.5 Jm 2 respectively. At the high u.v. doses of 5 and 10 Jm 2 the survival of the null 
fibroblasts dropped to 7% and 0.1% respectively whereas the majority of wild-type 
cells were still alive. These results are consistent with those obtained previously 
from either primary fibroblasts or the immortalised cell line PF24 derived from the 
original ER CC] knockout mice. ERCC 1 / primary fibroblasts were moderately 
sensitive to mitomycin C compared to their species control (Figure 8.10). In a 
previous report, we have demonstrated that the ERCCJ -deficient cell line (PF24) was 
less sensitive to mitomycin c than the hamster ERCCJ mutant cell line (CH043-3B). 
This may indicate that there may be an alternative pathway in mouse to correct DNA 
interstrand cross-links (Melton et al., 1998). 
We have previously reported that elevated levels of p53 protein were detected 
in liver, brain and kidney using an immunohistochemical method (McWhir et al., 
1993). In contrast to the in vivo finding, p53 was not elevated significantly in the 
original ERCCJ-deficient primary fibroblast extracts relative to the wild-type control 
following u.v. irradiation, as determined by western blotting (Melton et al., 1998). 
Cell extracts from the new ERCCJ-deficient line have also demonstrated similar p53 
levels to the wild-type control after a lethal u.v. dose of 50 Jm 2 [Figure 8.11(A)]. 
Meanwhile, the p21 protein level also appeared unchanged in the null fibroblasts 
although the transcriptional levels of p21 decreased 5 fold [Figure 8.11(B)]. At the 
u.v. dose of 5 Jm 2, the kinetics of p21 response were nearly equivalent in both the 
wild-type and null KT #209 primary fibroblasts [Figure 8.12], which is consistent 
with our previous finding in the original knockout line (Melton, unpublished data). 
We also did not find any aberrant nuclei such as those seen in the ER CC] null 
hepatocytes. Thus, the G2 cycle arrest observed in the hepatocyes is not 
reproducible in our primary fibroblast cultures. 
8.5 Discussion 
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Figure 8.9 ERCCJ-deficient primary embryonic fibroblasts (KT#209 
background) are hypersensitive to u.v. light. 
The u.v. survival curves for wild-type and ERCCJ-deficient mouse primary 
embryonic fibroblasts are shown. wild-type: M, PFE 5 11+/+ and A, PFE 5 18+/+; 















0 	2 	4 	6 	8 	10 	12 
u.v, dose (Jm2) 
Figure 8.110 IERCC11-deficient primary embryonic fibroblasts (IKT#209 
background) are only moderately sensitive to mitomycin C. 
The survival curves following 24 hours exposure to mitomycin C are shown. 
wild-type: El, PFE 511+/+ and A, PFE 5 18+/+; ERCC1 nulls: 0,PFE519-/- and V, 
PFE52O-/-. 
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Figure 8.1111 Normal p53 and p211 protein levels in the KT#209 ERCC1-deficient 
primary mouse embryonic fibroblasts 
Wild-type and ERCCJ-deficient primary mouse fibroblasts (passage 2) were 
grown to 70% confluence and u.v. irradiated (50 Jm 2). (A) 6 hours later, whole cell 
protein extracts were made and analysed by western blotting for p53. (B) 15 hours 
later, RNA extracts and whole cell protein extracts were made and analysed for p21 
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Figure 8.12 The kinetics of 1)21 response following 5 .Jm n.y. irradiation 
Wild-type and ERCCI-deficient primary mouse fibroblasts (passage 2) werc 
grown to 70% confluency and u.v. irradiated (5 Jm 2). 3, 7 and 29 hours later. RNA 
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8.5.1 Sequence analysis of the mouse ERCC1 protein 
Since the ERCC1 structure, either from nuclear magnetic resonance (NMR) 
spectroscopy or x-ray crystallography, is yet be determined, predicting the ERCC1 
protein function from its sequence becomes an important and appropriate route to 
seek unknown biological functions. With the amount of available genomic data 
rapidly increasing, we can interpret raw sequence data from different databases and 
software. However, common protein sequence alignment programs are at present not 
able to detect functional and/or structural homology, if the sequence identity is below 
the significance threshold of about 25%. To date all available information about the 
ERCC 1 protein structure is probably equivalent to the tip of an iceberg. A lot of 
unknown structures in ERCC1 remain to be identified. For instance, information 
about the ERCC 1 N-terminus for us becomes increasingly urgent, although some 
reports suggest that the C-terminus performs a crucial role in the NER pathway. 
Indeed, after searching at least 10 reliable and popular databases, we were unable to 
find high significant identity with the ERCC 1 N-terminal region. 
Doherty et. al. (1996) categorised proteins containing the HhH DNA binding 
motif into 14 homologous families. In this classification, ERCC1 and S. pombe 
SwilO are compiled in family 12, whilst FEN-1, XPG and S. cerevisiae RAD2 are in 
the second family (Doherty et al., 1996). Due to the availability of only five crystal 
structures of the predicted HhH motif in this novel superfamily, different software 
packages give a variable length for the ERCC 1 HhH motif. Since the XPF family 
does not include this structure, it seems to suggest that ERCC1 might have the 
function of tethering XPF close to distorted DNA lesions. Due to lack of the same 
motif in the RAD1/RAD1O complex, it would suggest that other unknown DNA-
binding motifs might exist in this complex of S. cerevisiae. The answers to such 
questions still remain to be elucidated by X-ray analysis. 
PSI-BLAST identifies many important but subtle relationships that previously 
were detectable only by fairly laborious applications on several programs. This 
software is easy to launch, but its use requires caution. If a source of deceptive 
alignment that has highly biased amino acid composition is included during 
production of a profile, unrelated sequences containing similarly biased regions will 
be easily amplified by iteration. Due to this apprehension, we used a SEG program 
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to filter out biased regions (Wootton and Federhen, 1996). A recent survey using 
PSI-BLAST has indicated a relationship between XPF-nuclease and the S1 72 RNA-
helicase family. Since this RNA-helicase from hepatitis C virus could bind at the 
junction between a 3' RNA tail and a duplex region, they predicted that XPF might 
show similar binding at the junction between 3' single-stranded tails and duplex 
DNA (Sgouros et al., 1999). If the prediction is right, it may give more clues to 
explain the additional role of XPF in illegitimate recombination. We utilised the 
same program and detected some DNA repair proteins in other species which 
showed high similarity with ERCC 1. Intriguingly, we also found ERCC 1 may have 
similar motifs as those in the SF2 RNA helicase. Further work is necessary to 
understand the relationship between the ERCC 1 -XPF complex and helicases. 
We have also tried to search for clues about a possible role for ERCC 1 in the 
repair of oxidative damage, and the PRINTS software (Attwood et al., 1999)seems to 
suggest that ERCC1 has a P450-like motif. However no other software and 
databases can confirm this finding. We are hoping more findings will emerge soon 
to shed light on the possible roles ofERCC1 
8.5.2 Production and use of a novel anti-mouse ERCC1 antibody 
We aimed to produce different length mERCC 1 fusion proteins for future 
biochemical studies. Unfortunately, we were unable to acquire the full-length 
mERCC1 protein under various bacterial culture conditions. Alternatively, we tried 
to use the GST gene fusion system with the full length ERCC1 coding region 
inserted into the pGEX-4T- 1 vector. A lot of ERCC 1 degradation products were 
found in the elution (data not shown) which were thought likely to interfere with the 
affinity-purification, so we did not pursue this system. Hoeijmakers and colleagues 
have pointed out that the hERCC 1 protein containing the N-terminal region could not 
be successfully expressed in E. coli (Koken et al., 1993). The reason for this remains 
uncertain, and the Dutch group utilised an ubiquitin fused with the N-terminus of the 
target protein to circumvent this obstacle. Because a lot of work was waiting and a 
smaller fragment could be expressed satisfactorily, we did not try the ubiquitin 
fusions. The fusion protein from recombinant pET_ERCC1B was overproduced in 
E. coli strain DE3 following induction by 1 mM IPTG. Employing the standard 
UZ 
protocol resulted in the production of insoluble protein. Numerous attempts to obtain 
the protein in a soluble form were undertaken; however, this fusion protein was 
always produced primarily in the insoluble form, i.e. as inclusion bodies (data not 
shown). Several attempts to renature this fusion protein from the denatured inclusion 
bodies were performed. However, none of the various protocols produced 
satisfactory results (data not shown), possibly because proper refolding of the 
denatured fusion protein required the simultaneous presence of associated cofactors. 
Two other groups also obtained similar insoluble hERCC 1 fusion proteins, but they 
needed to use a series of chromatographic columns to separate them and only got low 
amounts of purified fusion proteins (Biggerstaff et al., 1993; Park and Sancar, 1993). 
Due to equipment limitation and production of anti-mouse ERCC 1 antibody as our 
first priority, we did not employ this method in the purification step. 
Although RT-RCR detected alternative splicing transcripts from the original 
ERCCJ-deficient mice raising the possibility that some ERCC1 protein might be 
produced, we were unable to find any ERCC 1 protein in either the original or the 
new ERCCJ-deficient cells. The discrepancy could arise from the high sensitivity of 
RT-PCR, which can amplify a trace of material to visible levels. The elevated 
ERCC1 levels observed in the testis, both at the RNA and protein levels, may be as a 
consequence of its proposed role in recombination. The low level in the muscle 
(from heart and thigh) of ERCC 1 protein expression might indicate that this protein 
is not required in large amounts or is readily degraded in these tissues. The larger 
transcript in skin originates from an upstream promoter (Jim Selfridge, PhD thesis), 
but both the level and size of ERCC 1 protein in skin are normal. The reason for the 
different patterns of skin ERCC 1 expression in northern and western blot analysis 
remains unclear. Several possibilities might explain three distinct protein species 
seen only in liver: (1) there are different potential sites for N-glycosylation and 
phosphorylation in the mature protein (Section 8.2) which are utilised exclusively in 
the liver and affect the protein mobility during SDS-PAGE, (2) alternatively spliced 
transcripts involving the ERCC1 5'-flanking region (Section 3.3.2) or other sites 
could encode different peptides in liver, (3) specially flexible structures in liver, such 
as PCNA (Liang et al., 1992), could give rise to altered patterns. The unusual pattern 
of ERCC 1 expression in liver may be connected to the specific pathologic changes 
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seen in the liver of ERCCI-deficient mice. It would be worthwhile checking the 
different protein species by the microsequencing technique (Garlanda, 1999) and 
investigating whether each of the different species may have different functions. 
Even though only a small amount of affinity-purified antibody was produced 
by the batch method, it seemed quite useful in western blot analysis. If we can 
improve this technique to obtain more affinity-purified antibodies, we would utilise 
them in immunohistochemical staining or electron-immunohistochemistry to 
investigate the subcellular localisation of ERCC 1, particularly whether it localises in 
the cytoplasm or other specific organelles. Meanwhile, we can utilise the chimaeric 
green fluorescent protein (GFP) to compare these localisation patterns. Since the 
novel anti-mERCC 1 antibody can cross-react with ERCC 1 from other species, it will 
provide a useful tool in future studies of ERCC1 from different sources. 
We have yet to determine the reason for the variation evident between the 
levels of transcript and expressed protein in wild-type tissues. The consequences of 
ERCC 1 deficiency are most noticeable in the liver although, if the liver deficiency is 
corrected with a transgene expressed from a liver-specific promoter (Jim Selfridge, 
unpublished observations) and the lifespan of the mice is extended, then 
abnormalities also become evident in other tissues. The peculiar sensitivity of the 
liver to ERCC1 deficiency is not a simple consequence of the level of expression 
because ERCC 1 expression in liver is lower than in many other tissues examined. 
The sensitivity may be related to the presence of additional ERCC 1 protein species in 
the liver (perhaps carrying out some liver-specific function), or the liver may be 
particularly susceptible to endogenous DNA damage that is normally dealt with by a 
repair pathway requiring ERCC 1. Furthermore, comparison between in vitro studies 
is rather difficult, even in the same laboratory, due to different purification protocols, 
various assays and conditions, and some differences in protein composition in 
various tissues. Furthermore, several lines of evidence demonstrated that expression 
of protein is differ significantly from that observed in its mRNA ( Loyer et al., 1994; 
Albrecht et al., 1995). Although we believe that the amount of protein extract loaded 
in each track was equivalent since we observed a small range of standard deviation 
when each sample was checked in triplicate by the Bradford method (data not 
shown), we will try to use a different antibody as a control in the future to acquire 
more reliable information. 
8.5.3 Role of ERCC1 in T cell development 
Flow cytometric analysis indicated that from postnatal day 14.5 and 16.5 there 
was no difference between ERCCJ-deficient mice and their control littermates in the 
thymus and spleen. Surprisingly, CD3 markers and CD4 SP thymocytes in 18.5 
days ERCCJ nulls are dramatically elevated and CD4 CD8 DP thymocytes 
showed a reduction. 	Conversely, CD8 SP thymocytes and peripheral T 
lymphocytes (spleen) in ERCCJ-deficient animals remain consistent with their 
controls. There are several possible ways to explain these variations. 
Firstly, several lines of evidence suggest that CD3 expression is in fact 
essential for thymocyte selection and T cell maturation (Dave et al., 1997; DeJarnette 
et al., 1998). The elevation of the CD3 marker in ERCCJ nulls seems to implicate 
that it might affect successive positive/negative selections to produce SP thymocytes. 
Secondly, a significant increase in the CD4 thymocyte lineage and its 
immediate precursors is detected in mice lacking the Ikaros gene, which encodes a 
family of hemopoietic-specific zinc finger proteins and is required at the earliest 
stage of T and B cell specification. The increase in CD4 T cells is always 
accompanied by a concomitant decrease in double positive thymocytes with no 
apparent change in CD8 single positive thymoctyte profile in the Ikaros knockout 
mice. There might be an inappropriately selected pathway allowing an excessive 
number to mature along the CD4 pathway (Wang et al., 1996). Since the elevation in 
the CD4 lineage and decrease in double positive thymocytes were also found in our 
ERCCJ-deficient mice, the lack of ERCC 1 might have a similar role resulting in 
selection and deregulation in the lymphocyte maturation process. 
Finally, a lot of reports have indicated that reactive oxygen species (ROS) are 
powerful killers, capable of setting up destructive molecular chain reactions in both 
lipids and nucleic acids (Polyak et al., 1997; Wyllie, 1997). Since we suspect that 
ROS damage in our ERCCJ-deficient mice might be a major cause of death, there 
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could be an apoptosis or necrosis pathway, induced by the ROS damage in the null 
thymus, that changes the ratios of the different lineages. 
Double strand breaks (DSBs) not only occur during meiosis but are also 
generated during maturation of the immune system. Developing T and B 
lymphocytes undergo V(D)J rearrangement to generate a wide variety of antigenic 
specificity. The very specific types of breaks that occur during these processes are 
normally repaired via the end-to-end rejoining pathway and a number of genes are 
involved in processing these DSBs such as RAG1, XRCC4 and DNA-PK (Chu, 
1997). It remains to be identified which genes are involved in processing 5' or 3' 
overhangs or flaps during the V(D)J recombination process. A recent report has 
suggested that FEN-1 acts specifically at 5' flap structures and plays a role in 
nonhomologous DNA end joining (Kim et al., 1998). West and colleagues also 
demonstrated that yeast RAD1/RAD1O complex can trim off the 3'-end unpaired 
single strand for the recombination repair of DSBs by single-stranded annealing 
(Davies et al., 1995). Further, a recent report also suggested that XPF might possess 
a novel helicase function and share sequence similarity with ERCC 1 (Sgouros et al., 
1999), and vice versa, we also found similar results for ERCC1 using the same 
software. Our group and Sargent et.al. have also demonstrated that the ERCCJ gene 
product is involved in illegitimate recombination in vitro (Sargent et al., 1997; 
Melton et al., 1998). In this study, we did not check other markers for TCR 
rearrangement. A report has argued that other NER genes, XPA, XPD and CSB, are 
not required for the DNA repair in the somatic hypermutation of rearranged 
immunoglobulin genes (Jacobs et al., 1998). However, we cannot entirely exclude 
the possibility that the ERCC 1/XPF complex, with a role in recombination distinct 
from other NER genes, has a subtle effect on V(D)J rearrangement albeit there might 
be redundant enzymes involved in the same process. 
8.5.4 Response of ERCC1-deficient cells to u.v. and mitomycin C 
Since we did not find significant changes between the original and KT#209 
knockout lines by hi stopatho logical examination, it is not surprising to find a similar 
pattern in response to u.v. light and mitomycin C. Weeda et al. (1997) have reported 
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that the embryonic day 12-13 primary fibroblasts had a 3-fold longer generation time 
in the ERCCJ-deficient culture than the wild-type culture. Some giant nuclei were 
also found in the ER CC] null fibroblasts. Elevated levels of p21 by western blot 
analysis were reported for their ER CC] null fibroblasts treated with mitomycin C (no 
data shown in this paper) (Weeda et al., 1997). Although the in vivo phenotype of 
ERCCJ-deficient mice is very similar, it is very difficult to compare the in vitro 
results from two groups. For example, cultures were isolated from mice with 
different genetic backgrounds and the longer-life of their ER CC] knockout mice has 
already been mentioned. At this moment we have not yet examined the kinetic 
variations of p21 in our primary fibroblasts in response to cross-linking agents, so we 
do not know whether a similar cell cycle arrest would occur in our ERCC]-deficient 
fibroblasts. However, we have found an illegitimate recombination defect in the 
ERCC 1-deficient fibroblasts (Melton et al., 1998) and the G2 cell cycle arrest in 
ERCC] null hepatocytes by centrometric staining (Nunez et al. submitted). Since the 
conditional knockout mouse project is presently being carried on, we hope this new 
system will provide more information about the cell cycle regulation in ERCC1 
deficiency. 
In summary, we have generated a novel anti-mERCC 1 antibody and 
successfully employed it in western blot analysis. This antibody would be useful in 
future studies to determine whether mERCC 1 has a role in the cytoplasm. The null 
KT#209 primary fibroblasts showed similar patterns in response to u.v. light and 
mitomycin C treatment as the original ER CC] nulls. We are interested to determine 
the role of ERCC1 in recombination, and studies here provided some clues to the 





9.1 The ERCC1 gene and its protein 
9.1.1 The mouse ERCC1 5'-flanking region 
The human ER CC] gene was the first gene cloned in the mammalian 
nucleotide excision repair (NER) pathway, and subsequently the corresponding 
mouse ER CC] gene was isolated using a human ER CC] cDNA probe (van Duin et 
al., 1986, 1988). Previous reports did not analyse the promoter region of ERCCJ in 
great detail, and this thesis tried to provide more information about the mouse 
ERCC] 5 '-flanking region. We demonstrated that two stretches of CA and CT 
repeats are located in the mouse ERCC] 5 '-flanking region. Although we have not 
yet determined the function of these repeats, several lines of evidence have suggested 
that similar microsatellites are correlated with genome instability ( Thibodeau et al., 
1993; Paulson et al., 1996; Fleisher et al., 1999). Due to different repeat patterns in 
the 5'-flanking region in the ERCC1 gene from skin and ES cells, we suspect that 
there might be a process causing tissue-specific instability. Combining the analysis 
of putative GC, CAAT and TATA boxes and the findings of different transcripts and 
proteins in the wild-type mouse skin and liver, we conclude that the ERCCJ gene is 
expressed differently in different tissues. Furthermore, several liver- and brain-
specific transcription factor binding sites were found in the ERCC] 5'-flanking 
region, implicating that these might be responsible for specific phenotypes in the 
ERCCJ null liver and brain. Also, it is worth noting the possible relationship 
between the 3 '-flanking region of ERCCJ gene and the other overlapping gene, ASE-
](Whitehead et al., 1997). 
9.1.2 The relationship between ERCC1 and other DNA repair systems 
9.1.2.1 Introduction 
Nucleotide excision repair, which removes DNA lesions caused by u.v. light 
and bulky chemical adducts, is a dominant pathway in the repair of DNA damage 
(Sancar, 1996). However, recent studies have indicated that the NER components, 
especially ERCC 1 -XPF complex and their homologues in other species, are also 
involved in other DNA repair systems. In yeast, RADIO protein, the S. cerevisae 
ERCC 1 homologue, forms a stable and specific complex with RAD 1. In addition to 
the role as a structure-specific endonuclease making an incision 5' to the damaged 
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sites in the NER pathway, the RAD-RADIO complex also trims off the 3'-ended 
unpaired single strands in a specific mitotic recombination pathway called single-
stranded annealing (Fishman-Lobell and Haber, 1992; Davies et al., 1995). 
Mutations in the homologous gene of S.pombe, Swi 10 and Rad 16, also affect the 
frequency of mating type switching (a mitotic recombination event from a silent 
cassette into the expression site) and cause an increase in UV sensitivity. Consistent 
with these findings, mammalian ERCC 1 and ERCC4 (XPF), homologous to RAD 10 
and RAD1 respectively, also form a structure-specific endonuclease that incises a 
variety of DNA substrates, including bubbles, stem-loops, splayed arms and flaps, 
with the latter possibly responsible for recombination intermediates (de Laat et al., 
1999). Furthermore, hypersensitivity of rodent ERCCJ mutant cell lines to u.v. light 
is often accompanied by cross-sensitivity to DNA cross-linking agents, such as 
mitomycin C, suggesting that ERCCJ has a role in recombination repair (McWhir et 
al., 1993; Weeda et al., 1997). Recent in vitro studies have also demonstrated that 
the ERCC1 protein is involved in illegitimate recombination ( Sargent et al., 1997; 
Melton et al., 1998). 
Genetic and biochemical studies in fission yeast have indicated that removal of 
nonhomologous ends in the double-strand break repair pathway depends not only on 
the RAD1-RAD10 complex but also on mismatch repair (MMR) components, 
namely the MSH2 and MSH3 complex (Ivanov and Haber, 1995; Sugawara et al., 
1997). This suggests that the MSH2-MSH3 complex has a role in the recognition of 
branched DNA structures with a free 3' tail and subsequently acts to facilitate 
cleavage by RAD1-RAD1O. A recent report pointed out that RAD1 and MSH2 are 
required in the repair of large insertion/deletion homologies during meiosis, 
implicating that some components in NER and MMR might function in a single 
pathway (Kirkpatrick and Petes, 1997). An in vitro study in Drosophila also 
demonstrated that MEI9, a homologue of XPF, is required for MMR (Bhui-Kaur et 
al., 1998). Furthermore, two hybrid and coimmunoprecipitation studies found a 
physical interaction between MSH2 and RAD1 and RADIO (Bertrand et al., 1998). 
In S. pombe, the NER pathway (SwilO and Rad16 proteins) also has a role in 
correcting C.0 type mismatches (Fleck et al., 1999). 
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Most DNA lesions generated by reactive oxygen species are believed to be 
corrected by base excision repair (BER), but recent studies also suggested that NER 
plays a role in the repair of oxidative DNA damage. Cooper et al. have proposed a 
model for the repair of thymine glycol, which requires BER proteins and the XPG 
protein but without its nuclease activity (Cooper et al., 1997). A recent report also 
suggested that the XPG protein can activate BER proteins to remove oxidative DNA 
damage (Klungland et al., 1999). Cell free extracts from rodent NER mutant cell 
lines, including IJV20 (ERCC1) and UV41 (XPF), also exhibited inefficient repair of 
8-OH-G and thymine dimer lesions (Reardon et al., 1997). 
Although the relationship between ERCC1 and other repair systems in 
mammalian cells remains to be elucidated, these observations suggest that there 
might be a co-operation or competition amongst different repair pathways in the 
removal of some types of DNA damage. 
9.1.2.2 The mouse ERCC1 protein and other repair proteins 
Analysis with several software packages suggested to us that the C-terminal 
region of the ERCC 1 protein contains a helix-hairpin-helix (HhH) motif, which has 
been found in many DNA break processing enzymes, such as XPG and FEN-1, and 
has a function in non-sequence-specific DNA binding. Due to XPF lacking the HhH 
motif, these data suggest that ERCC1 might localise XPF toward the DNA lesions. 
An iterated PSI-BLAST non-redundant protein-sequence database search indicated 
that both ERCC 1 and XPF have similar structures to several archaebacterial RNA-
helicase superfamily 2 (SF2) proteins. This prediction seems to suggest that the 
ERCC 1 -XPF complex may have a function to unwind the distorted structure without 
the involvement of other NER helicases (XPB and XPD) in some situations, such as 
3' nonhomologous overhangs in recombination repair. 
As mentioned above, some components of MMR may act in the same pathway 
as the ERCC1-XPF complex, or their homologues in other species, to recognise or 
remove some types of DNA lesions. Although we have not yet learned why the level 
of MSH2 and PMS2 were elevated in the ERCCJ null livers, some studies have been 
proposed to investigate the relationship between the components of NER and MMR. 
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As mentioned previously, ERCC 1 and its homologues in other species may be 
involved in the recombination pathway, implicating that ERCC1 might have a role in 
V(D)J recombination. Interestingly, we found that the thymocytes of ERCCJ nulls 
showed changes to the flow cytometric profiles in markers (CD3, CD4 and 
CD4/CD8 double positive) relative to thymocyte maturation stages. Although it did 
not provide direct evidence of ERCC 1 involvement in this recombination pathway, it 
is worth continuing these studies to investigate the role of ERCC1 in V(D)J 
recombination. 
At this moment a lot of questions about ERCC1 functions remain to be 
answered. Since our institute possesses the ability to perform NMR or X-ray 
crystallography, the ERCC 1 fusion protein described in this thesis could be utilised 
in these methods to elucidate the ERCC 1 structure and further to give a reasonable 
explanation about ERCC 1 functions. 
9.2 Gene targeting 
9.2.1 Conventional gene targeting 
The ERCCJ gene was the first mammalian NER gene to be cloned and 
subsequently knocked out in mice. However, to date, in contrast to each of the other 
human NER genes, ERCCJ has not been found to be involved in any 
complementation group of the human NER syndromes or other human diseases. 
This implies that mutations in the human ERCCJ gene may be either very rare, lethal 
or induce an unexpected phenotype. Since there is no available human disease and 
previously reported ERCCJ-deficient mice might have residual ERCC1 activities, we 
were interested in comparing the phenotype from a fully inactivated ERCC1 gene 
with other established disruptions and, further, to study any additional changes in the 
novel ERCCJ-deficient mice. To facilitate gene targeting, a genomic map of the 
129/01a ERCCJ locus was generated. The genomic map of ERCCJ guided studies in 
which a contiguous set of ? DASH II clones spanning the 129/01a ERCCJ allele 
were isolated from the HM-1 genomic library. Mapping studies of the subsequent 
ERCCJ plasmid clones revealed that the plasmid pKpnl_9.3 contained all the 
sequence homology necessary for the construction of isogenic gene targeting vectors. 
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Seven ES clones were generated in which one allele of ERCC] was inactivated 
by the targeted introduction of a 5.2 kb HPRT minigene to replace a 4.85 kb BglH 
fragment containing the ERCCJ exon 3-5 region. Three clones with low levels of 
spontaneous 6-thioguanine resistance, which were suitable for the second gene 
targeting step, were tested for their ability to colonise the mouse germline. A 
chimera, designated KT#209, gave germline transmission and thus produced the 
novel ERCCJ-deficient mice. 
9.2.2 Conditional gene targeting 
The premature death of the original ERCCJ-deficient mice restricted the 
further observation of the ERCCI function in adult stages. In order to overcome this 
limitation, a conditional gene targeting strategy was adopted. We introduced two 
loxP sites into the ERCC] locus by means of a double replacement gene targeting 
strategy. The first gene targeting step chose the suitable ERCC1' ES clone (#209), 
mentioned above. In the second step gene targeting, we reconstructed the disrupted 
ER CC] allele and introduced two loxP sites flanking a smaller BamHI fragment 
containing the exon 3-5 region previously deleted in the first gene targeting step. 
An in vitro study has demonstrated that the exon 3-5 region between two loxP 
sites in the foxed ER CC] allele was deleted by transient expression of Cre 
recombinase. ES cells bearing the ERM +/flox  allele were used to produce chimeras 
and further to generate mice heterozygous for the foxed allele. To date we have 
produced a line of mice homozygous for the ER CC] foxed allele. Further studies 
will use these mice to study the Cre-mediated recombination in vivo. 
9.3 The specific phenotypes in the ERCC1-deficient mice 
9.3.1 Liver changes in the ERCCJ-deficient mice may be correlated with 
oxidative damage 
The KT#209 ERCCJ-deficient mice were also severely runted from birth and 
died before weaning by 3 weeks of age. The new ER CC] knockout line exhibited 
similar aberrant hepatocyte nuclei in the liver as previously reported for ER CCI 
nulls. We also found focal necrosis in the liver of some older mutants. In both 
original and KT#209 ERCCJ null liver FACS analysis indicated a high population of 
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4C and 8C nuclei at a much earlier age than the increased ploidy that is normally 
seen in older wild-type mice. It has been proposed that this process represents an 
irreversible aspect of hepatocellular differentiation and may provide a protective 
mechanism against endogenous lesions. Interestingly, we found remarkable lipid 
droplets (microvesicule steatosis) in both our ER CC] null hepatocytes with an oil red 
o staining. An electron-microscopic examination also indicated that a lot of 
abnormal mitochondria were evident in both ER CC] null hepatocytes. Several lines 
of evidences have suggested that impairment of mitochondrial functions can induce 
both necrosis and microvesicular steatosis (Goncalves et al., 1995; Cormier-Daire et 
al., 1997). Furthermore, recent studies indicate that inborn errors of mitochondrial 
oxidative phosphorylation will lead to fatal neonatal liver failure (Bioulac-Sage et al., 
1993; Saibara et al., 1994). Our findings suggested that some metabolic disturbances 
in fatty acid oxidation and/or oxidative stress may give rise to acute hepatic failure in 
these animals. Furthermore, the level of c-fos, which is regulated by intracellular 
oxidation and reduction state, is also elevated in the ER CC] null liver extracts. 
Although there is no strong evidence to indicate that ERCC1 is involved in 
mitochondrial DNA repair at this moment, our findings may provide an insight into 
this ambiguous area. 
9.3.2 The developmental delay in the ERCC1 null cerebellum 
The control of motor behaviour such as motor learning, spatial orientation and 
spatial learning and memory in vertebrates depends on the cerebellum. Neurological 
abnormalities affecting behaviour or locomotion have been identified frequently in 
connection with gene mutations. However, determination of the molecular 
mechanisms of cerebellar development and function remains one of the great 
challenges to scientists. Recent advances in genome technologies have led to the 
identification of several genes that are important for cerebellar development and 
function. Furthermore, gene disruption in the mice provides an opportunity to 
develop models and to test the contribution of specific genes to neurobiological 
processes. Elevated p53 levels in our original ERCC]-deficient brains have been 
reported using immunohistochemical staining. This thesis has also demonstrated that 
the external granular layer (EGL) in the cerebellum of both our ER CC] knockout 
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lines persisted until postnatal day 16.5, whereas the EGL in the control littermates 
disappeared at P13. We suspect this developmental delay might be correlated with 
some mechanism, such as glia cell defects, cell cycle arrest or apoptosis, or 
conversely, an anti-apoptotic effect of ERCC 1. Future studies will investigate these 
possibilities. The KT#209 ERCCJ-deficient mice also showed a leg-clasping reflex 
when the mice were lifted by the tail; conversely, the original ER CC] nulls and the 
control littermates did not exhibit similar behaviours. Although we assume that the 
two ER CC] knockout lines from our laboratory have no significant difference, there 
might be some subtle changes, such as the cerebellar behaviour, between the two 
knockout lines. We also demonstrated cerebellar culture without addition of any 
growth factor. These cerebellar cells will be used to study electrophysiological 
changes and in vitro migration in the near future. 
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